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Abstract
v7.6e final (!!)
Noncoding RNAs have emerged as highly conserved regulators for gene expres-
sion. Their detection is a biomarker for the identification and understanding of
fundamental biological processes and diseases. They also play an important role
in drug development.
To facilitate the detection of noncoding RNAs we set up a label-free direct binding
assay. The assay is based on nanomechanical cantilever arrays for the detection of
surface stress induced by immobilized biomolecules and their interaction partners.
We used various means to significantly reduce the drift of the cantilever readout.
Major improvements were achieved by tight control of temperature and mass
transport which led to a faster system equilibration. Experimental protocols were
improved to provide user-friendly and less time-consuming measurements. Further
enhancements were achieved (i) by coating the entire cantilever array wafer with
gold rather than individual cantilever arrays; (ii) by a directly implemented data
analysis tool as real time feature of the measurement software. We succeeded
to detect biomarker targets with high specificity in the picomolar range and we
can easily distinguish perfect match from mismatches that hybridize with lower
affinity.
We have demonstrated the detection of the biomarkers coagulation factor VII
messengerRNA transcripts (F7) and microRNA-122 (miR-122) in proof of concept
experiments with spike-in target in totalRNA background and cell lysates as well
as the detection out of biologically relevant cell lysate samples with naturally
occurring targets. Furthermore we have demonstrated the detection of miR-122
in acetaminophen treated rats’ plasma and therefore prove the cantilever array
technology to be a useful tool for the label-free direct detection of noncoding
RNAs.
Biacore’s surface plasmon resonance (SPR) system, the gold standard for label-free
quantitative biomolecular interaction analysis, was used as reference parallel to the
cantilever array technology (CLA). We compared the two fundamentally different
systems, where the SPR measures the change in index of refraction in a boundary
layer on the sensor surface and the CLA measures surface stress, in order to
further support the interpretation of our results. The SPR can distinguish specific
binding mostly by kinetic analysis and less by amplitude changes whereas the
CLA offers to date less kinetic information but direct observation of amplitude
changes. Plus, the CLA’s dynamic range and sensitivity is higher.
Be still when you have nothing to say; when genuine passion moves
you, say what you’ve to say, and say it hot.
D. H. Lawrence
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Introduction
1.1 Detection of Biomolecules
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Figure 1.1: Biology in nanoscience: Most targets for pharma research are in
the nanometer range (size of antibody ≈ 10 nm regime). Nanoscience delivers
new opportunities for better understanding of those disease related compartments
and offers new tools to improve drug treatment. Especially in the context of
personalized healthcare we have to understand and be able to analyze low level
structures such as supramolecular assemblies (e. g. DNA-double-helix).
Nanoscience is a promising technology for drug development and clinical and
non-clinical research. To understand the biology on a nanoscale level (see Fig. 1.1)
with a wide range of research tools; for drug delivery of new medicines to address
specific tissue and cellular targets; in “lab-on-a-chip” applications to enhance
diagnosis and treatment selection; and in regenerative medicine with e. g. surface
coatings and enhanced tolerability of implants.
Most of today’s common detection applications in applied biology are based on an
1
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amplified and labeled sensing. Two prominent members of this category are the
Enzyme-Linked Immunosorbent Assay (ELISA) and the Real Time Quantitative
Polymerase Chain Reaction (RTq-PCR or qPCR). The ELISA method is an
Antibody (AB) based protein sandwich assay that triggers an enzyme linked
color or fluorescent response upon detection. Real Time Quantitative Polymerase
Chain Reaction (qPCR) is an amplification method for nucleic acids based on the
Polymerase Chain Reaction (PCR) with the possibility for a quantitative readout.
Where the ELISA is the gold standard for protein detection, qPCR is the state of
the art detection method for Deoxyribonucleic acid (DNA) and Ribonucleic acid
(RNA). To analyze biological samples for the presence of specific genes or proteins
array based techniques have become common. For DNA/RNA the Affymetrix
platform by Affymetrix Inc. is representative for such so called gene chips.
GTGCATCTGACTCCTGAGGAGAAG
CACGTAGACTGAGGACTCCTCTTC
GUGCAUCUGACUCCUGAGGAGAAG
V H L T P E E K
DNA
(transcription)
RNA
(translation)
protein
http://commons.wikimedia.org/wiki/User:Madprime
Figure 1.2: Gene expression: During gene expression DNA is transcribed into
RNA and RNA translated into protein.
The key to all biological phenomena, our unique properties of living beings,
the pathways and mechanism of all cellular processes is gene expression (Fig. 1.2).
DNA is transcribed to RNA and RNA translated to protein. Therefore the most
common RNA is the messenger RNA (mRNA) that contains the information for
translation. Noncoding RNAs (ncRNAs) are a class of nucleic acids which do not
code for protein such as mRNA. Members of this class of molecules are involved in
many cellular processes and include highly abundant and functionally important
RNAs, such as [1]:
- Transfer RNA (tRNA) that transfers the amino acid to the growing peptide
chain during translation.
- Ribosomal RNA (rRNA) which is a component of the ribosome, the ma-
chinery behind the translation.
- Small interfering RNAs (siRNAs) and micro RNAs (miRNAs) expecting to
have regulatory functions.
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Along with these RNAs are some other ncRNAs. Their complete function is not
fully understood yet. Besides tRNA and rRNA which are involved in protein
synthesis, the functions of other ncRNAs are expected to be regulatory functions
as said before.
The detection of such noncoding RNAs would be of high interest for monitoring
miRNA or siRNA levels as biomarkers or for therapeutic approaches [2].
One of the present state of the art detection methods for low abundance RNAs
is the branched DNA assay, or DNA ELISA. As in an ELISA assay, an immobi-
lized capture probe binds the target sequence. Afterwards the sandwich structure
is completed with a detection probe (annotated as label extender). This label
extender then binds the branched DNA with label probe. The labeled branches
ensure a strong enough signal for detection [3]. The advantages of the DNA
ELISA is that no amplification is necessary and no reverse transcription such as
that in qPCR is needed. Measurements can be done directly on cell lysates. The
fact that time-consuming assay protocols are inherent for this ELISA type assay
is a disadvantage. Time consuming protocols are especially critical in diagnostic
tests for infectious diseases where a fast statement is very important. Furthermore
there is one major limitation for all labeled assays: To attach the label we need
a certain amount of nucleotides from the target strand which are not available
for recognition and to ensure specificity. A label free direct binding assay can
use the full strand length at a stretch for recognition, saves time-consuming wash
and labeling or amplification steps and is free of expensive primer and labeling
reagents.
State of the art methods are the Affymetrix platform and qPCR. Both techniques
can be used for a broad miRNA screening or specific target analysis. Prominent
qPCR assay is the TaqMan from ABI (Life Technologies) (Fig. 1.3). By reverse
transcription complementary DNA (cDNA) is constructed, amplified and detected
by the TaqMan label. Primers are normally ∼20 Nucleotide (nt) long. 10 nt would
be sufficient for amplification but the shorter the sequence gets, the less specific
the system is and errors might occur. Direct measurements such as the Cantilever
Array (CLA) and other direct binding assays are preferred compared to amplified
systems. Avoiding RNA isolation and amplification steps spares time and reduces
errors. Especially very low concentrated samples such as miRNA detection in
fluids would benefit from a highly sensitive and direct detection. Pre-amplification
often induces errors due to lack in primer specificity or unequal amplification
(PCR bias) of target and control [4, 5]. Especially in quantitative readouts the
amplification under the mentioned aspect might be an additional source of error.
Therefore a direct measurement is always preferred to a labeled and amplified
one.
Major disadvantages of unlabeled direct binding assays is the lack of certainty
in what the measured signal induced (did we really measure the target molecule
or did we record a signal due to unspecific binding?) and the need for relatively
3
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high “receptor occupancies” for signal response. The specificity problem can be
overcome by feasible references. Where in most labeled assays the detected signal
is amplified during readout (enzyme linked, Photomultiplier (PMT) in fluorescent
readout, . . . ), the sensor response in unlabeled assays is dependent on sufficient
binding efficiencies.
t  Ambion ®  Pre-miR ™  Precursors and Anti-miR ™  Inhibitors
t  TaqMan ®  MicroRNA Assays 
t  Custom TaqMan ®  Small RNA Assays (Early Access)
Q F
Reverse Transcription
Real-Time PCR
Stem-loop RT primer
Target Sequence
Forward Primer
TaqMan ®  Probe
Reverse Primer
Figure 1.3: ABI (Life Technologies) TaqMan MicroRNA Assay: Small RNAs are
isolated from the sample and reverse transcribed to make a cDNA library of the
small RNA population. A target-specific stem-loop reverse transcription primer
addresses the challenge of the short length of mature miRNA. The primer extends
the 3’ end of the target to produce a template that can be used in standard
RTq-PCR or qPCR by amplifying the cDNA [Applied Biosystems, Publication
127BR03-01, 2010].
In case of short oligonucleotides such as siRNA and miRNA no commonly
accepted assay exists. Even extremely elaborate sequencing technologies do not
find favor. A technology to fill the gap is of high interest.
From the primary invention of the Atomic Force Microscope (AFM) in 1986 a
great variety of new tools and a wide range of different applications evolved.
One of these devices is the CLA Sensor. Nanomechanical sensing systems based
on cantilever arrays are a basic research tool for exploring label-free assays and
can be used for a wide range of sensing applications. Investigators have shown
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several static mode applications for the detection of biological binding partners
such as DNA hybridization [6–8] and receptor-ligand binding [9–12].
Our focus lies on the label-free detection of noncoding RNAs for medium through-
put assays where half automated processes and less time consuming protocols
play an important role. Therefore our first intention was to set up a stable and
reliable device for this application in the field of genomics.
For comparative measurement we refer to a publication that showed the label-
free detection of biomarker transcripts in human RNA with a nanomechanical
cantilever setup [13].
As proof of concept for a newly designed setup our goal was to detect a single
stranded 21mer oligonucleotide at 100 pM in a physiological buffer solution.
For the detection of successful hybridization experiments we measured the trans-
duced surface stress which accumulated depending on the amount of specifically
bound single strand DNA (ssDNA) biomolecules. We operated our device in static
mode and measured in liquid. The induced bending of the cantilever (which lies
in the nanometer range) is measured by reflecting a laser beam on the top of
the cantilever and pointing it towards a Position Sensitive Detector (PSD) as
described in Ref. [14, 15] and Fig. 1.4.Cantilever Readout
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Figure 1.4: Schematic of deflection readout: (a) Time multiplexed sequential
illumination of all 8 cantilevers. (b) Cantilever bending measured by detecti g a
reflected laser beam on a PSD. (c) Shift of detected laser beam on PSD due to
cantilever deflection induced by a surface stress.
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1.2 Surface Plasmon Resonance Technology
Today’s state of the art label-free detection method for biomolecular interaction
analysis in drug discovery is the Surface Plasmon Resonance (SPR) technology [16].
SPR has been used to study a variety of biological processes [17], including
DNA hybridization [17–20], protein protein [21–24] and protein small molecule
interactions [25, 26].
Surface plasmon resonance is the phenomenon where light stimulates the reso-
nant oscillation of valence electrons in a metal layer. The induced electromagnetic
waves propagate parallel to the interface metal/dielectric. Slight changes in the
boundary layer between metal and dielectric, which is normally air or an aqueous
solution, influence the SPR oscillations.
The most common principle to excite surface plasmons in a resonant manner is
the so called “Kretschmann” configuration (Fig. 1.5).
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Figure 1.5: SPR setup in Kretschmann configuration: An additional mass load
on the sensor surface leads to a change in index of refraction and to a shift in the
angle at which the surface plasmon is brought into resonance.
SPR measures the shift of refractive index as average over an approx. 200 nm
thick layer above the sensor surface. The origin of this shift is the polarisability of
the biomolecules on top of the sensor surface. The polarisability of a biopolymer
(protein, DNA or RNA) is based on the amount of polarizable groups in the
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biomolecule — mainly the highly polarizable negatively charged moieties of the
molecule. Therefore the SPR signal’s origin is basically in a good approximation
proportional to the ad-layer’s mass. SPR shows a linear sensor response in terms
of mass (pg/mm2) even for a very small occupancy of the capture probes on the
sensor surface. This is one of the SPR technology’s basic advantages.
Biacore’s SPR technology is capable of detecting ad-layers of target molecules
of a few pg/mm2.
The signal response is stated in “Resonance Index Units” (RIU) or in short
“Resonance” or “Response Units” (RU). 1’000 RU correspond to a shift of 0.1◦
in the resonance angle or change in refractive index of 10−3. 1’000 RU equates
to a change of ∼1 ng/mm2 in surface protein concentration [GE Healthcare Life
Science, Real-Time Biomolecule Interaction Analysis, Biacore].
Due to the fact that the Biacore assay is in terms of chemical design (direct
binding assay based on ssDNA on an Au surface) identical to a possible CLA assay,
we used the SPR technology as a reference system. Biacore’s unique properties as
well as its importance in the label-free detection community will help to validate
the novel CLA technology. The main benefit of the comparison of SPR and CLA
are the different transducer properties (basically mass detection in SPR and stress
detection in CLA), whereby both assays are carried out on similar gold surfaces.
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1.3 Cantilever array technology1
A cantilever array chip is made by microfabrication out of silicon and consists
of eight cantilevers with a thickness of typically 300 nm to 1µm. The eight can-
tilevers can be differently functionalized and give an opportunity for reference
measurements for differential read out.
The cantilever can be used in several kinds of modes as transducer for a
sensing application. The two main operational modes are “static mode” and
“dynamic mode”. In dynamic mode the cantilever can be used as microbalance,
for thermogravimetry or as biochemical sensor measuring liquid properties by
tracking the damping. In static mode the change in surface stress is measured.
Diffusion into polymers and bimolecular recognition are two subcategories of the
static mode. Further categories can be set up such as “heat mode” (deflection due
to temperature changes) by catalytic reactions or in calorimetry; “voltage control”
to measure changes in potential on the cantilever surface. Different modes can be
run in parallel in a so called “combined mode”.
dynamic mode The principle of the dynamic mode sensors is based on oscil-
lating the cantilever, where additional mass loading onto the cantilever interface
results in a change of its resonance frequency. By tracking the resonance frequency
(amplitude and phase-shift) either a real mass load on the cantilever surface
or changes in the near cantilever environment influencing the damping of the
cantilever can be measured.
The actual measured physical changes leading to a signal are similar as in other
mass detection systems such as SPR or Quartz Crystal Microbalance (QCM). It
is a mass load on the sensor surface.
static mode In static mode the cantilever deflection due to surface stress is
measured. The technique is up to a certain point mass independent and therefore
an interesting alternative to other mass detecting transducers. In static mode the
measured quantity is the displacement ∆x as shown in Fig. 1.6 of the initial state
and bent state of the cantilever.
The correlation between surface stress σ and cantilever deflection is given by
1Partially published in Peter Noy et al.,“Instrument for Label-Free Detection of Noncoding
RNAs”, Journal of Sensors, vol. 2012, 2012.[27]
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Figure 1.6: Static mode deflection readout. L: cantilever length; R: radius of
curvature; θ: angle of deflection; ∆x: deflection; S: distance between the PSD
and the cantilever; ∆d: shift on PSD
Stoney’s formula [28] (Eq. 1.1):
σ =
Eh2
6R(1− ν) (1.1)
E and ν are elastic modulus and Poisson’s ratio of the cantilever material. h is the
thickness and R the bending radius of the cantilever. The deflection amplitude
depends on the spring constant k (Eq. 1.2):
k =
3EI
L3
(1.2)
The “softer” (lower spring constant) the cantilever the larger the amount of
deflection. I = bh3/12 is the moment of inertia for a cantilever with the width b.
L is the cantilever’s length.
The position, respectively shift of the light spot on the PSD ∆d is given by Eq. 1.3:
∆d =
Ia − Ib
Ia + Ib
× lPSD
2
(1.3)
Assuming the angle of deflection θ is very small, the bending angle is half the
deviation of the deflected beam and the angle of deflection can be calculated as
Eq. 1.4:
2θ =
∆d
S
(1.4)
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where S is the distance between the PSD and the cantilever. Furthermore the
relation between angle of deflection, deflection ∆x and cantilever length L is given
by Eq. 1.5 [29]:
θ =
2∆x
L
(1.5)
By substituting θ in Eq. 1.4 from Eq. 1.5 we receive:
∆x =
∆dL
4S
(1.6)
The radius of curvature R of the cantilever with applied surface stress is expressed
as circular curvature in Eq. 1.7:
R =
L
θ
=
2SL
∆d
=
L2
2∆x
(1.7)
Hence the surface stress from Eq. 1.1 can be calculated.
A PSD is a resistive photo element with an isotropic sensor surface. This
leads to a continuous position data. Light causes a local change in the resistance
on the sensor surface. The position can be calculated by measuring the current
through the device by the following equation 1.8:
x =
Ia − Ib
Ia + Ib
× l
2
(1.8)
, which we already used for the calculation of the cantilever deflection. x is the
position of the light spot on the psd; Ia − Ib the PSD’s differential signal; Ia + Ib
the PSD’s sum signal; l the PSD length
Surface stress is induced by the interaction between immobilized biomolecules
on the ssDNA bio-functionalized side of the cantilever bar and their interaction
partners in an injected solution. Various forces such as intermolecular interactions,
electrostatic forces and changes in the electronic density of the cantilever surface
lead to the resulting surface stress [30].
By subtracting the deflection signal of a non-specific reference cantilever from
the main signal as shown in the schematic drawing of the cantilever assay Fig. 1.7,
parasitic effects such as drift due to small temperature changes and non-specific
binding can be eliminated [30, 31].
Since measurable amount of signal drift is present in all known label-free
detection methods we focused on its reduction by stabilizing the major external
factors which affect drift in our nanomechanical setup. This was achieved by
implementing a fast local temperature regulation system and measurement in con-
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sample 
(antisense match or 
mismatch strands) 
probe cantilever 
(sense match strand) 
reference cantilever 
(control strand) 
Δx 
Figure 1.7: Schematic drawing of CL deflection due to DNA hybridization: We
always measure differential signals. Differential deflection results are state as
difference between the absolute bending of the probe cantilever minus the absolute
bending of a reference cantilever. Dimensions of a cantilever are: 500µm length,
100µm width, 0.5µm thickness. The drawing only shows a schematic principle.
The size proportions of biolayer and cantilever thickness are not correct and the
monolayer will never be that perfectly arranged.
tinuous liquid flow. Our goal was to optimize the system towards semiautomatic
device handling, which is essential for industrial applications.
To assist the interpretation of the recorded data we developed a real time analysis
software which applies simple operations and plots the results concurrently with
the measurement.
We considered buying a commercially available device from the University of
Basel. We decided instead to construct our own setup to provide the maximum
flexibility to design the device for our specifications of the mentioned application.
This also enabled a direct implementation of several improvements such as a new
laser source, camera observation module and thermo-controller.
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1.4 Assay Development
As implied in Fig. 1.7, we performed a simple oligo hybridization of an antisense
strand in solution to a sense strand immobilized on a gold surface (Fig. 1.8). All 21
nucleotides are needed to be hybridized to ensure a specific detection of the target
strand. There are not enough nucleotides in the antisense strand available for
hybridization of a label. This is why the assay needs to be carried out label-free.
The quantification of the antisense strand in cell and tissue lysates should tech-
nically be possible. The capture strand is easy to modify with a thiolated alkyl
chain for immobilization on gold. This is a common technique also used for
Biacore chips and other assays. Compared to the standard ligand binding assays
on Biacore we do not have a dextran layer for surface stabilization and molecule
fixation. The whole monolayer formation will be the first critical part for our assay.
The higher ordered the monolayer is, the more accurate results are expected.
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Figure 1.8: Schematic of the direct binding assay: Immobilized ssDNA strands
bound by thiol chemistry on gold react with their complementary single strand
oligo (DNA or RNA) in solution. In terms of terminology the bound thiolated
strand is the “sense” or capture strand, which correlates to the passenger strand
and the target in solution is the “antisense” strand, which is the guide strand.
Surface preparation in the assay development is critical for a successful detec-
tion of target hybridization. Probe density on the sensor surface affects the target
hybridization efficiency. This was shown by several groups for SPR assays [32–34]
as well as for cantilever based detection methods [6]. For both platforms there is an
optimal probe density to achieve maximal hybridization efficiency and maximum
response. Whereas, according to the mentioned literature, the cantilever platform
requires a dense surface coverage for optimal signal response, the SPR platform
does not seem to require this same coverage. The hypothesis from Ref. [6] for
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the cantilever platform is explained by the required steric crowding to induce
the contribution to one of the dominant effects leading to the nanomechanical
signal. For the SPR platform steric hindrance is contra-productive and therefore
a reduced surface coverage leads to a higher hybridization efficacy and higher
signal amplitudes.
Due to this known fact we optimized the assay for all SPR measurements with a
reduced immobilization density as shown in Fig. 1.9.
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Figure 1.9: Schematic of the direct binding assay with reduced immobilization
density: A certain percentage of immobilized ssDNA on the gold surface is
displaced by shorter unspecific alkyl chains.
1.4.1 Assay Properties
In a direct binding assay, the sample is injected over the sensor surface and the
analyte interacts with the immobilized biomolecule [35], which in our case is
a ssDNA. The sensitivity in a direct binding assay depends on the interaction
properties (ka and kd) of the reagents and on the injection time of the sample.
The hybridization isotherms are quite complex and cannot be fit with simple
kinetic models [32]. There is a strong dependence on probe density for both the
efficiency of duplex formation and kinetics of target capture [32]. Hybridization
of free target DNA strands (T) with capture probe strands (P) coupled to the
sensor surface can be modeled by simple irreversible second order process [36]:
T + P
k−→ P ∗ T (1.9)
P is the concentration of free (unbound) DNA probe on the surface, T is the
concentration of free DNA target strand in solution and P ∗T is the concentration
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of probe-target complexes that form on the surface [36].
One of the few fitted adsorption coefficients for a direct binding assay based on
surface plasmon resonance imaging measurements was achieved by Nelson et al.
[17]. They reported an adsorption coefficient Kads of 1.8×107 M−1.
1.4.2 CLA rear-side passivation
The cantilever’s rear side is a potential source for drift and counter forces leading
to a superposition of interactions on the CL which are difficult to interpret.
To avoid unspecific effects on the rear side of the cantilever the silicon surface had
to be passivated. We commissioned SuSoS (see Sect. 1.6) to modify the surfaces of
the CLA presenting two different materials: gold and silicon. The gold serves as
basis for the sensing device, while the silicon should be rendered resistant against
non-specific adsorption in order not to interfere with the measurement occurring
on the Au-side. The company SuSoS has experience in modifying surfaces of
various materials in order to reduce non-specific binding of biological molecules
to the modified surfaces. The principle demonstrated in the Lit. Franks et al.
(Ref. [37]) and modeled in Fig. 1.10.
S
NH3
+
S
NH3
+
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NH3
+
Si
Au native SiO2
-   -   -   -   -   -   -   -  
+ + ++
thiol-SAM
poly cationic
PLL-g-PEG
Figure 1.10: Selective treatment of Au/Si surfaces for functionalization according
to Lit. [37]: Au is protected respectively functionalized by a thiol SAM. Si
respectively native SiO2 is functionalized by cationic binding forces.
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Process step Au-side Si-side
Plasma or similar Remove adventitious
contaminations
Remove adventitious
contaminations
Thiol-SAM Assemble protective ad-
layer
No effect
Non-fouling ad-layer
(dipping and UV-curing)
Weak adsorption Render surface resistant
against non-specific pro-
tein uptake
Oxidation and rinsing Removes thiol-SAM and
assembled non-fouling
ad-layer
No effect
Table 1.1: General idea to bi-functionalize a Au/Si bulk material according to
SuSoS.
A general idea how to perform a bi-functionalization is given in Tab. 1.1.
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1.5 Biology
In 1998 a new molecular mechanism called the RNA interference (RNAi) was
discovered. Soon RNAi was used to study biological- and disease-related pathways;
for target identification and target validation; as gold standard for efficiency of
small molecules and biotherapeutics. Because of this the market size for reagents
based on RNAi increased to more than 100 M $.
In 2006 Andrew Fire and Craig Mello received the Nobel Prize in Medicine “for
their discovery of RNA interference — gene silencing by double-stranded RNA”
[“The Nobel Prize in Physiology or Medicine 2006”. Nobelprize.org. 11 Nov 2011
http://www.nobelprize.org/nobel prizes/medicine/laureates/2006/].
Gene silencing by antisense-technique was not at all a new field. Regulating the
protein synthesis by inducing a synthetic complementary RNA strand that forms
a double strand with its target and therefore blocks the RNA translation was
used before. In trials with nematodes (caenorhabditis elegans) Fire and Mello
showed that gene silencing is much more efficient by applying double strand RNA
(dsRNA) instead of just the antisense RNA. Today we know this is based on the
RNAi mechanism [38].
Before the discovery of the RNAi, most known ncRNAs fulfilled relatively generic
functions in cells, such as the rRNAs and tRNAs involved in mRNA translation,
small nuclear RNAs (snRNAs) involved in splicing and small nucleolar RNAs
(snoRNAs) involved in the modification of rRNAs [39].
A ncRNA is a functional RNA molecule that is not translated into a protein [1].
They are involved in many cellular processes (Fig. 1.11). Most of them are highly
abundant and functionally important. The many classes of small RNAs are differ-
entiated by their various aspects of origin, structure, associated effector protein
and biological roles [2]. siRNA and miRNA are in phylogenetic and physiological
terms the most important ones [2]. They are only known to be present in eukary-
otic cells, although parts of their mechanism can also be found in prokaryotic
species [2]. siRNA and miRNA are also the most interesting types of ncRNAs for
pharmaceutical industry because of their mentioned roles as described in Chap. 1.1.
siRNA
siRNAs are small 21 to 22 nt long RNAs. They are produced by the cleavage
of complementary dsRNA coming from the nucleus by an enzyme called Dicer
(Fig. 1.12).
In comparison, the smallest mRNA has a size of min. 300 nucleotides which would
lead to a protein of 100 amino acids. E.coli, one of the smallest organisms’ proteins
have 900–1’500 nucleotides in average.
The RNA fragments produced by Dicer can then form with Argonaute proteins
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Figure 1.11: Core features of miRNA and siRNA silencing [2]: (A) Common
aspects of all miRNA and siRNA pathways. dsRNA precursors are processed by a
Dicer protein into short fragments. One strand of the processed duplex is loaded
into an Argonaute protein, enabling target RNA recognition through Watson-Crick
base pairing. Once the target is recognized, its expression is modulated by one of
several distinct mechanisms, depending on the biological context.
(B) Dicer proteins cleave dsRNA precursors into characteristic lengths through
the action of two RNase III domains.
(C) Argonaute proteins are RNA silencing effectors that are guided to their targets
by short single-stranded nucleic acids. The canonical arrangement of Ago domains
is given at the top. Below is a crystal structure of the Thermus thermophilus
Ago protein, with a bound DNA guide strand base paired to an RNA target. The
5’ end of the guide strand associates with a binding pocket in the Mid domain,
and the 3’ end binds the PAZ domain. The target cleavage site is juxtaposed
with active-site residues in the PIWI domain, though in this case cleavage is
suppressed by mismatches between the guide and the target. (Structure reprinted
from Macmillan Publishers Ltd.: Wang et al., Nature, 456, 2008.).
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Figure 1.12: A diversity of siRNA sources [2]: Several different categories of
transcripts can adopt dsRNA structures that can be processed by Dicer into
siRNAs. These duplexes can be intra- or intermolecular, and although most are
perfectly base paired, some (e. g., hairpin RNAs and gene/pseudogene duplexes)
are not. A siRNA consists of a guide strand (red), which assembles into functional
siRISC, and a passenger strand (blue), which is ejected and degraded. All forms
of siRISC contain the siRNA bound to an Ago protein, and many if not most
forms of siRISC contain additional factors. Target RNAs are then recognized by
base pairing, and silencing ensues through one of several mechanisms. In many
species, the siRNA populations that engage a target can be amplified by the
action of RNA-dependent RNA polymerase (RdRP) enzymes, strengthening and
perpetuating the silencing response.
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a complex called RNA-Induced Silencing Complex (RISC). The fragments can
then bind in a specific way to mRNA, cleaves the mRNA strand what leads to
the degradation of the mRNA. This naturally occurring mechanism called RNA
interference (Fig. 1.13) can be used for gene regulation, transposon control and
defense against viruses [1].
Natural 
Process of 
RNAi 
cleaved mRNA 
Selective Gene  
Silencing  
mRNA 
degradation 
dicer dicer 
dsRNA 
siRNAs 
cleavage 
RISC 
strand separation 
cleavage 
complementary pairing 
mRNA 
(A) n 
Synthetic 
siRNAs 
Figure 1.13: Mechanism of the RNAi [Figure by courtesy of U. Certa,
F. Hoffmann-La Roche Ltd.]: An enzyme called dicer cleaves dsRNA into short
fragments. Those fragments can bind with the RNA induced silencing complex in
a specific way to messenger RNA, cleaves the complementary strand and leads to
the degradation of mRNA. The naturally occurring process can also be achieved
by synthetic siRNAs.
The same process works by an exogenous application of siRNA. For the phar-
maceutical industry this would be a whole new drug class (see Sect. 5.1). Growth
factors of tumors could be down regulated and due to a disease suppressed essential
proteins promoted. Or as said above, siRNA could even be used as defense against
all kind of virus infections.
The actual challenge is the delivery of the synthetically produced siRNA into the
cell. Several strategies have been approached as shown in Fig. 1.14 with varying
success.
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F7 The RNAi effect as a new class of therapeutics that specifically suppresses
gene-expression induced by small RNA, was attracting the attention of many
researchers shortly after its discovery. In a short time, the field of applied RNAi
therapeutics spread from the laboratory to the bedside. Many challenges and
some concerns do still exist although some Phase I and Phase II studies were
underway at the start of this thesis. Besides the mentioned difficulties of how
to transport the siRNA target-orientated into the cell’s cytoplasm, the possible
triggering of off-target effects might occur.
Factor VII (F7) was already used as a model for hepatocellular application of
siRNA and has properties which are of interest for in vivo analysis such as:
- exclusively expressed in hepatocytes
- secreted protein
- short half-life
- dose dependent suppression of the corresponding mRNA and their proteins
(Ref. [41])
- continuing effect in rats and non-human primates (Ref. [41])
In studies at Roche for gene-expression analysis of off-target effects induced by
siRNA against F7 which has an anticoagulating effect it was discovered that
in vitro it had a reductive impact on the mRNA of chemokine (C-X-C motif)
ligand 5’ (CXCL5). A reporter assay (Luziferase) was developed to enable the
suppression of CXCL5, F7 or the reporter itself by the siRNA and to test the
dependency of the siRNA concentration.
[free translated from untitled, unpublished text of Frey Siegrist, Stefan Weis and
Ulrich Certa, unpublished 2010.]
miRNA
Micro RNAs are a class of single-stranded RNA molecules 19 to 24 nucleotides
in length and generated through a complex maturation process (Fig. 1.15) [1].
They are generally regarded as negative regulators of gene expression that inhibit
translation and/or promote mRNA degradation by base pairing to complementary
sequences within protein-coding mRNA transcripts [42].
Furthermore miRNAs represent a new class of biomarker. Biomarkers are mea-
surable parameters to determine the health status. For example recent studies
demonstrate an association of several miRNAs with various cardiac defects [42].
Known roles of miRNAs in heart development and function exist and it is expected
that more miRNAs will be added to this growing list [42].
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D. Castanotto et al., Nature 457, 426-433 (22 January 2009)
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Figure 1.14: In vivo delivery strategies for therapeutic siRNAs [40]: Delivery
strategies, respectively carriers or additives can be separated into different classes
such as (a) chemically stabilized conjugates; (b) nanoparticles; (c) lipid vesicles;
(d) poly-conjugates; (e) antibody conjugates; (f) aptamer based delivery. Stability
enhancer such as 2’-O-methyluridine or 2’-fluorouridine substitutions (blue circles)
are common siRNA modifications [40]. siRNA release can be triggered under
specific conditions such as e. g. pH by pH-labile bonds. Targeted delivery would
also be possible by systems such as (d), (e) and (f).
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Figure 1.15: Biogenesis of miRNAs and assembly into miRISC in Animals [2]:
Nuclear transcription leads to capped and polyadenylated pri-miRNAs. The pri-
miRNA is processed by Drosha with the aid of DGCR8 to generate a pre-miRNA
species. This is exported from the nucleus and processed by Dicer to form the
mature miRNA/miRNA duplex. After processing, miRNAs are assembled into
miRISC. Only one strand of the duplex is stably associated with an miRISC
complex — the miRNA strand is usually more strongly favored than the miRNA*
strand, although there are exceptions.
miR-122 miR-122 is a microRNA that is conserved between vertebrate species
[43]. miR-122 is specific for liver tissue and is an established target for Hepatitis
C (HCV) [44].
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Chapter 2
Materials, Methods and
Instrumentation
2.1 General remarks
Unless otherwise stated, the chemicals were analytical grade, used without any
further purification and purchased from Sigma-Aldrich (Buchs, Switzerland).
We used Milli-Q H2O for water if not otherwise stated. For RNA/DNA assays
RNase and DNase free water was used (Distilled Water Dnase/Rnase Free #10977,
GIBCO Invitrogen).
Prior to use we degased all running buffers by sonication under reduced pressure.
For all hybridizations we used Phosphate Buffered Saline with Calcium and
Magnesium (PBS (+)) stated as Phosphate Buffered Saline (PBS) if not explicit
specified.
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2.2 Assay Development
Chemicals:
- “ECT” Eicosanethiol, 0.5 mM in abs. Ethanol (for hydrophobicity), C20H42S,
MW 314.61, e. g. 3.14 mg in 20 mL of Ethanol (0.5 mM)
- “PEG” Thiolated Polyethyleneglycol, 1 mM in abs. Ethanol (for hydrophily),
CH3O-POE-NH-CO-(CH2)2-SH, MW 750, e. g. 150 mg in 20 mL of Ethanol
(10 mM), Rapp Polymere GmbH, Germany
2.2.1 Detergent cleaning
To recycle Biacore SPR chips and for cleaning Au/Si micro devices, a detergent
cleaning protocol developed by Gregor Dernick et al., F. Hoffmann-La Roche Ltd.
was used (Tab. 2.1).
1. Rinse substrate with 1× PBS.
2. Put the chips in the chip holder, fill it with 1× PBS, can be stored for a
few days until cleaning procedure.
3. Fill chip holder with Deconex 12PA (Borer Chemie AG, Switzerland).
4. Put chips and holder in ultrasonic bath at 50 ◦C, sonicate for 15 min.
5. Rinse with water.
6. Put in wash bath with nanopure water and nitrogen bubbles for 10 min.
7. Fill chip holder with Deconex 20Ns (Borer Chemie AG, Switzerland).
8. Put chips and holder in ultrasonic bath at 50 ◦C, sonicate for 15 min.
9. Rinse with water.
10. Put in wash bath with nanopure water and nitrogen bubbles for 30 min.
11. Dry chips with nitrogen-jet, store protected from dust.
Table 2.1: Cleaning of Si/Au based microdevices after an experiment and/or
prior to surface preparation.
2.2.2 Thermal denaturation in plate-shaker
To mix samples and to denature the DNA/RNA probes, we used a BioShake
iQ high speed micro thermo shaker for SBS microplates, tubes and vials
(BioShake iQ, QUANTIFOIL Instruments GmbH, Germany). For Eppendorf
DeepWellplates 500µL (Eppendorf AG, Switzerland) we mounted a customized
adapter (#0030504.119, QUANTIFOIL Instruments GmbH, Germany). For
0.5 mL and 1.5 mL tubes an adapter 24× 1.5 ml and 15× 0.5 ml for BioShaker
serial (QUANTIFOIL Instruments GmbH, Germany) was used. Validation is
shown in Appendix B.1.
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For improved DNA and RNA hybridization we denatured all probes prior to
injection at 80 ◦C for 5 min followed by incubation on ice for 5 min.
2.2.3 XPS2
XPS analysis was performed using a PhI5000 VersaProbe spectrometer (ULVAC-
PHI, INC.) equipped with an 180◦ spherical capacitor energy analyzer and a
multi-channel detection system with 16 channels.
Spectra were acquired at a base pressure of 1×10−7 Pa using a focused scanning
monochromatic Al-Ka source (1486.6 eV) with a spot size of 200µm and 50 W.
The instrument was run in the FAT analyzer mode. Pass energy used for survey
scans was 187.85 eV and 46.95 eV on detailed scans.
Data were analyzed using the program CasaXPS (Version 2.3.15 www.casaxps.com).
The signals were integrated following Shirley background subtraction. Sensitivity
factors were calculated using published ionization cross-sections, (Scofield, J. H.
J. Elec. Spec. Rel. Phen. 1976, 8, 129.) corrected for attenuation, transmission-
function of the instrument and source to analyzer angle.
The measured amounts are given as apparent normalized atomic concentration
and the accuracy under the chosen condition is approximately ±10 %.
All XPS measurements were performed at SuSoS by SuSoS technicians.
2Complete information received from SuSoS (SuSoS AG, Switzerland) as part of the purchase
order for surface analysis and modification.
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2.3 CLA Instrumentation
The cantilever deflection is measured by tracking a reflected laser spot on a PSD
(1L10-10-A SU15, SiTek Electro Optics, Sweden). For detailed specs, refer to
Appendix A.2. Due to the fact, that we are measuring in static mode we are
only interested in DC signals. Therefore a 5 Hz Low-Pass filter was directly
implemented in the PSD chassis. To run the PSD a ±15 V power supply with a
VB 1/2/15 transformer (BLOCK Transformatoren-Elektronik GmbH, Germany)
as core part was built. As laser source we chose pigtail lasers (LPS-635-CLEAVE-
SP, Thorlabs GmbH, Germany) equipped with laser diodes 635 nm wavelength
(HL6320G, Opnext Japan Inc., Japan), completed with SM600 fibers (Fibercore
Limited, UK), flat cleave. To avoid electrostatic damage during device handling,
we equipped all lasers with an Electrostatic Sensitive Device (ESD) protection
and strain relief with DB9 connector (SR9A-DB9, Thorlabs GmbH, Germany).
For testing purposes a benchtop LD current controller (LDC201CU, Thorlabs
GmbH, Germany) was used. We established the stripping and cleaving procedure
on bare SM600 single mode optical fibers with a fiber stripping tool T06S13
(Thorlabs GmbH, Germany) and fiber cleaver FkII (PK Technolgy, USA). For
all measurements we operated the lasers in constant power mode. The effective
optical output power was calibrated for each laser diode to 140µW at the CLA’s
position with an optical power meter (E UNO, Gentec-EO, USA). By arranging
the eight laser coupled fibers in a linear array we achieved readout of the eight
cantilevers through their sequential illumination. The quality of the fiber cleave
was visually checked by projecting the laser spot on a flat surface in wide distance
as shown in Appendix B.2.
Alternatively several other laser sources were considered. In the original setup
at the University of Basel and CRANN (Trinity College Dublin), Vertical Cavity
Surface Emitting Laser (VCSEL) were used. The providing company, Avalon
Photonics, Switzerland, did not exist anymore. Alternative companies such as
Bookham AG, Switzerland or Philips Technologies GmbH ULM Photonics, Ger-
many could not provide VCSEL arrays with the right specifications. Either
wavelength, pitch size or beam divergence were not compatible or ideal for our
setup. Instead of a sequentially illuminating eight lasers, an alternative of us-
ing one high-end laser could be used either mounted on a travelling stage (e. g.
M-122.2DD, PI GmbH & Co. KG, Germany) or connected to a fiber switch for
example by DiCon Fiberoptics Inc, USA.
The fiber dimensions were chosen to fit the cantilever array pitch size of 250µm.
This was achieved by a 1:2 optic (BFPL-12.7-25.0-C-633, BK7 singlet lens positive
bestform, d=12.7 mm, f=25.0 mm, surface figure: lambda/10 at 633 nm before
coating, antireflection coating 633 nm R<0.25 %, damage threshold: 10 J/cm2,
8 nsec pulse, 1 MW/cm2, CW at 1’064 nm typical, Melles Griot GmbH, Germany).
Outer fiber dimension is 125µm. A deflection mirror (02MFG001 with antireflec-
tive coating /023, Melles Griot GmbH, Germany) guides the laser towards the
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PSD.
Our setup is divided into three parts. The main part is a temperature-controlled
box containing the cantilever instrument and the fluidic system (Fig. 2.1 and
Fig. 2.2). To keep the temperature at the cantilever array stable, we installed
two controlled loops. (i) An external flow cycle thermostat (ministat 125, Peter
Huber Kaltemaschinenbau GmbH, Germany) to stabilize the temperature inside
the temperature-controlled box. (ii) The second temperature regulation module is
a Peltier element (TEC1-1703, NTS electronic and components GmbH, Germany)
mounted inside the measurement chamber at a distance of about 2 mm from
the cantilevers. The Peltier element was regulated by a Peltier controller which
is normally used for laser temperature stabilization (LDT-5525, ILX LIGHT-
WAVE, USA). For the ILX controller we chose a setpoint of 24.7 ◦C for best
corresponding to room temperature. The flow cycle thermostat was set to 25 ◦C
with −0.6 ◦C process temperature offset. For temperature feedback we installed
several temperature sensors. The flow cycle thermostat measures the temperature
with its external sensor (pt100 module) inside the post holding the flow chamber.
The Peltier controller measures the temperature for feedback directly inside the
flow chamber (SEMI833ET NTC thermocouple, HYGROSENS INSTRUMENTS
GmbH, Germany). This value corresponds to the recorded temperature named
“Tchamber”. Furthermore the temperature inside a dummy probe vessel (Tbox) and
room temperature (Troom) are recorded (NTC thermocouple).
We performed all measurements in liquid phase. Two syringe pumps
(neMESYS system, Cetoni GmbH, Germany) pull the system liquid and samples
through the measurement chamber. The system consists of one base module (V2
NEM-B100-01 A CET-000987-1045) and two neMESYS dosing modules equipped
with valves (14:1 gear NEM-B1010-02 B CET-001024-1045 to CET-001025-1045;
see Appendix A.2). We used for slow flow speeds such as the system flow of
10µL/min a 5 ml, 10.3 mm diameter Hamilton glass syringe (1005 TLL, 81520/01,
Hamilton Bonaduz AG, Switzerland) and for faster flow speeds such as injections
with >100µL/min a 10 ml, 14.57 mm diameter Hamilton glass syringe (1010 TLL,
81620/01, Hamilton Bonaduz AG, Switzerland) with a BD plastic piston (piston
from BD 10 ml syringe, REF 300912, BD, USA) to reduce stick-slip effects due to
high friction forces with the original piston. To compensate for the pressure loss
due to pulling we applied 80 mbar (nitrogen) overpressure on all sample vessels and
the system buffer reservoir. Halar tubing (4030XL Tub Halar 1/16x.030, Ercatech
AG, Switzerland) was used to reduce loss of probe molecules in the sample due to
adsorption onto the tubing surface. The flow chamber is completely sealed and
has a window (Mirogard Magic, 2 mm, SCHOTT AG, Supplier: Blaser Bauglas
AG, Switzerland) to pass the laser beam. To automatically switch between a
buffer reservoir and several probe vessels, we installed a VICI valve (C25 6180
EMHMA-CE, VICI AG International, Switzerland) in the flow path.
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Figure 2.1: CLA instrument photo: View inside temperature controlled box
containing the cantilever instrument. Laser ray-path visible due to slight haze.
(1, 2, 3) x, y, z positioning; (4) parallel alignment of fibers to cantilevers; (5)
longitudinal focusing on cantilevers; (6) optical fibers (laser sources); (7) lens; (8)
flow-chamber (holds cantilever array chip); (9) tubing to syringe pump; (10) mirror
with tilt function; (11) position sensitive detector (PSD); (12) PSD alignment; (13)
camera module; (14) ground plate connected to flow cycle thermostat; (15) thermal
insulated box; (16) inset of cantilever array image mounted in flow-chamber (8)
taken with the camera module (13); (i) and (ii) illustrate the two temperature
controlled zones.
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Figure 2.2: CLA instrument: CAD drawing for the construction of the instru-
ment with a transparent bottom to show the pipes for heat exchange from the
flow cycle thermostat.
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To align the lasers and view inside the flow chamber, we installed a camera
module (USB UI-1540SE, IDS Imaging Development Systems GmbH, Germany)
with optics (MLM-3XMP, Computar - CBC (Deutschland) GmbH, Germany). To
avoid oversaturation due to the strong laser light an additional short wavepass
filter (SPF-550-25.0M, Melles Griot GmbH, Germany) was mounted in front of
the camera lens.
For measurements the cantilever can be installed either under dry conditions
or in a pre-filled system where the chamber and tubing are filled with buffer.
In both cases we flush the system with CO2 prior to filling with buffer. CO2
dissolves 80 times better in water than nitrogen and leads to a gas bubble free
fluidic system.
In addition to the temperature controlled box the setup comprises a 19" rack
containing the laser controller and power supply for the PSD.
The setup is controlled by LabVIEW (NI PCI-6221 interface and LabView 8.0
software kit, National Instruments, Switzerland). A table with all connections is
shown in Appendix A.2, Tab. A.1. All measured values are recorded and processed
by LabVIEW software. The data analysis is based on algorithms which were
tested and previously applied for kinetic microarray signals [45].
We used cantilever arrays with eight cantilever sensors pre-coated with 2 nm
titanium 20 nm gold (IBM Research GmbH, Switzerland). External dimensions of
these sensors are as follows: 500µm length, 100µm width and 0.5µm thickness.
To regenerate and clean the gold surface of environmental organics for subsequent
ssDNA functionalization, the arrays were treated with UV ozone for 60 minutes
(NIQ 40/18, Heraeus, Germany, radiation flux at 185 nm: ∼4 W; ambient O2)
prior to use [46]. An oxygen plasma treatment to clean the gold surface is not
recommended due to the widely distributed electron energy leading to radiation
damages and a poor controllability [46].
All measurements were performed under continuous flow (10µL/min for equili-
bration before and after the injections and 100–150µL/min for the probe injection
and wash step) using the above mentioned syringe pumps. Cantilever arrays were
functionalized with thiol modified ssDNA (Microsynth, Switzerland) for 60 minutes
in 50 mM acetic acid - triethylamine solution buffer (Fluka #09748, Switzerland)
in a home-built capillary device. Capillaries (KG-33, ID=0.18 OD=0.25, King
Precision Glass Inc., USA) allow individual functionalization of the various sensors
(Fig. 2.3).
The DNA sequences chosen for the proof of concept (Sect. 3.2) were
AGAATAGGTATTTTTCCACAT for the biomarker target and AGAATAGGTATAATTCCACAT
for the mismatch sequence. The chosen sequences do not tend to form hair-
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+ + - - + + - - 
1  2  3  4  5  6  7  8 
CL1                   CL8 
 
scan direction 
flow direction 
+ capture probe 
- reference 
Figure 2.3: Schematic drawing of CLA showing the normally used pattern for
functionalization: An even distributed pattern was chosen to avoid local effects
during differential calculation. Two similar neighbors were chosen to minimize the
risk of crosstalk during functionalization. Scan direction for the readout is from
CL1 to CL8. Liquid flow in the chamber runs in direction CL8 to CL1 during
measurements. Numbering of CLs as shown in the picture.
pins and do not dimerize. For proof of concept (Sect. 3.2) the following thio-
lated ssDNA oligonucleotides were used to functionalize the cantilever interface.
(Sensor sequence: ATGTGGAAAAATACCTATTCT-C6 linker-SH, Reference sequence:
CTTACGCTGAGTACTTTGA-C6 linker-SH). We used PBS with calcium and magne-
sium (Invitrogen #14040091, Switzerland) as running and hybridization buffer.
Compared to Saline-Sodium Citrate (SSC) buffer we observe less salt crystal
formation leading to coverage of the glass window and blocking of the light path.
Furthermore the bivalent magnesium supports the hybridization.
For later experiments we used the corresponding sequences according to the target
of interest. All sequences were provided by Microsynth, Switzerland and do not
tend to form hairpins and do not dimerize. The full list of used oligonucleotides
and their specifications is shown in Tab. 2.2.
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2.4 SPR Technology
All SPR measurements were performed on a Biacore 2000 instrument (Biacore
Life Sciences, GE Healthcare). As sensor chip we used either recycled CM5 or SM
Biacore sensor chips or commercially bought Biacore Au sensor chips (BR-1005-
42, Biacore AB, Sweden). To recycle the CM5 and SA chips we cleaned them
according to protocol (see Sect. 2.2.1) with detergents and treated the chips prior
to the functionalization with UV/O3 for 10 min.
In most of the cases the SPR chip was functionalized outside the instrument.
If not otherwise stated the oligos were immobilized onto the surface by pipetting
50µL, 10µM thiolated ssDNA in 50 mM TEAA buffer. The solution was incu-
bated on the chip overnight (>10 h). The chip was washed by rinsing with TEAA
buffer for 30 s, respectively 3× aspirated and pipetted with buffer.
Afterwards the chip was incubated for 1 h with 50µL, 10µM 11-Mercapto-1-
undecanol (MCU) solution. The chip was washed by rinsing with H2O for 30 s
(3× aspirate and pipette), dried in an air-stream of N2 and stored under Argon
atmosphere at 4 ◦C.
Oligo solutions were prepared and stored in Biopur Safe-Lock reaction tubes
0.5 mL (Eppendorf #0030121.570). Samples were filled in either glass vials,
Ø9 mm, 1.8 mL, borosilicate vials (Biacore #BR-1002-07) or plastic vials, Ø7 mm,
0.8 mL rounded polypropylene microvials (Biacore #BR-1002-12) to mount into
the Biacore 2000. Vials were autoclaved in-house before use and closed with rubber
caps, type 3 penetrable cap made of kraton G (SEBS) (Biacore #BR-1005-02).
In case the Biacore instrument was used before without any cleaning procedure
in between, the system was cleaned by injecting 20µL, 0.1 M HCl followed by
injecting 20µL, 1.0 M ethanolamine-HCl pH 8.5 on a maintenance chip.
For exploratory conditions either 0.1× SSC or PBS (PBS with Calcium, Magne-
sium, Invitrogen #14040091) was used for hybridizations. For standard conditions
we used PBS (PBS with Calcium, Magnesium, Invitrogen #14040091). Sensor-
grams were recorded with 5µL/min flow through all channels if not otherwise
stated. Injections were made by automated injection with the program “Inject”
or “Kinject”. In case of the kinetic inject program “Kinject” a distortion time
had to be set.
Standard experiments with repeated conditions were later on run by written
methods in a fully automated mode.
Under standard conditions 50µL probe were injected with 5µL/min flow. Regen-
erations were achieved by injection of 2× 5µL urea (pulsed injection recommended
by the manufacturer in case of harsh conditions to protect the tubing and mi-
crofluidics).
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Thiolated oligo samples were shipped containing Dithiothreitol (DTT) for stabiliza-
tion. DTT acts as strong reducing agent and avoids disulfide bonds between the
several thiol groups. Before immobilization on gold the DTT hat to be removed.
We processed a sample (200µL) by extracting 3× with 1:1 diethyl ether, mixed
in an Eppendorf tube and shook well. The aqueous (lower) phase was collected,
aliquoted and evacuated for 20 min in an exsiccator. Afterwards the exsiccator
was flushed with argon and the tubes closed under argon atmosphere. We sealed
all tubes with Parafilm. The final concentration was checked by NanoDrop for
one aliquot each.
2.5.1 totRNA fragmentation
As background and as pool of unspecific RNA we used universal human reference
RNA (Stratagene #740000, Agilent Technologies, USA). To make the total RNA
(totRNA) more competitive we fragmented the sample to receive ∼90 nt long
RNA strands.
RNA samples were stored at −80 ◦C. We unfroze the samples and transferred
them according to the Stratagene protocol into 50µL H2O (Appendix A.1). A
1:10 diluted sample was analyzed by NanoDrop (NanoDrop 2000, Thermo Fisher
Scientific) resulting to 500,4 ng/µL. The stock solution (5µg/µL) was diluted 1:5
in H2O resulting in a 1µg/µL solution. 5 aliquots with the 1µg/µL fraction were
fragmented according to the “Bauer Core Standard Protocol” (Appendix A.1)
in an Eppendorf Thermomixer (Eppendorf AG, Switzerland) at 94 ◦C, 350 rpm.
Each one tube was processed for 10 min, 20 min, 35 min, 45 min and 60 min and
afterwards immediately cooled down on dry ice. After storing the probes for one
night at −80 ◦C the samples were checked on an agarose gel (3µL each). Before
a Bioanalyzer (Agilent Technologies, Switzerland) test, we had to precipitate
the RNA to get rid the fragmentation buffer. RNA was precipitated according
to the Solid (Applied Biosystems, Life Technologies, USA) protocol. Samples
were resolved in 20µL H2O and checked by NanoDrop. For the Bioanalyzer
run we diluted 2µL in an additional 2µL H2O. The run was performed on an
Agilent total RNA Analysis ng sensitivity (Eukaryote) assay (Agilent Technologies,
Switzerland).
2.5.2 Cell culturing
For the detection of ncRNA under realistic conditions (e. g. as toxicology screening
test), we aimed to detect ncRNA out of cell lysates. For this purpose we cultured
four different types of cell lines (see Tab. 2.3). Hep G2 and Hep 3B as model for
F7-1 (F7 mRNA transcript) and HuH 7 and ME 15 as model for miR-122. Hep G2
is negative for F7 and Hep 3B positive. From the literature Ref. [47] we know
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that ME 15 is negative for miR-122 and HuH 7 highly overexpressing the target.
1 mL cell stock was seeded in a small cell culture flask (BD Biosciences) with
10 ml corresponding medium according to Tab. 2.3 (Gibco, Life Technologies
Corporation). We checked the cells on a two daily basis if they are confluent. If
not, we changed the medium. In case the cells were confluent, the medium was
removed, the flask washed with 5 mL PBS, the PBS removed and 500µL Trypsin
(Gibco, Life Technologies Corporation) added. To dissociate the cells, they were
incubated for 5 min with the Trypsin. We added 5 mL medium, aspirated the
cells and transferred them in a medium flask. 20 mL medium were added to a
total of 25 mL. To split the cells from the medium flask to two large flasks, after
dissociation the cells with Trypsin, 10 mL medium were added and each 5 mL
transferred to a large flask. We added 25 mL medium in each flask to a total of
30 mL. For dissociation in the medium flask, 1 mL Trypsin was added, in a large
flask, 2 mL Trypsin were added. Cells were split from a large flask in a ratio of 1:3
to three new large flasks (4 mL cell solution in each flask plus 26 mL medium). To
harvest the cells from the large flask, the medium was removed, the flask washed
with 10 mL PBS, the PBS removed, 2 mL Trypsin added and incubated for 5 min.
Afterwards 10 mL medium were added and the cells aspirated. All fractions were
transferred in a 50 mL falcon tube (Falcon, BD Biosciences) and additional 25 mL
medium were added to inhibit the Trypsin. With 10µL solution we performed
a cell count. Two fractions of cell solution containing each 10× 106 cells were
transferred to two 15 mL falcon tubes (Falcon, BD Biosciences). The tubes were
centrifuged for 5 min at 400 rpm. We removed the buffer and resuspended the
pellet in 10 mL 1× lysis-buffer (8 mL H2O + 2 mL Lysis-buffer (Promega Passive
Lysis Buffer 5×, #E194A, Promega)) to a final concentration of 106 cells/mL.
Cell lysates were normalized on their total protein concentration. To get the
total protein concentration we did a Bradford assay. As calibration line we used
a BSA standard (Albumin Standard #23209, Thermo SCIENTIFIC). Bradford
Assay Reagent (BIO-RAD-PROTEIN ASSAY #500-0006, BIO-RAD) was diluted
1:5 with H2O. Cell lysate samples were diluted 1:1, 1:2, 1:5, 1:10, 1:20, measured
in doubles with 10µL probe. 10µL of each standard and probe (in doubles)
were transferred in a 96-well plate. 240µL assay reagent were added. Signal was
measured in a MTP-Reader (BioTek Synergy 4, BioTek Instruments) at 595 nm.
2.5.3 Peltier Test
To prove the consistency over several injections with the same cantilever we
performed repeated Peltier peak tests. We record prior to each experiment a
heat induced stress test — Peltier test. The temperature in the chamber (Peltier
element) was increased for 10 s at 30 ◦C. The resulting cantilever deflection peaks
were used for cantilever normalization to compensate for differences in mechanical
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properties or as control to check their functionality. By repeating this test before
each injection and at the end of the whole series we monitored the functionality of
the array plus consistency for several sample injections, respectively regeneration
steps.
Sample graphs are shown in Appendix B.4.3.
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Chapter 3
Results and Discussion
The following sections describe the experimental results towards the final goal,
the label-free detection of noncoding RNA.
3.1 Assay Development
The general section “Assay Development” describes the Research & Development
(R&D) of the assay which then later was used for the Biacore SPR and CLA
experiments. Specific assay validations are partial described in the separate result
sections for each corresponding topic.
Appendix B.1 shows the results from the plate-shaker validation.
3.1.1 Surface analysis and CLA rear-side passivation3
To avoid unspecific effects on the rear side of the cantilever the silicon surface had
to be passivated.
In a first attempt a protocol was established and the resulting surface characterized
in order to render the silicon surface resistant against unspecific adsorption and
to provide a clean and reactive gold surface. In a second step the protocol was
transferred to be applicable on the IBM cantilever arrays.
Two polymers were tested as non-fouling layer: (i) Polyethylene glycol (PEG)
and (ii) Polyvinylpyrrolidone (PVP). Problems with crystallization occurred with
the PEG polymer. Therefore PVP was favored. It was possible to coat the
cantilevers with SuSoS protocol, but a few parameters had to be optimized, such
as concentrations of coating solutions to obtain a desired thickness. Nevertheless
a first proof of concept could be obtained. In none of the cases the cantilevers
brake, but if the coating was too thick, a permanent bending in the dry state was
3Results achieved in collaboration with SuSoS (SuSoS AG, Switzerland) as part of the
purchase order for surface analysis and modification. Text partially free translated from untitled,
unpublished protocol and results of SuSoS, unpublished 2011.
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observed. An XPS spectra of a thick versus thin layer proofs the presence of the
coating in both cases with a higher amount of gold from the substrate detectable
for the thinner coating as expected. Thick layer means a denser ad-layer than the
thinner one. The shape of the C 1s signal is as expected for PVP. Wash steps had
to be adapted to the microdevices, because the common known protocols were
too harsh for the fragile structures.
XPS analysis of surfaces from commercially bought clean Au Biacore sensor
chips and the IBM cantilevers are similar and therefore comparable bases for the
two assays. Nevertheless some impurities were detected on the CLAs (Si, Au, O,
F, Ca) with very high chip to chip variabilities. Impurities from manufacturing
are less critical on the upper side, because the last step is the gold coating that
should cover all the remaining particles. For passivation the Si rear-side impuri-
ties can be critical. Impurities can impair a full adsorption of the non-fouling layer.
Further trials were performed with the addition of a thiol protection step (to
protect the Au side from uptake of the Silicon side adhesion promoter). These
trials were successful and resulted in training for the coating process. These
samples were then taken to Roche for experimental work, and returned to SuSoS
for analysis.
It was observed that after EtOH wash and drying in ambient air or desiccator,
the CLs are mostly fully bent (180◦) and do not relax reproducibly. Most of the
CLs relax after a certain time period up to hours. Worst is the situation if water
is used as last wet step. There all the CLA were bent and only few relaxed. A
positive effect was observed by drying the arrays in an air-stream. The actual
protocol for the selective functionalization of Si/Au cantilever is stated in Table 3.1.
The cantilevers of one fully passivated CLA chip were functionalized with
DNA. After washing in immobilization buffer (TEAA), the array was dried in an
air-stream (all according to the protocol). After drying all CL on the passivated
chip were broken somewhere in the middle region whereas a reference chip not
treated for passivation did survive the functionalization as usual.
An XPS survey spectra and detail spectra of C 1s, O 1s, Si 2p, N 1s, S 2p, Fe 2p,
Ca 2p, N 1s, F 1s and Au 4f were acquired on a wide set of cantilevers (sometimes
on multiple positions as specified) except ’as received’ Au side cantilevers where
only a survey was acquired. In addition, P 2p was measured on a set of SPR
chips. Table 3.2 shows a brief overview of the analyzed samples. Fig. 3.1 shows
the measured binding energy spectra for the mentioned samples. Full XPS results
can be found in the Appendix B.1.
The following results were achieved by the XPS analysis for the CLA chips
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1. Plasma (O2, 2 min)
2. Dip in EtOH
3. Dry in desiccator under vacuum
4. Dip in thiol (HS C11 NH2 HCl, 0.25 mg/mL in EtOH, 1 h)
5. Dip in EtOH
6. Dry in desiccator under vacuum
7. Dip in adhesion promoter, HVA (0.1 mg/mL in 3:2 EtOH/H1, 30 min)
8. Dip in 3:2 EtOH/H1, twice
9. Dip in ultra-pure water
10. Dip in EtOH
11. Dry in desiccator under vacuum
12. Dip in PVP (1 mg/mL in EtOH, 2 min)
13. Dry overnight in air
14. UV-C (2 min)
15. Rinse o/n in ultra-pure water
16. Fresh dip rinse in ultra-pure water
17. Dry in desiccator under vacuum
Table 3.1: Coating process for Au/Si microdevices according to SuSoS: Addi-
tional wash steps after (16.) with 50 % EtOH and 100 % EtOH can be implemented.
By drying the CLs in an air-stream (N2 puriss) a sticking of the cantilevers to
the CLA body (bent state for 180◦) can be avoided. Furthermore drying the
chip from a H2O rise is too slow and therefore leads to more sticking cantilevers
compared to a final EtOH rinse.
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No. Substrate Conditions
1 Si Side Array 10/5 Position 1 As received (plain)
2 Si Side Array 10/5 Position 2 As received (plain)
3 Si Side Array 9/5 Position 1 As received (plain)
4 Si Side Array 9/5 Position 2 As received (plain)
5 Si Side Array 9/5 Position 3 As received (plain)
6 Si Side Array 10/4 As received (plain)
7 Si Side Array 9/3 Position 1 As received (plain)
8 Si Side Array 10/3 As received (plain)
9 Si Side Array 9/4 Position 1 As received (plain)
10 Au Side Array 10/1 Position 1 Only thiol coating step
11 Au Side Array 10/4 Position 1 PVP
12 Si Side Array 10/4 Position 1 PVP
13 Si Side Array 11/3 PVP, UV/O3, oligo
14 Si Side Array 11/4 No PVP, UV/O3, oligo
15 Au Side Array 11/1 No PVP, UV/O3
16 Au Side Array 11/2 PVP, UV/O3
17 Au Side Array 11/3 PVP, UV/O3, oligo
18 Au Side Array 11/4 No PVP, UV/O3, oligo
19 SPR Chip 1 Au chip, UV/O3, oligo, MCU
20 SPR Chip 2 CM5 chip, UV/O3
21 SPR Chip 3 CM5 chip, UV/O3, oligo, MCU
22 SPR Chip 4 CM5 chip, UV/O3, oligo
23 CLA Au side 1µm chip, UV/O3, oligo
Table 3.2: Catalog of XPS analyzed substrates: Preparations according to 3.1.
PVP: PVP coated (incl. all necessary steps in advance); UV/O3: 10 min UV/O3
treatment at Roche; oligo: 1 h oligo functionalization for CLA and >10 h for SPR;
MCU: 1 h MCU post treatment.
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(a) (b)
(c) (d)
(e)
Figure 3.1: XPS results: (a) Tab. 3.2: #12, C 1s region of PVP coated Si
side of cantilever showing typical PVP peak shape (pink C-C, blue C=O, red
CON). (b) Overlay of Si 2p region for ’as received’ Si side cantilever (Tab. 3.2:
#8, upper) with PVP coated Si side (Tab. 3.2: #12, lower). (c) Overlay of C 1s
region for Tab. 3.2: #13 (red curve) and Tab. 3.2: #14 (green curve), Si side
treated cantilevers. (d) Overlay of C 1s region for Tab. 3.2: #15-18 (red to blue
curve), Au side treated cantilevers. (e) Overlay of C 1s region for SPR chips
#19-22 (red to blue curve) (Tab. 3.2, upper to lower) fitted peaks from right to
left: C-C, C=O, CON/COO.
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(Numbers refer to Tab. 3.2):
- Thiol coated Au side analysis by XPS does not show the presence of thiol
(no S) but perhaps the concentrations are below detection limit.
- PVP successfully coated onto cantilevers Si side (good PVP C 1s signal
and ratio, N, little or no substrate (Si) components). The reproducibility
between samples could be improved.
- PVP is also present on the Au side in very small amounts (but not so
convincing with the C 1s peak components).
- The Roche treated microdevices PVP coated ones have a different C 1s
signal. Perhaps the PVP is partially attacked by the UV/O3 treatment.
Some F is present (perhaps from the adhesion promoter underneath).
- #15 Au side has a lot more C than expected (not clean), this then probably
has an influence on the coating processes used. #15 also had P which is
unexpected.
- It would be expected that the Si side of #15 is also similarly C contaminated.
- #16 Au side has less and not the expected C components for PVP, which is
perhaps partially destroyed by the UV/O3 treatment. The C contamination
is slightly less than on #15, although this is difficult to say exactly.
- It would be useful to have the data for the Si side of #16, with expected
PVP.
- #13 Au side, it would be expected to have the oligo present, there is P
but no difference from some non oligo treated samples. It is difficult to
determine this compared to the PVP composition (both contain C-C, C-O,
C-N).
- #13 Si side contains PVP as expected (also some P, which is not expected).
- #18 Au side has a similar composition to #17, but with no P (which should
be present).
- #18 Si side still contains quite a lot of C, but not PVP (as expected).
The following results were achieved by the XPS analysis for the SPR chips
(Numbers refer to Tab. 3.2):
- It is expected that #20 is a clean Biacore chip. This chip still has around
25 normalized At.-% C, but less than the other chips. There also is some P
present, which is not expected.
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- Chip #22 has more C and more P (slightly), which is expected as the chip
has immobilized Oligo1.
- Chip #21 has a lot more C than #22 as expected, as the chip, as well as
immobilization of oligo also has the MCU spacer. The amount of P also
decreases as expected when compared with #22.
- Chip #19, the original Au chip is similar in composition to #21 as expected
(both have oligo and MCU spacer) but #19 has slightly more P.
- #23 was only measured one cantilever (position not known) so there is
difficulty concluding anything from this measurement. It seems there is
oligo immobilized (C-O and N) but slightly odd that no P was detected.
Besides the fragile structure and device handling difficulties due to its size,
the CLA assay has a further disadvantage compared to the SPR. Where in the
SPR setup only the sensor surface is exposed to the analyte, in the CLA setup
the whole cantilever is surrounded by liquid. This implicates that effects on the
cantilever rear-side can interfere with the ongoing measurement on the actual
sensor surface — the upper side.
For static mode experiments, already during functionalization of the CLA chip we
must apply a selective immobilization of capture probes on only one sensor surface
(usually the upper-side). Only one side might be functional to avoid canceling the
forces from opposite directions. This is achieved by gold coating the upper CL
side and a selective thiol chemistry to apply the capture probes.
Although silicon has a “neutral” appearance to biomolecules a certain affinity is
given. Especially with the recently gained knowledge about the origin of forces
leading to a cantilever deflection (see Sect. 1.3), we have to be cautions and effects
occurring on the CL rear-side cannot be neglected.
A passivation of the cantilever’s silicon rear-side might lead to a closer compa-
rability with the one-side SPR system and will impair parasitic effects on the
rear-side.
With a selective treatment of upper and rear-side we might be able to reduce the
remaining drift even more. A non-fouling ad-lyer (good omniphobe functionaliza-
tion) would be a good solution to passivate the Si rear-side. The question of gain
in sensitivity remains. With an assumption of a high drift value of 10 nm/min
drift and a low signal of 100 nm we might be able to reduce the drift for 50 %. In
terms of signal win, the gain would only be 5 %. As long as it is not proven that
the chemical-physical conditions do have a significant influence on the drift, it
is not necessary to passivate the cantilever’s rear-side. Furthermore we expect
the parasitic effects on the rear-side to be canceled by subtracting the reference
cantilever which does experience the same effects.
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The protocol by SuSoS recommends a UV-curing application of the non-fouling
polymer on top of the Si surface (UV-linker to attach the hydrophilic brush forming
polymer). Several advantages compared to other commonly known methods are
given:
(i) A functionalization by applying a poly lysine PLL-PEG layer would add
charge on top of the surface respectively neutralize the negatively charged
SiO2. The stability of this binding, respectively the charge during an exper-
iment with different buffer and salt concentrations might be questionable.
(ii) Polyelectrolytes do swell under certain pH conditions and differing ionic
strength.
(iii) A silanization would not be reproducible enough because the chemical
properties significantly change with humidity.
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3.2 CLA Instrumentation4
3.2.1 Proof of concept
With the described setup, we could detect a 100 pM antisense strand (F7) and
differentiate between a perfect match and mismatch sequence. Fig. 3.2 shows
the overlay of two consecutive experiments. Before each injection a stable base-
line was recorded to ensure that all cantilevers were equilibrated (phase (I)).
Due to the automated injection program the timing for the following injection
steps was the same for each experiment. This allowed the overlay of the two
sequential experiments shown in Fig. 3.2. The effect of switching the valve from
running buffer reservoir to the probe container and changing the flow speed from
10µL/min to 100µL/min is visible at the beginning of the sample injection in
phase (II). It takes about 3 minutes until the sample reaches the chamber with
the cantilevers. This explains why the slope did not change significantly until mid
phase (II). The heavy fluctuations can be explained by the change in refractive
index, flow effects and the exchange of molecules in the chamber before a new
equilibration is set. After 10 min the sample (1’000µL) is completely injected,
the valve switches back to running buffer and the flow speed is decreased to
10µL/min (transition to phase (III)). In phase (III) the chamber is still filled
with probe solution. A stable equilibrium is not reached during this incuba-
tion period. Several reactions leading to a cantilever deflection as described in
Ref. [30] tend to occur. To remove the remaining probe solution and wash the
chamber the buffer flow was increased (phase (IV)) to 100µL/min. We flushed
with 1’000µL buffer. Here we see again the delay before the probe solution in the
system was fully replaced by buffer (change in slope). The peak at the changing
point can be explained by the change in electrostatic conditions of the plain
buffer solution compared to the buffer solution with probes. Fast effects such
as valve switching and bulk buffer changes cannot be fully recorded due to the
comparatively slow data acquisition (0.25 Hz) and therefore sequential injection
traces are not completely identical. Finally the program switches back to the
standby conditions (10µL/min buffer flow) and the resulting deflection values
are monitored. Compared to the end point of the deflection in phase (III), the
start point of phase (V) is slightly higher (∼50 nm) although we have the same
flow speed in phase (III) and (V): 10µL/min. A small amount of deflection is lost
due to the dissolution of weakly bound strands (not fully hybridized) during the
washing step. The two injections shown (red curve and black curve) were recorded
sequentially. First the negative probe (mismatch configuration) was injected and
after a new equilibration the match injection was monitored. Finally the two
starting points of the baselines were shifted to zero and the graphs plotted in an
overlay. The resulting net deflection of ∼200 nm for the 100 pM matching probe
4Partially published in Peter Noy et al.,“Instrument for Label-Free Detection of Noncoding
RNAs”, Journal of Sensors, vol. 2012, 2012.[27]
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injection is repeatedly measured in our experiments. The resulting surface stress
of about 9 mN m−1 is relatively high compared to previous experiments such as
Ref. [13] (Young’s modulus (Si): 130 GPa, Poisson ratio: 0.28). Reasons therefore
could be due to longer cantilever functionalization times and due to different
buffer properties which affect steric hindrance and ionic repulsion of the molecules.
3.2.2 Drift Analysis
By means of temperature stabilization and continuous flow measurements drift
in the raw deflection signal was reduced from ∼12 nm/min to ∼2.5 nm/min as
shown in Fig. 3.3. The described setup and protocols represent a significant drift
reduction by a factor 5 compared to previous experiments with readout in station-
ary fluid before and after sample injection. The gain in accuracy is especially of
importance for the hybridization measurement with reaction times >1 min. The
typical drift shown in Fig. 3.3 was observed in all actual measurements.
In an experiment with a bare Au chip without any immobilized molecules
we could show that reactions on the CL surface do have a significant drift effect.
Although temperature and sum signal were absolutely stable we observed massive
drift >10 nm/min (constant flow of 10µL/min to avoid diffusion effects). An open
question is how much deflection results from effects on the Au surface and how
much from the silicon backside.
3.2.3 Electronics
In terms of electronic parts we used state of the art components. The amplifier has
a noise level of approximately 1µV, the PSD ∼3µV (Bandwidth (BW) = 100 Hz).
The analogue digital converter NI PCI-6221 with ∼122µV noise level is therefore
the main source of electric disturbance (values from datasheet stated in VRMS
to illustrate the critical components). Therefore we adjusted the full range scale
to the maximum signal voltage and took the average over several measurement
points (1’000 samples in 500 ms). This is possible due to the slow reaction time
(>1 Hz) compared with the sampling rate characteristics of the electronic parts.
The precision of the National Instruments (NI) card is dependent on its dynamic
range. For ±5 V detection voltage range, the random noise is 122µV and the
sensitivity 48.8µV. For ±10 V dynamic range, the random noise is 244µV and
the sensitivity 97.6µV (see Attachment A.2). Furthermore we optimized the
settling time of the laser controller and adjusted the data processing to let the
laser stabilize after switching. Before averaging we discard the first half of the
data points to be sure to have a stable laser signal. The remaining 500 samples
are still enough for noise reduction by averaging. Due to the sequential readout a
too long sampling time might lead to missing a reaction event.
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Figure 3.2: Overlay of two consecutive experiments to prove the detection of
a 100 pM antisense strand: The graph shows the significant difference between
an injection of 100 pM antisense match strand (black curve) and an injection of
100 pM antisense mismatch strand (red curve, the mismatch has two nonmatching
base pairs in the center of the target). Injecting the match sample induces
approx. −200 nm differential deflection whereas the injection of the mismatch
configuration leads to almost no differential signal. Phase (I) shows the recorded
baseline at 10µL/min buffer flow. (II) 1’000µL sample injection at 100µL/min.
(III) incubation phase at 10µL/min. (IV) flushing with buffer 100µL/min. (V)
resulting differential deflection after injection cycle is completed (10µL/min
buffer flow). Curves correspond to the differential deflection signal of positive
minus reference CL. Therefore the bending of the cantilevers are not absolute
but differential deflections. The two injections were performed in series on the
same cantilever array chip. A baseline correction, normalization, averaging and
differential signal calculation (probe minus reference) were done according to the
literature [45]. Hatched area highlights the increased flow speed during injection
and wash phase. Colored area indicates the presence of probe molecules in the
flow-chamber.
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Figure 3.3: Typical drift before (red curve) and after implementation (blue
curve) of means for drift reduction (continuous flow, temperature regulation etc.
as described in this thesis): Curves show the average of the raw data from 8
recorded cantilevers and the corresponding standard deviation. Curves have an
offset at zero. Red curve measured under stationary conditions (flow: 0µL/min).
Blue curve measured in flow (10µL/min).
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Super luminescent diodes might lead to a more stable laser signal due to their
characteristics.
3.2.4 Temperature
By placing a temperature controlling element close to the cantilever array we
obtained a controlled loop with very short time constant for temperature equi-
libration. Time to regulate the temperature in the chamber from 21 ◦C room
temperature to 25 ◦C setpoint is approx. 0.5 min (Fig. 3.4 (b)). The much slower
flow cycle thermostat regulation loop than that of the Peltier element leads to
a stable temperature for all probe vessels, the buffer reservoir and surrounding
elements. In addition, a large (23 × 35 × 2.5 cm) aluminum ground plate provides
a good heat exchange. To regulate the temperature from room temperature to
setpoint by the flow cycle thermostat it takes ∼50 min (Fig. 3.4 (a)). Even by
opening the box for a few minutes (<7 min) the temperature in the box (Tbox) is
not affected (Fig. 3.4 (c)). The chamber temperature Tchamber remains stable even
by opening the box for 30 min. Once the flow cycle thermostat reaches equilibrium
it only takes ∼25 min to restabilize Tbox after closing the box. Although we did not
want to risk any temperature fluctuations by injecting not perfectly equilibrated
solutions. Therefore we always waited long enough until a stable temperature was
recorded for Tbox.
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Figure 3.4: Temperature characteristics: (a) After switching on the flow cycle
thermostat. ILX controller was not on until minute 154. (b) After switching on
the ILX temperature controller the setpoint is reached almost instantaneously.
(c) Compensation of Tbox after box was opened.
A Negative Temperature Coefficient Thermistors (NTC) thermocouple element
changes its resistance depending on the temperature. In a specific range this
behavior is linear. To receive the temperature in degree Celsius (◦C) a calculation
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with a linear regression is necessary. From the reference curve Fig. 3.5, the
following formula is received:
T = −1.0642× 68
Uref
UT
− 1
+ 72.351 (3.1)
, where UT is the measured voltage at the temperature sensor and Uref an
applied reference voltage.
y = -1.0642x + 72.351
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Figure 3.5: Thermocouple characteristics: Calibration curve for the NTC
thermocouple element. With a linear fit we determine the characteristics for the
temperature calculation for Troom and Tbox.
The ILX temperature controller in combination with the NTC thermocouple
has a polynomial correlation between measured voltage and temperature. To
calibrate the LabVIEW software for correct temperature display we performed a
measurement series with a calibrated reference temperature sensor and applied a
polynomial fit to the recorded data (Fig. 3.6).
We decided to run all experiments at room temperature although an increased
temperature is favored for hybridization experiments. Hybridizations at room
temperature are possible as demonstrated in Ref. [13]. For temperature sensitive
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Figure 3.6: ILX characteristics: Calibration curve for the ILX temperature
controller in combination with a thermocouple element. With a polynomial fit we
determine the characteristics for the temperature calculation for Tchamber.
transducers such as the CLA and SPR it is also a technical issue. It is much easier
to keep the temperature stable inside the enclosed box close to room temperature
than an increased value.
Although our instrument is highly improved in terms of temperature regulation
it still takes slightly more than 3 hours to get a stable temperature of 35 ◦C.
Furthermore, keeping this increased temperature stable during sample exchange
(opening the box) is much more difficult. Sample exchange without temperature
drop, respectively long restabilizing times, is absolutely possible for the newly
built setup for measurements close to room temperature.
3.2.5 Fluidics
The stated 10µL/min flow speed corresponds to approximately one chamber
volume per minute (approx. chamber volume = 4 mm × 2.35 mm × 1.5 mm =
14.1 mm3 = 14µL. The injection flow speed of 150µL/min has its origin in the
experience of Martin Hegner’s group to achieve a feasible time until the probe
reaches the chamber and until the sample in the chamber is completely exchanged
with injected probe.
The two pulsation-free syringe pumps were embedded in our LabVIEW control
software. With two dosing modules an endless flow could be programmed, even
for running measurements overnight. Besides electronic and temperature drifts
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the main portion of the overall drift visible in the deflection signal is drift due to
diffusion effects (for example ionic exchanges between the cantilever surface and
the surrounding liquid). The continuous flow led to a fast equilibration between
the cantilever surface and the surrounding liquid which is diffusion independent.
One feature which has to be taken into account when measuring in flow is the
effect of the laminar flow on the cantilevers, as we see a deflection due to flow
forces. In experiments with readout in stationary fluid before and after sample
injection the liquid phase is moving during the injection process as well. This leads
to significant flow induced deflections (see for instance in Ref. [13]). Depending on
the position of the sensors relative to the liquid chamber channel the flow forces
will be different for the eight cantilevers, inducing different additional bending
that could potentially affect the measured deflection values. By measuring the
baseline and the actual hybridization signal at equivalent buffer flow speeds, the
comparability is given. The typical flow induced bending by switching from
stationary fluid to 10µL/min is up to 7 nm (see Fig. 3.7 (a)). For the increased
injection flow rate the induced bending is up to 400 nm (see e. g. Fig. 3.7 (c)
or Fig. 3.2). For the differential deflection signal the flow induced bending is
completely reversible as visible in Fig. 3.7 (right). Stop flow read out with only a
short stop phase to record the data points (much smaller time period than the
drift kinetics) could add additional improvement.
Due to instrument design restrictions (flow path, lack of space and temperature
sensibility) we decided to set up the flow with a syringe pump in pulling mode.
The disadvantage with this pulling method is the risk of sucking air into the flow
path. Small air bubbles will stick to the cantilever array and lead to an abortion
of the measurement. By compensating the pressure loss with a positive pressure
on the probe side we avoided these problems. We applied 80 mbar. The value
was estimated by a rough calculation for the pressure loss over tubing distance
(Appendix B.2, Tab. B.1).
Additionally, Halar tubing was chosen to avoid gas diffusion into the system.
The gas permeability value for oxygen for Halar is similar to PEEK and ∼30
times less than Teflon (according to the specification guide from the provider:
Appendix B.2, Tab. B.2). Moreover, Halar tubing is almost as flexible as Teflon
tubing, in contrast to PEEK which would otherwise be a perfect material in terms
of gas diffusion and low affinity for biomolecules.
3.2.6 CO2 Sparging
Air bubbles tend to stick in small corners in the fluidic path and require a time
consuming procedure for their removal. CO2 sparging allows a fast fluidic system
priming without any bubbles. The buffering characteristics of the solution, and
closing the CO2 connection after priming, ensure that the effect of the CO2 on
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Figure 3.7: Flow force influence: Flow induced deflection for (upper) 10µL/min,
(lower) 100µL/min. Both for the baseline corrected raw signal (left) and averaged
signal and differential signal (right).
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the acidity of the buffer is negligible.
3.2.7 Laser stability
(a) (b)
Figure 3.8: Photo of laser reflection on CL in flow chamber: (a) Interference
pattern with normal setup after implementation of bandpass filter in front of
camera module. (b) Setup without parallel optical surfaces. Cover glass was
removed and bandpass filter slightly tilted.
To avoid interference patterns as visible in Fig. 3.8 (a) we prevent parallel pla-
nar optical surfaces. An inspection has shown that the source for the interference
pattern visible in Fig. 3.8 (a) is the bandpass filter in front of the camera module.
Due to the fact that this optical element does not belong to the path of the actual
measured laser beam for deflection readout, this is not crucial. No interference
patterns can be achieve by tilting the bandpass filter and avoiding any parallel
optical surfaces leads as shown in Fig. 3.8 (b).
In most of the experiments the PSD sum signal is quite stable for CL2–8.
The PSD sum signal for CL1 has a significant drift as shown in Fig. 3.9 (a)
representative for a randomly picked experiment. This behavior can be observer
in more or less all experiments. By comparing the slope of the drift of the sum
signal with the matching deflection signal we do not see any correlation. Slow
drifts in the sum signal do not seem to have an influence on the deflection values
which is expected from the PSD formula (Equation 1.8). Slow fluctuations in
the sum signal do not affect the final deflection result. Fast fluctuations do have
an influence as shown in Fig. 3.10. Nevertheless the influence on the differential
deflection signal is negligible.
Laser stability might be affected by fluctuations in the room temperature as
shown in Fig. 3.11. Furthermore we can see in Fig. 3.11 (minute 230 to minute 260)
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Figure 3.9: PSD sum signal drifts: PSD sum signal (a), temperature development
(b) and resulting deflection signal (raw (c) and averaged (d)) from a control
experiment. Measurements performed on a 180 ◦ rotated CLA chip to measure
on a stable CLA body. Therefore the measured signal does not has its origin in
cantilever deflection. (a) Visible drop of CL1’s laser sum signal compared to stable
signal for all other CLs. Drop might correlate to increase of room temperature
over time (b). No effect on deflection signals either raw (c) or averaged (d) is
visible.
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Figure 3.10: Influence of fast and high sum signal fluctuations on the measured
deflection as well as averaged differential deflection: The figure shows a combined
graph of the PSD sum signal (right axes and data in the lower third), the baseline
corrected deflection signal (left axes and date in the upper third) and the averaged
deflection of probe and reference cantilever as well as the calculated differential
deflection (left axes and date in the middle third). At minute 91.7 and 92.7 the
laser power was increased. The laser for CL1 was not affected thereby. The
influence of the fast fluctuation in sum signal on the deflection signal can be seen
in the graph.
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what happens when we open the box and ambient light shines on the PSD: The
sum signal increases and a lot of fluctuations are induced. If we zoom in we can
see the 50 Hz from the ambient light source.
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Figure 3.11: Room temperature influence on laser power: Correlation between
Troom and drifts in the PSD sum signal especially with the unstable laser diode
for CL1. Peak at minute 216 is due to a realignment of the PSD. Artifacts at
minute 230 to minute 260 are due to the open box.
3.2.8 PSD
After assembling the PSD its functionality and especially linearity were tested
in a liner setup. Therefore we mounted the PSD on a linear micro position-
ing stage and pointed a focused laser beam perpendicular towards the vertical
center of the PSD area. The sum and differential signal were recorded while
shifting the PSD horizontally from beyond one end to the other. The values
were plotted against the absolute position of the micro positioning stage (Fig. 3.12).
For the sum signal we performed an analogue experiment (Fig. 3.13). A linear
region of ±3 mm from the center of the PSD is given. This value correlates with
the spot size of ∼6 mm because beyond that limit too much light is pointed not
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Figure 3.12: PSD differential signal vs position: (a) Recorded differential signal
of PSD output while the PSD was shifted horizontally versus a perpendicular
laser beam pointing towards the sensor area. Measurement started with laser spot
beyond the sensor area. (b) Plot of linear region from dataset shown in (a). A
linear fit proves the linear behavior of the PSD differential signal (b).
on the sensor area. This leads to a loss of sum signal that influences the position.
Plus, the center of the light spot is falsified due to the fact that not the whole
spot is represented on the sensor area.
3.2.9 Optical Fibers
The proper cleavage of optical fibers plays an important role for the quality and
quantity of the light guided through the fiber. Several badly cleaved fibers were
recognized by checking the shape of the projected output (Appendix B.2) and
inspecting the fiber with a binocular. A perfect cleaved fiber has a round shaped
light projection and shows no cracks or other damages on the core and cladding
(Appendix B.2, Fig. B.1).
By newly cleaving all fibers we achieved a clean fiber cut with perfectly shaped
output (final results not shown).
Two criteria have to be fulfilled for the alignment of the laser spots on the
CLA: (i) the pitch from one spot to the other has to be the same as the 250µm
pitch between two cantilevers and (ii) the CL should be in focus, thus in the
narrowest beam waist. To achieve this we reduced the laser light with a neutral
density filter for better visibility of the laser spot with the camera. Then the
distance from the laser to the chamber ((2) in Fig. 2.1) and the distance from the
laser to the lens ((5) in Fig. 2.1) were set in an iterative way. After the visual
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PSD Experiment 26.08.2009
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Figure 3.13: Results from the experiment to check the linearity of the PSD: On
the left side the PSD sum signal versus absolute position adjusted with a micro
positioning stage On the right side additionally the variation of the absolute
position from the micro positioning stage to the calculated position received from
the PSD.
impression of a good result, we verified the focal distance by a simple experiment.
The laser was shifted horizontally across one cantilever. Thereby the sum signal
was recorded by the PSD (Fig. 3.14). This was repeated for a slightly changed
distance between laser and CLA in a plus and minus direction. The slope at
full width at half maximum indicates the size and sharpness of the laser spot.
With the settings zlaser−lens = 2.90 mm and zlaser−CLA = 8.58 mm we have the
best result.
A theoretical disquisition to calculate the spot size can be found in Appendix B.2.3.
Touching, respectively moving the optical fibers has an influence on the sum
signal. This is not due to increased or decreased couple efficiency. This was
excluded by observing the same effect with fixed fiber ends. Furthermore we
know that the influence is due to movement and not due to a temperature change,
because the same effect is observed if we touch the fibers with bare fingers or with
a tool. Further investigations with a test setup resulted as follows: The laser light
is polarized. The polarization changes by moving/bending the fiber. This was
shown in the test setup with a polarization filter. Thus the position/curvature
has an influence on the polarization of up to 10 mV PSD sum signal.
In an ideal setup we should align, respectively rotate each fiber to end up with
an identical polarization direction and protect all fibers against movements. The
polarization becomes critical, because all optical planes such as the Au cantilever
surface do not reflect p-polarized and s-polarized light identically.
The fibers were never aligned like mentioned. This due to the enormous effort to
fulfill this task and due to the fact that we never observed any direct influence
during a measurement. Section 3.2.7 proves that small changes in the sum signal
are negligible because they do not have an influence on the differential deflection
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Figure 3.14: Recorded PSD sum signal while shifting a laser spot horizontally
across a cantilever: The slope correlates directly with the laser spot size and shape
quality.
signal.
3.2.10 Software
To control the CLA instrument an adaption of the original NOSE software by
W. Grange was used (developed in M. Hegner’s group and adapted to the new
instrument at Roche). We realized some deficits during the first period of mea-
surements. Short term fluctuations were up to ∼100 nm. For a feasible detection
they should be in the 1 nm range. Major improvements were achieved by letting
the laser stabilize before measurement. E. g. discarding the first 500 recorded
datapoints before averaging as described in 3.2.3. Furthermore we implemented
faster controlled loops for regulating the lasers. Finally the software was improved
by reprogramming all allocations. Global variables were exchanged by absolute
connections, because they can delay in complex programs.
Over time the whole software was reprogrammed and only a few core-parts such as
temperature and deflection display were copied from the original NOSE software.
A module to restore all parameters, one to control the syringe pumps (neMESYS)
and a separate Virtual Instrument - A LabVIEW program (VI) for the whole
data analysis were programmed and implemented step by step during the thesis.
Additionally a VI to overlay two consecutive experiments and display plus store
the results was programmed.
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Software Memory
We experienced several times a software crash from a memory overflow in the
neMESYS control module. The LabVIEW support document ID 2T9ICKTL
describes the problem and offers a solution. According to the document the
software error was due to high memory usage and wrong memory allocation. To
check the memory usage we ran a “profile analysis”. As expected the result
showed a high memory usage in several neMESYS module blocks. Especially the
sub-module VI “NCS GetFloUnitString.vi” which handles the option to choose
the flow unit such as [l], [ml] and [µL] seemed to use a lot of resources. This
correlated with the LabVIEW document, which tells us that saving and passing
“strings” are very memory intensive. In a new version we removed all unnecessary
functions and set the flow unit to the fix unit in [µL.]
3.2.11 Cantilever arrays
All cantilever arrays were provided by IBM (IBM Research GmbH, Switzerland)
as described in the material and methods section (Sect. 2.3). IBM offers several
chip designs such as with or without protection bars on one or both sides. We
have chosen a standard chip design as shown in Fig. 3.15 without protection bars.
The chosen wafer design has the best yield of arrays per wafer with the right
dimensions (chip-type A) for the application of interest.
IBM processed a batch of wafers (2 wafers of a total of 3). One with 500 nm
cantilever thickness and one with 1µm cantilever thickness. The third wafer went
to M. Hegner.
The two wafers for Roche were kept at IBM and stored for further processing.
A batch of 5 cantilever arrays was gold coated (2 nm Ti, 20 nm Au) by IBM and
sent to Roche for quality check. The main concern was the initial bending that
gold coated cantilever mostly have. The gold coating process induces a force
on the cantilevers. Depending on heat dissipation from the sputter source and
distance between source and target, the influence is different. Good quality chips
do have less initial deflection, which makes it easier to image the laser spot in the
CLA instrument on the PSD.
Initial bending values from the two IBM batches were: <3µm for the 1µm wafer
and <15µm for the 500 nm wafer. Those values are comparable to arrays pro-
cessed by M. Hegner and in tolerance for the instrument.
After proofing the successful Au coating by IBM, the whole wafers were gold
coated. Due to problems during the 500 nm wafer processing, the Au coating had
to be stripped and the coating process renewed. Therefore the yield of complete
arrays was lower than expected (∼100 pieces). Initial bending values were in
range and not higher as the values stated before.
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Figure 3.15: IBM mask layout for static arrays: Mask division 80 % 500µm
and 20 % 750µm length. Target thickness: 500 nm respectively 1µm. Tolerance
within a wafer: ±60 nm. Tolerance within a chip: ±10 nm. Minimum good chips
per wafer: 200 for 500 nm respectively 250 for 1µm thickness.
M. Hegner detected some impurities on their CLAs. The impurities were only
visible under a darkfield microscope or by scanning electron microscopy. We had
the concern that impurities might have an effect on the stiffness of the cantilevers
and therefore might lead to different results in referenced measurements. The
concerns were not confirmed and no further research was initiated.
Cleaning the arrays in Piranha solution did not dissolve the impurities (results
from M. Hegner et al.). An overall analysis of the entire wafers of the IBM
batch mentioned before, as well as a former batch from 2007 showed randomly
distributed clean and contaminated areas (results from M. Hegner et al. and
Roche). Fig. 3.16 show images of the mentioned impurities on randomly picked
CLAs from M. Hegner et al. and Roche.
Due to the fact that the impurities are only on a small percentage of the
cantilever area the effect is expected to be minor.
Additional information was given by IBM: Before gold coating the Roche CLAs
were stripped in 1:100 HF for 30 s which removes ∼5 nm of the silicon oxide.
Contact angle measurement would result in the change from ∼5◦ hydrophilic to
>80◦ hydrophobic due to the fact that the SiOH is stripped and converted into
SiH. Afterwards the wafer was cleaned in Piranha solution before gold coating.
The HF etches inorganic oxides. Therefore the Roche CLAs, Au coated by IBM,
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(a) M. Hegner: 0.5u
fresh BF
(b) M. Hegner: 0.5u
fresh DF
(c) M. Hegner: 1u Pi-
ranha cleaned BF
(d) M. Hegner: 1u Pi-
ranha cleaned DF
(e) M. Hegner: 0.5u Pi-
ranha SEM
(f) M. Hegner: 0.5u Pi-
ranha SEM (zoom)
(g) Roche: 0.5u fresh
DF
(h) Roche: 0.5u fresh
DF
(i) Roche: 1u fresh DF (j) Roche: 1u fresh DF
Figure 3.16: BF, DF and scanning electron microscopy images of contaminated
CLAs: (a) and (b) BF and DF image of untreated 0.5µm M. Hegner CLA (typical
sample for heavily dirty cantilever). (c) and (d) BF and DF image of Piranha
cleaned 1µm M. Hegner CLA (typical sample for moderately dirty cantilever).
(e) and (f) SEM image plus magnification of Piranha cleaned 0.5µm M. Hegner
CLA. Piranha cleaning was performed without salt solution cleaning steps to
avoid crystal formation on the CL surface. Contaminations did marginally reduce
after three times wash. (g) and (h)DF images of untreated 0.5µm Roche CLA.
(i) and (j) DF images of untreated 1µm Roche CLA.
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do have fewer impurities than the ones from M. Hegner who only does the Piranha
cleaning without the HF etching step.
The impurities on the CLAs might have their origin in the manufacturing
process. IBM uses a “Novolack” photo-resist which is normally stripped of during
etching. This could be the source of impurities on the CLs.
To get rid of the impurities on the CL the following steps could be applied: RCA
cleaning might remove inorganic contaminations. This is not applied at IBM till
now. An oxygen plasma or CF4 would oxidize impurities and might help to get
rid of them.
Further investigations could be made. For our purpose this should not be neces-
sary. By the Peltier test a sufficient uniformity can be observed. Furthermore no
irregularities were ever observed during all experiments.
In an experiment where 500 pM antisense match respectively mismatch was
hybridized on one of the new IBM cantilever arrays, we prove that their func-
tionality was intact. The results were analogue to previous experiments with
individually functionalized gold surfaces. We could not detect any differences
in the hybridization signal (sensitivity) nor specificity (no differential deflection
signal for the mismatch injection).
3.2.12 Cantilever Functionalization
The literature proposes several different functionalization times and strategies
(Ref. [32–34]). A long functionalization time seems to be favored to receive highly
ordered SAM. Small volumes used during functionalization by immersion the CLA
into capillaries lead to a fast evaporation of the solution. For our application the
solution volume needed for the functionalization is not even critical, because we use
synthetic DNA oligos which are available in sufficient amounts. Therefore we set
up a functionalization station (Fig. 3.17) with a reservoir to avoid the drying-out
of solution in the capillaries. Additionally we placed the whole functionalization
station in an enclosure. A water bath in the enclosure leads to a high relative
humidity that increases the dew point.
Plasma treatment of the capillaries prior to use for functionalize the CLA chip
leads to an enhanced hydrophilicity which is an advantage for a good filling of
the capillaries. In return it is a disadvantage in terms of cross-talk. Liquid might
flow on the outside of the capillaries and the different immobilization solutions
might merge.
68
Chapter 3: Results and Discussion 3.2 CLA Instrumentation
(a) (b)
(c) (d)
Figure 3.17: Photos of improved capillary functionalization device for long term
functionalization: (a) Setup is placed in a tight enclosure with a water bath to
avoid evaporation. (b) The capillaries ends are placed in tubes acting as reservoir
for the immobilization solution. Depending on the functionalization pattern two
or more tubes are required. (c) To avoid cross contamination by flow on the
outside of the capillaries a droplet of vacuum grease was placed on the support
table around the center of the capillaries. (d) The cantilever is aligned by an x, y,
z micro positioning stage and immersed into the capillaries till the hinge. Before
filling the capillaries, respectively reservoirs the chip was retracted a tiny bit to
avoid wetting of the cantilever support and a possible cross contamination by
liquid flowing around the cantilever support up to the chip body.
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3.3 Surface Plasmon Resonance Technology
3.3.1 Biacore chip preparation
For SPR experiments we used recycled Biacore Dextran sensor chips (type CM5
or SA). The idea was to strip the Dextran layer and end up with plain Au surfaces.
This was achieved by a cleaning protocol described in Material and Methods
Sect. 2.2.1. First we washed the chips by sonification in detergent. Covalently
bound monolayers and other organic remaining where then finally removed by
UV-ozone or plasma treatment.
To verify the result we analyzed the surface with three different methods: (i)
Contact angle measurement (rough analysis), (ii) in dark field, (iii) by vapor
condensation.
We determined 60 s plasma treatment to be the upper limit before damaging the
polymer chip holder. After the treatment an extremely good wetting with H2O
was observed as expected. Before plasma treatment we measured contact angles
of ∼60◦. After plasma treatment we ended up with an extremely hydrophilic
surface (contact angle <30◦. After the first stripping we functionalized the Au
surface with ETC for 2 min. An absolutely hydrophobic surfaces with contact
angle >90◦ was formed. We were able to remove the hydrophobic functionality
by stripping the ETC SAM by plasma treatment (30 s). After plasma treatment
we measured contact angles similar to before the functionalization of <30◦.
The same result was achieved by a 10 min UV/O3 treatment as shown in Fig. 3.18.
Observing the cleaned Biacore sensor chip in dark field does not show any
residues on the sensor surface. To validate the chip cleaning process we experienced
a vapor condensation test to be the best method. By condensing vapor on the
surface of the sensor chip we could immediately see if the cleaning process was
successful. Vapor tends to condense first at remaining molecules on the otherwise
absolute perfectly clean surface. This leads to a different pattern for clean and
dirty areas. With this method we could distinguish between clean and substandard
sensor chips. In most of the failed cleaning processes the Biacore flow channel
stamp was perfectly visible by the mentioned vapor condensation test.
UV/O3 treatment was determined to be the favored cleaning process compared
to plasma treatment as described in Sect. 2.3 and in Ref. [46].
Increased time during UV/O3 treatment lead to thermal radiation damages to
the plastic Biacore chip body. Therefore we used a reduced time for the SPR
chip preparation compared to the CLA. Furthermore we manufactured a special
aluminum frame to protect the plastic parts from UV radiation and for increased
heat dissipation.
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(a) (b)
(c) (d)
Figure 3.18: Biacore sensor chip regeneration: (a) Taken photograph of a water
droplet on a recycled Biacore sensor chip. The chip was cleaned with detergent
before and stored for several days at ambient air. The resulting contact angle
is ∼60◦. (b) Resulting contact angle of <30◦ after 5 min UV/O3 radiation. (c)
After a second 5 min exposure to UV/O3 the Au surface was functionalized with
ETC for 2 min. The resulting contact angle is now >90◦ due to the hydrophobic
functionalization. (d) By 10 min UV/O3 treatment we could completely remove
the hydrophobic properties and a contact angle of <30◦ can be observed leading
to the conclusion that UV/O3 radiation removes organic monolayers from the
chip surface.
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3.3.2 DMSO series
To validate the recycled Biacore sensor chips (see Sect. 2.4) we checked the signal
quality and stability during a standard DMSO concentration series experiment
(Fig. 3.19). We mounted a cleaned chip with expected bare gold surface in the
Biacore device and injected ten differently concentrated samples of DMSO diluted
in SSC buffer. By plotting the amplitude of the injection response versus the
DMSO concentration a linear dependency can be observed. Furthermore we can
see a slight drift.
(a) (b)
Figure 3.19: (a) Recorded sensor response during the injection of a series of
DMSO (0.5 %–5 %) in SSC buffer on a recycled Biacore SPR sensor chip. (b)
Expected linear behavior of signal peaks proves the correctness of the chip response.
Besides a slight drift, the recycled chip does not show any irregularities. Therefore
the recycling process will be applied for further experiments.
In the graph we can see the measurement of a series of DMSO dilutions in
our hybridization buffer. Due to linear increase of the concentration of DMSO,
the signal should also increase linear. Unfortunately we have a small drift in our
baseline signal, which should not be. We extracted the ten peaks and plotted
their amplitude in a new graph. The concentration series should behave linear.
As expected we can show the linear behavior with a linear fit. Although the slight
drift we could prove that we do not have any unexpected background noise from
a bad sensor chip. The chip recycling seems to be acceptable and can be used for
further experiments.
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Figure 3.20: Immobilization of thiolated DNA on Biacore sensor chip: The
mass increase was recorded in situ in the Biacore device. 25µL, 50µM thiolates
oligo sense match in 50 mM TEAA buffer were injected. Saturation was finally
reached at ∼200–250 RU. The value of ∼2–2.5×1010 oligos/mm2 correlates with
the value from the reference literature Zhang et al. [13] were they reported an
immobilization value of 2×1012 oligo/cm2. Signal does not significantly drop even
by washing with buffer (peaks visible in graph). Signal drifts quite strongly.
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3.3.3 Immobilization in Biacore instrument
DNA immobilization was performed in situ in the Biacore device in a test series
(Fig. 3.20). 25µL, 50µM thiolates oligo sense match in 50 mM TEAA buffer
were injected onto a cleaned gold sensor chip. The mass increase was tracked by
recording the RU versus time. By washing several times with buffer we tested if
the adsorbed mass was effectively bound to the sensor surface.
The resulting ∼200–250 RU correspond to ∼0.2–0.5 ng/mm2. This value correlates
with the reported 2×1012 oligo/cm2 by Zhang et al. from the reference literature
[13].
Immobilization ends in saturation. Even after washing with buffer, the signal
stays at the reached value. In all future experiments the chip functionalization
was done outside the instrument for more flexibility in terms of chosen buffers
and immobilization times.
General Discussion
Whereas for the SPR platform many studies exist determining the optimal surface
coverage for probe molecules [32–34], for the CLA platform only a few data exist
showing that probe density on the sensor surface affects the signal amplitude.
The optimal immobilization density for CLA measurements is somewhere between
the highest dense coverage and reduced coverage. The optimal setting has an
increased hybridization efficiency without losing the steric repulsion leading to
cantilever deflection.
An open question remains how the changes in conformation of a SAM over
time do have an influence on the SPR signal. Concrete, how much of the measured
300 RU is due to mass adsorption and how much is due to changes in conformation
in the ad-layer over time.
3.3.4 Proof of concept
Our attempts to detect DNA hybridization on the Biacore SPR system were
not successful until we changed the hybridization buffer from SSC to PBS. The
reason for this observation is not clear yet. In previous experiments on a mi-
croarray platform (results not shown) several hybridization buffers such as SSC
(0.1×, 0.5×, 10×), PBS, PBS (+), SSC 5× with 50 % Formamide, as well as an
Affymetrix buffer (Affymetrix Inc.) and an Illumina buffer (Illumina Inc.) were
validated. PBS with magnesium and calcium ions (PBS (+) stated as follows as
PBS) resulted to be one of the favored hybridization buffers. The bivalent ions
give thereby an additional support for the hybridization.
After switching to PBS as hybridization buffer successful results were achieved
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Fig. Chip
type
Prep-
aration
Immobilization
buffer
Hybridization
buffer
Injected
sample
Fig.
3.21
(a)
CM5 UV/O3
+ EtOH
NaCl-TE SSC
(not shown),
PBS
25µL,
1µM anti-
sense match
in PBS,
5µL/min
Fig.
3.21
(b)
CM5 UV/O3
+ EtOH
KH2PO4 PBS 50µL,
1µM anti-
sense match
in PBS,
5µL/min
Fig.
3.21
(c)
SA UV/O3 NaCl-TE PBS 25µL,
1µM anti-
sense match
in PBS,
5µL/min
Fig.
3.21
(d)
SA UV/O3 KH2PO4 PBS 30µL,
1µM anti-
sense match
in PBS,
5µL/min
Table 3.3: Experimental conditions referring to Fig. 3.21.
as shown in Fig. 3.21. We tested several different functionalization protocols listed
in Tab. 3.3. All assays were functionalized with reduced density (implemented
MCU spacer) of capture molecules for improved hybridization as recommended
by the literature (Sect. 1.4 and Ref. [32–34]).
For the established hybridization experiment with 1µM target we observe sat-
uration after injecting 25µL probe (Fig. 3.21 (a)). The resulting signals differ for
the four experiments shown in Fig. 3.21. Reason therefore might be the different
functionalization protocols or chip types used for recycling. For a final statement
too many parameters were changed and therefore no absolute conclusion could be
made.
3.3.5 Regeneration during SPR
After the study of immobilization and hybridization we focused on regenerating
the chip after hybridization.
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Figure 3.21: DNA hybridization on SPR chip: (a) Response units versus time
during the injection of 25µL, 1µM, 5µL/min antisense match DNA in PBS on
a recycled CM5 chip immobilized with sense match DNA in NaCl-TE buffer.
Chip cleaned according to protocol with detergents, UV/O3 and immersed in
EtOH. Injection was performed after a first attempt of hybridization in SSC
buffer without any result. Fc4 (blue curve) was used as reference without sample
injection. (b) Sensorgram of the injection of 50µL, 1µM, 5µL/min antisense
match DNA in PBS on a recycled CM5 chip immobilized with sense match DNA
in KH2PO4 buffer. Chip cleaned according to protocol with detergents, UV/O3
and immersed in EtOH. (c) Sensorgram of the injection of 25µL, 1µM, 5µL/min
antisense match DNA in PBS on a recycled SA chip immobilized with sense match
DNA in NaCl-TE buffer. Chip cleaned according to protocol with detergents,
UV/O3 without immersion in EtOH. (d) Sensorgram of the injection of 30µL,
1µM, 5µL/min antisense match DNA in PBS on a recycled SA chip immobilized
with sense match DNA in KH2PO4 buffer. Chip cleaned according to protocol with
detergents, UV/O3 without immersion in EtOH. In (a) the change in refractive
index during the injection is abnormally high due to the fact that SSC was used
as running buffer and PBS as hybridization buffer.
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A Biacore CM5 sensor chip was recycled by cleaning according to protocol with
detergents and UV/O3. 1µM thiolated sense match DNA was immobilized on
the chip in NaCL-TE buffer overnight. We reduced the functionalization density
by post-processing with an MCU immobilization for 1 h. Figure 3.22 shows the
signal response versus time while hybridizing and regenerating the immobilized
biomolecules. For hybridization we injected 25µL, 1µM, 5µL/min antisense
match DNA in PBS. As regeneration agent we used HCl and injected once or
twice 10µL, 0.1 M at 5µL/min.
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Figure 3.22: Repeated hybridization and regeneration of DNA on the Biacore
chip sensor surface: Hybridization was achieved by injecting 25µL, 1µM, 5µL/min
antisense match DNA in PBS. Regenerating was achieved by injecting one or
twice 10µL, 0.1 M, 5µL/min HCl. The baseline was corrected to zero before each
cycle for each channel. The graph shows the decrease in hybridization efficiency:
less amplitude for each renewed cycle after probe hybridization. Regeneration
efficiency is not 100 %: endpoint of each cycle is slightly higher than the recorded
baseline at the beginning.
The graph proves that HCl leads to a partial recovery. The recovery cannot be
repeated for several times as shown by the superposition of the signal over several
cycles. Mass seems to accumulate on the surface over the several cycles (increase
of RU signal). Even two injections of HCl lead to a slight increase of signal. This
leads to the conclusion that not only mass accumulates but that HCl might alter
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the sensor surface or the biolayer on top. Furthermore the recovery is not 100 %.
A certain ad-layer is not removed from the surface, visible by the discrepancy
of baseline and endpoint. The differential signal from each hybridization cycle
decreases by each repetition after regeneration.
For further measurements standard conditions and protocols as described in
Sect. 2.4 were used. Furthermore most injections were performed by a scripted
program operating the Biacore instrument.
After testing the chip regeneration by HCl leading to a non-satisfying result,
we switched to a different regeneration agent. Figure 3.23 shows the overlay of
an extract of 88 repeated cycles of hybridization and regeneration by urea. All
hybridizations were performed on the same Biacore sensor chip. For each cycle we
first recorded a stable baseline. Then we injected 25µL, 1µM, 5µL/min antisense
match DNA in PBS. After a short dissociation time 2× 5µL, 8 M urea, 5µL/min
were injected. The graph shows the response signal versus time for the cycles 10
and 13 at the beginning and 67 and 78 at the end of the experiment.
After each regeneration the signal ends on the same level as the baseline at the
beginning. This proves that the regeneration by urea is feasible. Furthermore the
loss of signal amplitude in hybridization 78 compared to hybridization no. 10 is
minor and can almost be neglected. Assay functionality (amount of binding part-
ners and affinity) did not decrease, which is crucial for a successful regeneration.
The loss in signal after 88 hybridizations is 4 %.
The “nose” in the signal right before saturation is an irregular effect and seems
to disappear after repeated hybridizations/regenerations. A possible reason is
explained in Sect. 3.3.7.
3.3.6 Specificity
With a functional assay and the possibility to perform several hybridization in
series on the same Biacore sensor chip with regeneration in between we next
wanted to focus on the specificity of the Biacore assay. Where the cantilever might
experience a different force for unspecific adsorption and therefore respond with
less signal (see Fig. 3.2), an SPR instrument cannot differ between “real” bound
molecules and unspecific adsorbed mass on the sensor surface. Both will lead to
the same shift in refractive index if the mass is similar.
Figure 3.24 shows the overlay of three consecutive experiments. The Biacore
sensor chip was recycled from a former SA chip by cleaning it according to protocol
with detergents and UV/O3. Functionalization was done by incubation with 1µM
thiolated sense match DNA in NaCl-TE buffer overnight and post-processing with
1 h MCU spacer incubation to reduce the immobilization density for improved
hybridization. Before each injection a stable baseline was recorded to ensure
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Figure 3.23: Overlay of an extract of 88 repeated hybridizations with followed
regeneration by urea: All injections were performed on the same Biacore sensor
chip. The chip was recycled from a former SA sensor chip by cleaning according to
protocol with detergents and UV/O3. Functionalization was done by incubation
with 1µM thiolated sense match DNA in NaCl-TE buffer overnight and post-
processing with 1 h MCU spacer incubation to reduce the immobilization density
for improved hybridization. Only a minimal loss of signal in a series of over 50
hybridizations is visible. Furthermore the baseline is absolutely consistent after
each regeneration (endpoint on same level as recorded baseline at the beginning).
For each injection the recorded baseline was corrected to zero.
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that the system was equilibrated. Then 25µL, 1µM, 5µL/min antisense DNA in
PBS were injected. After injection the system switches back to buffer flow (PBS
5µL/min). After 1 h dissociation time, the chip was regenerated by injecting 2×
5µL, 8 M urea, 5µL/min (not shown in Figure). First we injected the fully match-
ing antisense match strand (green curve). After dissociation and regeneration the
process was repeated for two kinds of antisense mismatch strands (blue and red
line). The mismatch configuration 1 had two mismatch sites in the center of the
strand. Mismatch configuration 2 had three mismatch sites in the first halve of
the strand (see Tab. 2.2: F7 Antisense Mism. 1 and F7 Antisense Mism. 2).
The graph shows the mass adsorption after injecting a fully or partially matching
antisense DNA by hybridizing to an oligo on the sensor surface and its dissociation
over time. Where the signal amplitude for all injections is besides a slight decrease
for Antisense Mism. 2 almost the same, the dissociation is different for the match-
ing and non-matching strands. Antisense Mism. 2 has the fastest dissociation,
followed by Antisense Mism. 1 and Antisense Match does almost not dissociate.
With the shown experiment we could prove that the differentiation between specific
(antisense match configuration) and unspecific (antisense mismatch configurations)
is possible by observing the dissociation kinetics.
By changing the stringency we should be able to wash away partially bound
strands due to the fact that unspecific bound ssDNA has less affinity to the sensor
surface compared to full matching targets. Before proving our hypothesis, we had
to show that a wash step with H2O does not affect fully hybridized strands.
Figure 3.25 (a) and (b) show the signal response during a H2O flush. Both
experiments were performed on the same Biacore sensor chip in series. The
chip was prepared as described before. In (a) we injected 25µL, 1µM, 5µL/min
antisense match DNA in PBS. The typical reaction pattern for oligo hybridization
can be observed. After the injection was finished and the program back to standby
conditions (5µL/min buffer flow), we injected in channel Fc1–3 10µL, 5µL/min
H2O. The change in buffer stringency will induce a stress and therefore removes
not well bound oligos from the sensor surface. Fc4 (pink curve) was not flushed
with H2O as reference. The graph shows that the loss of specific bound target
is less than 5 % by flushing with H2O. The drop during H2O injection time in
the reference curve Fc4 is due to changes in the flow and fully recovers after the
injection is completed. The reference curve does not show any loss of target as
expected. A slight drift leads to a decrease of the signal even in the reference
curve, but can be neglected. At the end channel Fc1–3 were washed with urea
for regeneration. In (b) the experiment was repeated with 25µL, 1µM, 5µL/min
antisense mismatch (Antisense Mism. 1) DNA in PBS for Fc1–3. Fc4 was kept
in hybridized state, respectively fully bound with perfect match. We injected
2× 10µL, 5µL/min H2O (all channels) and finally Fc1–3 were regenerated with
urea. Where the signal in the reference channel with the specific bound match
strand did not drop more than 5 % per H2O injection, the signal for Fc1–3 with
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Figure 3.24: Reaction kinetics of match and mismatch configurations: The
differentiation between specific and unspecific bindings to a single strand oligo on
a Biacore sensor surface can be done by tracking the dissociation. The graph shows
the binding of a full matching strand (green curve) and two kinds of mismatching
strands (blue and red curve) to an oligo on the sensor surface. The Biacore sensor
chip was recycled from a former SA chip by cleaning it according to protocol
with detergents and UV/O3. Functionalization was done by incubation with 1µM
thiolated sense match DNA in NaCl-TE buffer overnight and post-processing with
1 h MCU spacer incubation to reduce the immobilization density for improved
hybridization. After injection the hybridization can be observed by the increase
of signal response. The mismatch configuration 2 (red curve) with three non-
matching bases led to slightly less deflection than the mismatch configuration 1
(blue curve) with two non-matching bases and the fully matching strand (green
curve). To distinguish between the three configurations, the dissociation has to be
observed. Where the signal amplitude right after the injection is almost identical
for match and mismatch 1, the dissociation is for all three samples different. The
fastest dissociation can be observed for the mismatching configuration with three
mismatch sites.
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not fully specific bound antisense strands decreased more than 15 % by flushing
with H2O during the first injection. A repeated H2O wash step did not lead to
the same decrease than before (second: ∼12 %). This might be due to the fact
that during the first H2O wash already very badly bound strands were removed
whereas during the second H2O wash only better hybridized strands remain.
3.3.7 Sensitivity
In the previous subsections we have shown the specific detection of antisense
oligos on the described Biacore assay and its feasible regeneration by urea. Next
we want to check the sensitivity of the Biacore SPR assay.
In a first experiment we injected several concentrations of 25µL, 5µL/min an-
tisense match DNA in PBS. The assay was prepared as described before: The
Biacore sensor chip was recycled from a former SA chip by cleaning it according to
protocol with detergents and UV/O3. Functionalization was done by incubation
with 1µM thiolated sense match DNA in NaCl-TE buffer overnight and post-
processing with 1 h MCU spacer incubation to reduce the immobilization density
for improved hybridization. Before each injection we recorded a stable baseline
to ensure that the system was equilibrated. Eleven samples with concentrations
between 1’000 nM and 0 nM were injected in series with urea regeneration in
between. Samples were diluted in 1:2 steps.
Figure 3.26 (a) and (b) show the signal response during the injection of the
titration series on the described assay. The typical reaction curve can be observed
for the 1’000 nM sample. After each injection the program switches back to
standby conditions (5µL/min buffer flow). The switching leads to a rapid signal
increase induced by switching the valves and slight changes in buffer conditions.
After a short dissociation phase, 8 M urea was injected twice for regeneration.
The endpoint perfectly ends at the same level like the baseline proving that the
regeneration was successful (as shown before in Fig. 3.23). In (a) a baseline
corrected (baseline set to zero) overlay of the data for the eleven injected samples
is shown. The data is only shown for Fc3. In (b) the reference injection (1 nM
respectively 0 nM) is subtracted from each curve which reduces the refractive
index conditional steps by buffer changes. Where in the rising phase in (a) a
“nose” is visible (at about s 200) this artifact is almost eliminated in (b) leading
to the conclusion this artifact might be due to buffer changes. In (b) therefore
the reaction curves are easier to interpret. The explanation that the “nose” is
a superposition of hybridization signal (actual mass adsorption on the surface)
and changes in refractive index due to buffer changes correlates with the fact that
running buffer and probe solution do slightly differ.
With 1 nM concentration we clearly reach saturation after injecting the 25µL
sample. This might also be the case for the 500 nM injection whereas at lower
concentrations saturation is not reached.
With Fig. 3.26 we have proven that the differentiation between concentrations is
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Figure 3.25: Effect of stringency on match and mismatch configuration: Both
figures show the hybridization of a single strand oligo to the immobilized ssDNA
on the sensor surface under similar conditions than before. In (a) a perfect match
antisense strand was injected and hybridized specifically to the capture probe.
Injecting H2O does almost not affect the binding (loss <5 %). Fc4 (pink curve)
acts as reference and was not flushed with H2O, therefore does not show any loss
of signal respectively bound material. In (b) Fc1–3, a mismatch sequence with
two non-matching bases was injected. The target is expected to bind unspecific
respectively partially specific to the immobilized ssDNA on the sensor surface. By
flushing with H2O we induce enough stress to partially remove unspecific bound
material (loss >15 % during first H2O flush). In contrast the reference Fc4 with
a perfect match is almost not affected by the H2O flush. This proves that the
affinity of our assay is significantly less for unspecific bound oligos and therefore
we can distinguish between specific target and unspecific binding effects.
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possible. For further statements a series of experiments at lower concentrations
had to be set up.
3.3.8 High sense SPR detection and assay conditions
Finally we wanted to gain insight in different assay conditions to improve the
sensitivity of the assay. Several variables were altered to check their influence on
the sensitivity: (i) chip source (recycled or new), (ii) immobilization time (1 h or
>10 h), (iii) immobilization post-treatment with MCU to reduce the immobiliza-
tion density (none or 1 h). As analyte we chose target concentrations around the
actual lower limit of detection from the experiment shown in Sect. 3.3.7. Besides
the hybridization of a perfect match oligo we injected in each series a mismatch
control to observe the signal behavior.
Results are shown in Tab. 3.4, 3.5 and 3.6. The Biacore sensor chip was either
recycled from a former CM5 chip by cleaning it according to protocol with deter-
gents and UV/O3 (stated as CM5), or as commercially bought clean Au chips
activated by UV/O3 treatment (stated as Au). Functionalization was done by
incubation with 1µM thiolated sense match DNA in TEAA buffer for 1 h or
overnight (stated as >10 h). TEAA was chosen although slightly better results
were achieved with NaCl-TE buffer in previous experiments. This decision was
made to have direct comparability to the CLA experiments and reference experi-
ments in Martin Hegner’s group. Certain chips were post-processed by incubation
with a MCU spacer for 1 h to reduce the immobilization density for improved
hybridization.
Each column in Tab. 3.4, 3.5 and 3.6 belongs to one sensor chip. Multiple
samples were injected in series with urea regeneration in between. Before each
injection we recorded a stable baseline to ensure that the system was equilibrated.
50µL, 5µL/min sample were injected for each hybridization. The increased sam-
ple volume compared to previous experiments was chosen due to the fact that
saturation was not reached at 25µL sample volume for low concentrations (as
shown in Fig. 3.26).
We recorded the response signal for each injection. Tables 3.4, 3.5 and 3.6 show
the resulting amplitudes for each hybridization, as well as the drift plus mentioned
assay conditions. The stated drift corresponds to an average value of the first
injection cycle. Drift normally decreases over time.
The experimental series displayed in Tab. 3.4 proves a positive effect of the
MCU post-treatment on the drift. The recycled chips do also have less drift. In
terms of signal amplitude no significant statement can be made by comparing the
described assays. The chip to chip variability is very high and therefore we can-
not conclude which immobilization protocol leads to the most sensitive result so far.
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Figure 3.26: Concentration series on SPR assay: Both graphs show the identical
experiment of a series of injections of various samples with differently concentrated
targets. The 11 samples were injected sequentially on the same chip which was
prepared as described before. The data is shown as an overlay of each injection
for Fc3. After each hybridization the chip war regenerated by injecting 2×
urea. In (a) only a baseline correction was applied to set all baselines to zero.
In (b) the reference injection (1 nM respectively 0 nM) was subtracted for each
curve. The decrease of signal for lower concentrated samples can be observed.
1’000 nM and 500 nM seem to reach saturation and therefore do have similar
amplitudes. Expected decrease by 1
2
due to the 1:2 dilution steps is not visible.
For lower concentrations (<125 nM the signal seems to suddenly break down. The
differentiation between concentrations is possible.
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Chip Au CM5 CM5
DNA immobilization 1 h >10 h >10 h
MCU post-treatment no no 1 h
Drift 6 RU/min 2.4 RU/min ∼0 RU/min
antis. Match 100 nM 70 RU 65 RU 80 RU
antis. Match 50 nM <10 RU 8 RU 3 RU
antis. Match 100 nM 55 RU 70 RU 43 RU
antis. Mism. 100 nM 55 RU 50 RU 75 RU fast dissociation
antis. Match 100 nM 45 RU 70 RU 67 RU
antis. Match 50 nM - 20 RU 3 RU
Table 3.4: SPR results for different chip functionalization times and MCU
post-treatments.
Chip CM5 Au
DNA immobilization >10 h >10 h
MCU post-treatment 1 h 1 h
Drift ∼0 RU/min ∼0 RU/min
antis. Match 100 nM 90 RU 60 RU (peak 285 RU)
antis. Match 50 nM 70 RU 20 RU
antis. Mism. 100 nM 60 RU 15 RU
antis. Match 100 nM 80 RU 60 RU
antis. Match 50 nM 80 RU 55 RU
antis. Mism. 100 nM 60 RU 15 RU
Table 3.5: SPR results to compare a recycled CM5 chip and a commercially
bought Au Biacore sensor chip.
The detection of low concentrations (<100 nM) is still challenging and the sig-
nal tends to fall below the lower limit of detection. Differentiation between match
and mismatch sequences can only be done by observing the kinetics (dissociation).
The signal amplitude is almost identical for 100 nM antisense match and 100 nM
antisense mismatch probes.
In the experimental series displayed in Tab. 3.5 the previous findings were
directly implemented. Therefore both chips were post-treated with MCU. The
focus lays on the difference between a recycled CM5 Biacore sensor chip and a
commercially bought clean Au chip. In terms of drift both chip types do show
very stable signals. This was expected due to the previous findings with the
MCU post-treatment. Both chips lead to feasible results even for 50 nM. The chip
type to chip type variability is not very high. By trend the recycled CM5 chip
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Chip CM5 CM5 Au
DNA immobilization >10 h >10 h >10 h
MCU post-treatment 1 h 1 h 1 h
Drift <0.5 RU/min ∼0 RU/min ∼0.3 RU/min
antis. Match 100 nM 75 RU 110 RU 40 RU
antis. Match 50 nM 15 RU 5 RU 5 RU
antis. Match 10 nM 7 RU 3 RU 3 RU
antis. Match 1 nM 0 RU 0 RU 0 RU
antis. Mism. 100 nM 8 RU 70 RU 15 RU
antis. Match 100 nM 60 RU 105 RU 45 RU
antis. Match 50 nM 3 RU 7 RU 5 RU
antis. Match 10 nM 3 RU 5 RU 3 RU
antis. Match 1 nM 0 RU 0 RU 0 RU
antis. Mism. 100 nM 12 RU 60 RU 20 RU
Table 3.6: SPR results from measured concentration series down to low concen-
trations (1 nM matching target strand): Results listed for three experiments on
two chip types with identical immobilization conditions.
led to higher signal amplitudes. Compared to measurements on assays without
MCU post-treatment we measured slightly higher signals. This correlates with
the literature. Therefore the MCU post-treatment is favored for this type of assay
and can lead to higher signal responses under ideal conditions.
The chip to chip variability is very high. The intra chip variability is much smaller.
Several injections on the same chip with regeneration in between do show similar
results.
Hybridization signal amplitudes shown for the CM5 chip in Tab. 3.5 are
surprisingly high compared to previous experiments. Even the 50 nM antisense
match injection signal is above the lower limit of detection.
In terms of comparability with the CLA assay there is one major difficulty.
The long functionalization times we use for the SPR protocol cannot be applied on
the cantilevers. Long immobilization times lead to high initial deflections. CLA
with strongly bent CL cannot be used for proper readout due to technical reasons.
Therefore we had to adapt the SPR protocol several times to the CLA protocol.
The set of experiments shown in Tab. 3.6 focuses on relatively low target
concentrations in SPR. Two recycled CM5 Biacore sensor chips were used to check
the chip to chip variability. Furthermore a clean Au chip was used to compare it
with the recycled ones.
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The results did not show any unexpected behavior. Drifts were small as expected
for the assay with MCU post-treatment. Recycled chips lead to slightly higher
signal amplitudes compared to the Au chip. Especially for higher target concen-
trations the statement is valid. At low target concentrations the signal seems to
drop below the lower limit of detection. Nevertheless we can distinguish between
samples with 10 nM and 1 nM target concentration. The sensitive results achieved
in the previous experiment (Tab. 3.5: CM5 chip: >50 RU at 50 nM antis. Match)
could not be repeated.
General Discussion
Plain Au sites have a high affinity for biomolecules. Uncovered Au sites lead
to drift by attracting biomolecules during the measurement. The MCU post-
treatment might cover such “unprotected” sites and therefore be less prone to
drift. Recycled chips might be not fully cleaned and therefore have less plain Au
sites compared to commercially bought plain Au chips. Therefore recycled chips
do show less drift than bare Au chips.
Reason for the high chip to chip variabilities could be varying qualities in
probes and buffers for functionalization and hybridization. Thiolated sense strands
for immobilization tend to form S-S double bonds which would lead to poor func-
tionality. Furthermore the buffer components in TEAA are all volatile. To ensure
the best functionalization results freshly prepared buffers are required and thio-
lated probes have to be protected with inert gas after extracting the DTT. The
major reason for the chip to chip variability is for sure the fact that the cleaning
process during recycling is not absolute. Results from XPS (shown in Sect. 3.1.1)
lead to the conclusion that the sensor surface is not completely free of remains.
The percentage and composition of remains will be highly different from chip to
chip and therefore alter the immobilization density and quality. The antisense
probe concentration was checked by NanoDrop and normalized for all experiments.
Instrumental sensitivity is for SPR often not a crucial factor. A monolayer of
water which is in terms of biology one of the smallest detectable molecules, already
leads to a sufficient resonance peak shift corresponding to approx. 310 pg/mm2.
What limits the assay’s sensitivity is the affinity. The most common surface
functionalization method is a self-assembled monolayer by thiolated probes. This
fits perfectly in our strategy to build an analogue assay for CLA and SPR
technology. High functionalization densities offer many binding partners, but have
poor affinity due to steric hindrance as discussed before. Although an optimized
immobilization protocol was used, we expect further improvements by focusing
on immobilization strategies.
Compared to previous label-free DNA hybridization assay experiments we are in
range (10 nM Nelson et al. [17]; 1µM Peterson et al. [32]; 500 nM Lao et al. [18].
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3.3.9 Summarized dose response curve
A dose response curve was plotted summarizing all SPR measurements (Fig. 3.27).
For points with more than on measurement the average value was taken and error
bars are shown. Included in those values are different assay preparations such as
different chip types, buffers and reaction times.
The curve does not represent a perfect kinetic study. At lower concentrations the
reactions did not reach saturation.
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Initial(A1) 3.18542 7.09637
Final  (A2) 392.16393 11.06463
EC50   (x0) 184.61852 9.29067
Power  (p) 2.62951 0.26473
R
es
po
ns
e 
(R
U
)
log Concentration (nM)
Figure 3.27: Dose-response curve for summarized SPR data: A logistic model
was applied and a sigmoidal fit plotted. Error bars include chip to chip variabilities
and intra chip results. Lower limit of detection, respectively sensor response
threshold level is not shown. For the summarized experiments a very poor
dynamic range is observed and the field of operation, respectively sensitivity is in
the 10 to 1’000 nM range.
Generally it is not necessary to wait for saturation during SPR experiments.
Kinetics can be calculated from association and dissociation. Therefore a kd can
be determined although the reaction did not reach saturation yet. For very low
concentrations association cannot be calculated due to the fact that only a linear
slope can be observed. For correct prediction at least a flattening of the curve
must be visible. We have not done kinetic studies with our data.
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3.3.10 Overlay of dose response curve for SPR and CLA
Comparing sensitivity and specificity from CLA and SPR data did not lead to
a satisfying result for better understanding the two technologies. Main reason
therefore is the fact that we were not able to detect similar concentrations by
SPR as with CLA.
In Figure 3.28 we plotted an overlay of the dose response curve from the CLA
experiment Sect. 3.4.6 (green curve) and a combined overview of all performed
SPR experiments leading to a dose response curve for the SPR platform (blue
curve) (equal to Fig. 3.27). By comparing the two curves side by side we see
differences in the two types of assay. The result leads to a better understanding
in terms of sensor response such as dynamic range and sensitivity.
For each concentration the corresponding response was plotted (cantilever deflec-
tion in [nm] for CLA and shift of refractive index in [RU] for SPR). A sigmoidal
fit (logistic model) was applied to the existing data points. For the CLA, data
points in the upper region are missing and therefore the fit is not very accurate.
For CLA the data was recorded in a study with cell lysate background; sample
volume 600µL, injection speed 150µL/min, incubation for10 min at 10µL/min
(about one chamber volume per minute). This leads to a possible time for hy-
bridization of ∼12 min (2 min are lag time until the probe reaches the chamber).
For SPR the data was recorded in PBS without background; sample volume 50µL,
respectively 25µL; flow speed 5µL/min (the camber volume in the Biacore 2000
device is estimated to be 0.5µL). This leads to a hybridization time of 10 min,
respectively 5 min.
0.1 1 10 100 1000 10000 100000 1000000 1E7
100
200
300
400
500
600
0
100
200
300
400
500 CLA: Model: Logistic
Parameter Value Error
---------------------------------------------
Chi^2/DoF 118.13859
Initial(A1) 101.10995 10.74021
Final  (A2) 556.30983 698.68283
EC50   (x0) 2126.60182 10498.80475
Power  (p) 0.53077 0.27137
R
es
po
ns
e 
(R
U
)
R
es
po
ns
e 
(|n
m
|)
log Concentration (pM)
SPR: Model: Logistic
Parameter Value Error
---------------------------------------------
Chi^2/DoF 125.14847
Initial(A1) 3.18542 7.09637
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Figure 3.28: Overlay of Figure 3.38 and Figure 3.27 to compare the SPR and
CLA dose response: Dynamic range, sensitivity and field of operation are different
for SPR and CLA.
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Although it is not a perfect comparison due to the missing CLA data and the
varying SPR conditions, a trend is visible and comparability with the literature
given. The SPR conditions are identical with Peterson et al. [32]:
- Same immobilization procedure (>10 h DNA immobilization, 1 h MCU).
- Analogue immobilization buffer. KH2PO4 was tested and compared to PBS
with no special benefit.
- Capture probe density of 2.8×1012 molecules/cm2 = 2.8×1010 molecules/mm2
= 306 pg/mm2 would lead to 300 RU signal which correlates perfectly with
the measured 270 RU during the immobilization experiment on the Biacore
device (Mw oligo: 6’581.8 g/mol, Avogadro constant: 6.022×1023 mol−1).
Expected value for improved immobilization outside the instrument is
11×1012 molecules/cm2 = 11×1010 molecules/mm2 = 1’202 pg/mm2 equals 1’200 RU.
Saturated hybridization with 100 % efficiency would lead to an additional 1’200 RU.
With the improved immobilization outside the device we achieved 400 RU. This
would be 30 % efficiency. Not taken into account is the reduction of immobilization
density by the MCU leading to less than 1’200 RU signal. This would lead to
about 50 % efficiency which is close to the results from Peterlinz et al. [20].
A possible explanation for the observed deflection of the CLA at target
concentrations beyond the SPR assay’s lower limit of detection is a nonlinear
response of the CLA. A nonlinear response can lead to a detectable signal at very
low concentrations of hybridized probes on the sensor surface. A high dynamic
range and increased sensitivity at lower concentrations compared to SPR would
be the logic consequence. Consequently, CLA should have a lack in sensitivity
at higher concentrations compared to SPR with its linear response to surface
concentration of bound molecules.
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3.4 Biological Application
Our goal was the label-free detection of noncoding RNAs. After showing the
cantilever array instrument’s feasibility to be a tool for such short oligo detection
(see Sect. 3.2) we started a series of experiments towards the detection of miRNA
in biological relevant probes. Table 3.7 shows the summarized results which will
be explained in details in this chapter.
We started with the in vitro detection of synthetic samples to check the feasibility
of sensing a specific strand out of a pool of totRNA (Sect. 3.4.2). Further we tested
the detection of synthetic oligos in a cell lysate background (HepG2, Hep3B, ME15
and HuH7) (Sect. 3.4.3). Compared to the totRNA in vitro experiments cell lysates
contain proteins, lipids and other cellular fragments making the background much
more complex. As target for the experiments we chose a possible siRNA target
construct (F7-1) and a miRNA of biological interest (miR-122). The first cell
lysate experiments were done with synthetic target spiked in. Finally we analyzed
biological samples with naturally occurring targets (Sect. 3.4.4, 3.4.5), concluded
on their target concentration by referring to a dose-response curve (Sect. 3.4.6)
and tested the detection of miRNAs directly in rat plasma (Sect. 3.4.7).
For diagnostics or as test in non-clinical safety several work-flows are conceivable.
Either the total RNA including all micro RNA is purified and only the RNA is
analyzed, or full cell lysate or plasma is used directly. Direct detection is preferred
as explained in the introduction (Sect. 1.1).
The measurements present a new approach for label-free direct miRNA biomarker
detection.
3.4.1 totRNA fragmentation
We used total RNA as artificial background for several hybridization studies.
Either for improved competition to the short ncRNA targets or in case of sequence
detection on mRNA, the totRNA has to be fragmented. Besides fragmentation
to increase competition, fragmentation could be a method to improve sequence
detection of specific targets on long mRNA strands.
We fragmented totRNA according to an established protocol for cRNA frag-
mentation for Affymetrix GeneChips (see Appendix A.1). Fragmentation time
was varied from 10 min to 60 min to find the best fragmentation conditions to yield
strands of similar length to ncRNAs. The resulting fractions were analyzed by
standard methods to check for quality and size (Fig. 3.29). Complete Bioanalyzer
data can be found in the appendix (Appendix B.4.2).
Table 3.8 shows the results from the NanoDrop check before fragmentation
and for each fraction after fragmentation and precipitation.
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Instrument Name: DE24802247 Firmware:
Serial#:
Assay Information:
C.01.069
DE24802247
Instrument Information:
Assay Origin Path: C:\Program Files\Agilent\2100 bioanalyzer\2100
expert\assays\RNA\Eukaryote Total RNA Nano Series II.xsy
Assay Class:
Version:
Assay Comments:
Eukaryote Total RNA Nano
2.6
Total RNA Analysis ng sensitivity (Eukaryote)
 
© Copyright 2003 - 2009 Agilent Technologies, Inc.
Chip Information:
Chip Comments:
Type: G2938B
Chip Lot #:
Reagent Kit Lot #:
1/10 unfragmented
RIN: 8.60
10' fragmented
RIN: 2.40
20' fragmented
RIN: 2.50
35' fragmented
RIN: 2.50
45' fragmented
RIN: 2.60
60' fragmented
RIN: 2.60
2100 Expert (B.02.07.SI532) © Copyright 2003 - 2009 Agilent Technologies, Inc. Printed: 01.09.2010 09:42:04
2100 expert_Eukaryote Total RNA Nano_DE24802247_2010-09-01_09-24-18.xad Page of1 11
Created:
Modified:
01.09.2010 09:24:18
01.09.2010 09:40:03Data Path:
Eukaryote Total RNA Nano
C:\...Eukaryote Total RNA Nano_DE24802247_2010-09-01_09-24-18.xad
Assay Class:
Electrophoresis File Run Summary
Figure 3.29: Overview of results from Bioanalyzer run: Data displayed for
fragmented fractions 10 min to 60 min and an unfragmented control 1:10 from
stock. Visible shift from 1’400 nt and 4’000 nt probably from the 18S and 28S rRNA
towards lower fragmented length around 90 nt. The longer the fragmentation time
was chosen, the more defined is the peak towards 90 nt. For times longer than
35 min the differences are minimal.
Stock 10 min 20 min 35 min 45 min 60 min
Concentration
(ng/µL)
500.4 611.5 885.1 889.8 776.2 780.3
A260 12.511 15.288 22.128 22.246 19.405 19.509
A280 6.340 7.718 10.824 10.899 9.680 9.830
260/280 1.97 1.98 2.04 2.04 2.00 1.98
260/230 2.21 2.25 2.21 2.20 2.21 2.20
Table 3.8: NanoDrop results for original and fragmented totRNA.
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3.4.2 F7-1 detection in totRNA background
With the proof of concept experiment Sect. 3.2.1 we have shown the detection of
a 100 pM antisense strand and the differentiation between a perfect match and
mismatch sequence. As next step we tried to prove the detection of the same
target strand in background. Figure 3.30 shows the detection of 1 nM F7-1 target
in 10 nM totRNA background that consists of 346µg fragmented 90 nt long human
reference RNA. The cantilever chip was functionalized as before with four CL
target capture and four CL non-matching reference sequence (see Fig. 2.3). The
injection protocol was the same as described in Sect. 3.2.1 and the experiment
shown in Fig. 3.2. Sample volume was decreased to 600µL. For a real biological
sample this is still way too much, but it was a first attempt to decrease the
sample volume and our intention was not the optimization of the instrument
towards microfluidics. Injection flow speed was increased to 150µL/min. This
value was recommended by M. Hegner due to experiences from former experiments
to achieve an optimal fluid exchange in the flow chamber.
The graph (Fig. 3.30) shows the overlay of two consecutive injections: the
first injection was a negative control with only totRNA and the second injection
the totRNA sample with spike-in target. Between the two injections the chip
was regenerated with 4 M urea. Urea denatures double stranded nucleic acids.
Previous experiments without regeneration step but otherwise identical conditions
did not lead to a successful detection of a target.
With the resulting net deflection of ∼−150 nm we could show that the detec-
tion of a short single strand oligo target (1 nM) is possible even in a background
of totRNA (10 nM). Total RNA in a concentration of 10 nM does not lead to any
differential deflection, but binds in an unspecific way such that a regeneration for
subsequent specific hybridization is necessary.
Normalization as described in Ref. [45] did not had a significant effect on the result.
The experiment was repeated with a decreased spike-in target concentration
of 500 pM. The net deflection resulted in ∼−75 nm proving the detection of a
short single strand oligo target (500 pM) is possible in a background of totRNA
(10 nM).
We did not analyze further concentrations for the detection of a short oligo
target strand in totRNA background. A concentration series target versus back-
ground was one of R. Mishra’s goals in a parallel study.
Mistakes by wrongly chosen sequences or due to failed chemistry during
immobilization can lead to badly functionalized cantilevers and false positive
results. Therefore we decided to inject prior to each measurement a negative
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Figure 3.30: Overlay of two consecutive experiments to show the detection of a
1 nM antisense strand in a background of 10 nM fragmented totRNA: The graphic
shows the significant difference between the injection of a 10 nM fragmented
totRNA sample with 1 nM antisense target strand spiked in (black curve) and
the injection of only the totRNA (red curve). Injecting the probe sample induces
approx. −150 nm differential deflection, where the injection of only a sample with
unspecific totRNA leads to no differential signal. Phase (I) shows the recorded
baseline at 10µL/min buffer flow. (II) 600µL sample injection at 150µL/min.
(III) incubation phase at 10µL/min. (IV) flushing with buffer 150µL/min. (V)
resulting differential deflection after injection cycle is completed (10µL/min buffer
flow). Curves correspond to the differential deflection signal of positive minus
reference CL. The two injections were performed in series on the same cantilever
array chip. A baseline correction, normalization, averaging and differential signal
calculation (probe: CL1,2,5 minus reference: CL7,8) were done according to the
literature [45].
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control, although the CLA assay by itself is already a referenced system. False
positive results from badly functionalized CLs either by wrong sequences or due
to failed chemistry can be excluded.
3.4.3 Spike-in F7-1 detection in HepG2 cell lysate
Compared to totRNA cell lysates contain besides unspecific nucleic acids a signifi-
cant amount of proteins, lipids and tissue fragments. Therefore measurements to
analyze cell or tissue lysates are much more complex. As close model towards the
detection of naturally occurring oligo targets we have chosen a HepG2 cell line as
background for the following set of experiments. HepG2 is by nature negative for
the F7 target. For detection we spiked in the F7-1 ssDNA. As negative control
either the pure or diluted cell lysate in 1x lysis buffer (dilution with hybridization
buffer) was used.
Figure 3.31 shows the detection of: (a) 500 pM spike-in target in 1:1 diluted
HepG2 cell lysate and (b) 500 pM spike-in target in undiluted HepG2 cell lysate.
Functionalization was done according to pattern Fig. 2.3. In (a) we injected first
the negative control followed by a regeneration step with urea and the second
injection with target probe. In (b) we skipped the negative control and only
injected the target sample. All samples were denatured before injection for im-
proved subsequent hybridization.
A typical injection pattern can be observed which is slightly different from previous
experiments with pure samples or totRNA background. After recoding a stable
baseline (phase (I)), we injected the sample (phase (II)). The increased flow speed
of 150µL/min induced an impact on the CLs. Following a short lag phase the
sample entered the chamber and induced various forces led to a typical signal
pattern with a peak towards the minimum before the signal equilibrates. Switching
the flow speed for the incubation phase to 10µL/min leads to a relaxation of
the CLs and a deflection in the opposed direction than increasing the flow speed.
Much more fluctuations can be observed during the incubation phase (III) with
cell lysates compared to less complex probes. This is mainly due to the change
in refractive index of the not fully clear solution plus the higher sample viscosity
inducing more flow forces. Furthermore the PSD sum signal decreases rapidly due
to the opacity, which makes a feasible kinetic readout difficult. With undiluted
cell lysates it is almost impossible to interpret the data during the injection cycle.
Nevertheless an endpoint measurement is feasible, because remaining probe was
removed during the wash step (phase (IV)) by flushing the chamber with buffer.
The increased flow speed in phase (IV) induced again strong deflection and a
short lag phase can be observed, before a stable signal was recorded. Finally
the automated injection cycle switched back to standby conditions (10µL/min),
and the resulting deflection values were monitored (phase (V)). Typical for all
cell lysate injections is the short relaxation after the wash step. Therefore we
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waited before the signal started to drift and took as final resulting values the local
minimum for all cell lysate experiments.
The two graphs prove the detection of 500 pM spike-in F7 target strand either
in 1:1 diluted HepG2 cell lysate or undiluted HepG2 cell lysate. Probe injection
patterns (black curves) are similar for diluted (a) and undiluted (b) cell lysate
experiments.
An additional injection of 100 nM pure F7-1 probe sample did not induce any
further deflection (not shown in graph) indicating a saturation of probe on the
CLs or blocking by unspecific bindings.
By directly injecting the probe solution without a previous negative control
injection (Fig. 3.31 (b) compared to (a)) we were not able to observe higher
deflections. This means the regeneration works well for this set of experiments.
Negative controls are useful to check the functionality of the array and for absolute
statements. With the cell lysate samples even the negative control induces a
differential deflection. This might be on one hand due to higher effects of unspecific
bindings. Even more likely is the possibility that negative samples do not contain
absolutely zero target. Depending on the affinity and sensitivity of our assay we
might catch up a signal even by very low remaining concentrations.
3.4.4 F7 detection in Hep3B cell lysate
The detection of RNA transcripts in biological samples is essential for microbio-
logical applications. In the following section we detected full-length F7 mRNA in
a biological sample to prove the feasibility of the CLA system for this application.
A Hep3B cell line expresses mRNA with the F7 sequence and was selected as
probe. A HepG2 cell lysate was used as negative control.
To validate the system we first tried to detect F7 RNA in Hep3B cell lysate in
1x lysis buffer (graph not shown). Functionalization was done according to pattern
Fig. 2.3. As negative control we could refer on HepG2 injections from previous
experiments. As in cell lysate experiments before, we can observe the typical
injection pattern such as lag phase, peaks and minimums, and the relaxation
after wash step. Due to the sample properties expected fluctuations during the
incubation phase were induced.
The sample was denatured before injection by tempering up to 80 ◦C. The forma-
tion of some visible particles was observed due to the denaturing of all proteins.
Those particles form a pellet during a short spin on a mini centrifuge according
to protocol. Some particles remained in the liquid phase after spinning.
The injection led to a signal of ∼−150nm average differential deflection with
almost no drift. The resulting signal is high compared to the previous spike-in
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(a) 500 pM detection in 1:1 HepG2 cell lysate
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(b) 500 pM detection in undiluted HepG2 cell
lysate
Figure 3.31: Two consecutive experiments to prove the detection of a 500 pM
spike-in antisense strand in cell lysate: (a) The graph shows the significant
difference between the injection of a HepG2 cell lysate containing a spike-in
target (black curve) and the injection of the cell lysate negative for the target
(red curve). Injecting the positive sample induces approx. −100 nm differential
deflection whereas the injection of only the cell lysate leads to approx. −50 nm
differential deflection signal. Phase (I) shows the recorded baseline at 10µL/min
buffer flow. (II) 600µL sample injection at 150µL/min. (III) incubation phase
at 10µL/min. (IV) flushing with buffer 150µL/min. (V) resulting differential
deflection after injection cycle is completed (10µL/min buffer flow). (a) Both
injections were performed in series on the same cantilever array chip with a 1:1
diluted cell lysate. A baseline correction, normalization, averaging and differential
signal calculation (probe: CL2 minus reference: CL8) were done according to
the literature [45]. (b) An experiment with positive probe was repeated for a
undiluted 100 % cell lysate. No negative control was repeated in (b) due to its
similarity to (a). Post-processing in (b) was performed with differential signal
calculation (probe: CL2,5 minus reference: CL7,8) and otherwise same conditions
as in (a).
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experiments. This leads to the conclusion that the concentration of F7 transcripts
in the Hep3B cell lysate is quite high which could be expected from the Lit. Ravon
et al. (Ref. [48]). Therefore the detection of F7 RNA in Hep3B cell lysate looks
promising (sufficient amount of target for the detection by CLA technology). The
experiment should be repeated with negative control.
The detection of F7 in Hep3B cell lysate was repeated including negative
control. Figure 3.32 shows the analysis of Hep3B cell lysate in 1x lysis buffer
1:1 diluted with PBS. Due to high signal intensities in the previous validation
experiment we decided to dilute the sample to reduce the amount of denatured
proteins and fluctuations due to the sample properties (viscosity and opacity). As
negative control we used the HepG2 cell lysate. Both samples were normalized
on their total protein concentration. The negative control was injected first and
in between the two injections a regeneration step with urea was performed. Ex-
ceptionally we did not denature the samples to check the binding affinity under
those conditions.
Injecting the probe sample induced approx. −60 nm differential deflection whereas
the negative HepG2 sample led to almost no differential signal. Values for the final
result were taken after the short relaxation right after the wash step. Although
signals intensities are less than before, mainly due to the diluted probe and no
denaturing, the detection of F7 in Hep3B cell lysate is possible and verified by
the negative control.
The shown experiment proves the detection in diluted samples works as well
as in undiluted cell lysates. We can distinguish between positive and negative
probe (shown Fig. 3.33). The ±1 SD areas (blue) for the differential signal of
positive and negative probe do not overlap. Therefore Statistical relevance is given.
Finally we repeated the previous experiment with undiluted cell lysate, with
denaturing and negative control to have a full set of target detection in undiluted
cell lysate with negative control. Figure 3.34 shows the analysis of undiluted
Hep3B cell lysate in 1x lysis buffer. As negative control we injected primarily
a HepG2 cell lysate with normalized protein concentration for both samples.
Between the two sample injections we regenerated the cantilever chip with 0.5 M
NaOH. A different chip regeneration agent was chosen with the idea to optimize
the regeneration. With an optimized regeneration higher signal intensities were
expected for the second injection. NaOH is a commonly known denaturing agent
for nucleic acids used in Southern and Northern blot techniques.
Injecting the Hep3B sample induced approx. −260 nm differential deflection
whereas the injection of the negative control (HepG2) led to approx. −80 nm
differential signal (values taken right after relaxation in end phase and before the
signal started to drift). A strong drift can be observed during the end phase (V)
of the second injection possibly due to the NaOH chip regeneration (see Ap-
pendix B.4.1).
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Figure 3.32: Overlay of two consecutive experiments to prove the detection of F7
in diluted Hep3B cell lysate: The graph shows the significant difference between
the injection of Hep3B positive for F7 cell lysate (black curve) and the injection of
HepG2 negative for F7 cell lysate (red curve). Both cell lysates were normalized
on their total protein concentration and diluted 1:1 with PBS buffer. Injecting
the Hep3B sample induced approx. −50 nm differential deflection whereas the
injection of the negative control (HepG2) led to no differential signal. Phase
(I) shows the recorded baseline at 10µL/min buffer flow. (II) 600µL sample
injection at 150µL/min. (III) incubation phase at 10µL/min. (IV) flushing with
buffer 150µL/min. (V) resulting differential deflection after injection cycle is
completed (10µL/min buffer flow). The two injections were performed in series
on the same cantilever array chip. A baseline correction, normalization, averaging
and differential signal calculation (probe: CL1,2 minus reference: CL7,8) were
done according to the literature [45].
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Figure 3.33: ±1 SD areas for the analysis of Hep3B cell lysate 1:1 diluted: Raw
data for averaged and baseline corrected deflections of probe (green) and reference
(red) cantilever as well as differential deflection (orange). In blue the ±1 SD is
given for each data line. Combining the two graphs (a) and (b) would lead to the
conclusion that the differential deflections of (a) and (b) do not interfere with
each other (no overlap of ±1 SD areas (areas of interest highlighted in blue)).
Therefore the we can differentiate between probe and negative control.
As before we observed the formation of many particles during denaturing and the
formation of a pellet during a short spin on a mini centrifuge (common step by
protocol) due to the denatured proteins.
We can distinguish between positive and negative probe (Fig 3.35).
Undiluted cell lysates lead to higher deflections but do also induce a signal during
negative control injections. The reason therefore we discussed before and might
be due to the fact that negative control samples are not absolutely free of target.
Several attempts such as repeated injections (to test the reproducibility), skip
of negative control (to test variations between injection 1 and 2) and different
regeneration methods were shown to prove accuracy and consistency during a full
experiment. A Peltier peak test was performed to monitor the functionality of
the cantilever array as stated in Materials and Methods Sect. 2.5.3. Results are
shown in Appendix B.4.3, Fig. B.4 and prove that the mechanical properties of a
cantilever array do not change during multiple injections with regeneration.
3.4.5 miR-122 detection in ME15 and HuH7 cell lysate
Up to this point we measured mRNA transcripts which could be used for off-
target analysis of siRNAs analogue to the Ref. [48]. Now we focus on the the
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Figure 3.34: Detection of F7 mRNA in a Hep3B cell lysate: The graph shows
the significant difference between the injection of Hep3B positive for F7 cell lysate
(black curve) and the injection of HepG2 negative for F7 cell lysate (red curve).
Both cell lysates were normalized on their total protein concentration. Injecting
the Hep3B sample induced approx. −260 nm differential deflection whereas the
injection of the negative control (HepG2) led to approx. −80 nm differential
deflection signal. Phase (I) shows the recorded baseline at 10µL/min buffer flow.
(II) 600µL sample injection at 150µL/min. (III) incubation phase at 10µL/min.
(IV) flushing with buffer 150µL/min. (V) resulting differential deflection after
injection cycle is completed (10µL/min buffer flow). The two injections were
performed in series on the same cantilever array chip. A baseline correction,
normalization, averaging and differential signal calculation (probe: CL1,2,6 minus
reference: CL4,8) were done according to the literature [45].
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Figure 3.35: ±1 SD areas for the analysis of Hep3B cell lysate: Raw data for
averaged and baseline corrected deflections of probe (green) and reference (red)
cantilever as well as differential deflection (orange). In blue the ±1 SD is given for
each data line. Combining the two graphs (a) and (b) would lead to the conclusion
that the differential deflections of (a) and (b) do not interfere with each other
(no overlap of ±1 SD areas (areas of interest highlighted in blue)). Therefore the
we can differentiate between probe and reference and the experiment gains in
statistical correctness.
detection of miRNAs as biomarkers of special interest. Therefore the presented
assay has a high relevance for biological applications. Problematic could be the
fact that miRNA is typically double strand. This would impair the binding to
our immobilized capture single strand.
In the following set of experiments we prove the feasibility to detect naturally
occurring miRNA targets with our label free direct binding assay based on nanome-
chanical cantilever arrays.
Figure 3.36 shows the detection of miR-122 in HuH7 and ME15 cell lysate in
1x lysis buffer. Both samples were denatured prior to injection. ME15, known as
negative control for miR-122 (Ref. [47]), was injected prior to the HuH7 sample.
In between the CLA chip was regenerated with with NaOH. No sample dilution
or normalization on total protein was done.
Injecting the HuH7 sample induced approx.−300 nm differential deflection whereas
the injection of the negative control (ME15) led to approx. −100 nm differential
signal (values taken at the local minimum in the end phase (V) after relaxation
and before the signal starts to drift). The detection of miR-122 in HuH7 cell
lysate is possible. Differences between positive and negative sample injection are
visible even without optimized cantilever selection (not shown in graph).
During the injection particles stuck to CL4, CL6 and CL7, although denatured
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proteins were partially removed during a spin centrifuge step. Particles sticking
to CLs lead to the loss or a drop of the PSD sum signal. The effect is caused
either due to large deflections or by scattering the laser light at such particles.
Particles sticking to CLs result in high fluctuations in the deflection signal. An
increased buffer flow rate can sometimes wash away sticking particles and solve
the problem.
The results from the Peltier peak test to monitor the functionality of the cantilever
array are shown in Appendix B.4.3, Fig. B.5.
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Figure 3.36: Overlay of two consecutive experiments to prove the detection of
miR-122 in HuH7 cell lysate: The graph shows the significant difference between
the injection of HuH7 positive for miR-122 cell lysate (black curve) and the
injection ME15 negative for miR-122 cell lysate (red curve). Injecting the HuH7
sample induces −300 nm differential deflection whereas the injection of the negative
control (ME15) leads to −100 nm differential deflection signal. Phase (I) shows
the recorded baseline at 10µL/min buffer flow. (II) 600µL sample injection
at 150µL/min. (III) incubation phase at 10µL/min. (IV) flushing with buffer
150µL/min. (V) resulting differential deflection after injection cycle is completed
(10µL/min buffer flow). Curves correspond to the differential deflection signal of
positive minus reference CL. The two injections were performed in series on the
same cantilever array chip. A baseline correction, normalization, averaging and
differential signal calculation (probe: CL2,5 minus reference: CL3,8) were done
according to the literature [45].
As experienced before (Sect. 3.4.4), strong fluctuations were induced by in-
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jecting NaOH for chip regeneration (see Appendix B.4.1). An adapted injection
cycle protocol with shorter incubation phase and longer wash phase was more
successful than the old protocol that was used before. The resulting differential
deflections are very high and look promising (high signal amplitudes).
To exclude unknown effects due to the NaOH chip regeneration and the skipped
sample normalization on total protein, we repeated the previous experiment as
shown in Fig. 3.36 with different conditions: sample normalization on their total
protein concentration; samples diluted 1:1 with PBS; chip regeneration with urea.
The repeated experiment led to the following result: Injecting the HuH7 sample
induced approx. −120 nm differential deflection whereas the injection of the neg-
ative control (ME15) led to approx. −60 nm differential deflection signal. The
recorded PSD sum signal was much more stable than with undiluted lysates and
NaOH chip regeneration. We experienced no problems due to sticking particles
which might be due to the sample dilution. In exchange the resulting differential
deflections were less in amplitude.
Finally we proved the consistency for a repeated injection with regeneration
in between for the presented type of miRNA detection. This was shown by a
repeated injection of positive probe in Fig. 3.37.
Figure 3.37 shows the detection of miR-122 in HuH7 cell lysate in 1x lysis buffer.
The negative control was skipped and the HuH7 probe was directly injected during
the first run. We repeated the injection after chip regeneration with urea. Samples
were not diluted. Samples were denatured for improved subsequent hybridization.
Both injections induced approx. −170 nm differential deflection. Injection 1 and 2
do have almost identical injection patterns which proves the consistency of our
assay.
CL8 was excluded for further proceedings due to the loss of the PSD sum signal
of CL8 during injection 1 caused by a particle from denatured protein.
3.4.6 miR-122 dose response curve
Most of the performed experiments were of qualitative significance and for most
biomolecular applications a qualitative result is sufficient. Referring from the
CLA signal to a concentration of target molecules is difficult because multiple
factors influence the CL bending. Most commonly referenced systems map the
result to a dose response curve. For the detection of miR-122 in HuH7 cell lysate
we recorded a dose response curve with spike-in target in ME15 cell lysate as
reference (Fig. 3.38). Several spike-in concentrations were measured in the control
cell lysate ME15. As shown in Fig. 3.38 the dose response dependency can be
fitted with a logistic model as expected for such sensor systems. A sigmoidal fit
through the measured values has an R2 value of 0.98559 which proves the logistic
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Figure 3.37: Overlay of two consecutive experiments to prove the detection of
miR-122 in HuH7 cell lysate and to check the consistence of repeated injections
with urea regeneration in between: The graph shows the correlation of an injection
of HuH7 cell lysate which is positive for miR-122 (black curve) and an analogue
repeated injection (red curve). Injection 1 and 2 induce both approx. −150 nm
differential deflection. Furthermore the injection patterns are almost identical.
Phase (I) shows the recorded baseline at 10µL/min buffer flow. (II) 600µL sample
injection at 150µL/min. (III) incubation phase at 10µL/min. (IV) flushing with
buffer 150µL/min. (V) resulting differential deflection after injection cycle is
completed (10µL/min buffer flow). Curves correspond to the differential deflection
signal of positive minus reference CL. The two injections were performed in series
on the same cantilever array chip. A baseline correction, normalization, averaging
and differential signal calculation (probe: CL1,2 minus reference: CL3,4) were
done according to the literature [45].
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behavior of our system. Resulting deflections from unknown measurement with
same conditions can now be mapped on the curve and a quantitative result can
be calculated.
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Figure 3.38: Dose response curve for miR-122 detection in ME15 cell lysate: The
final differential deflection for several spike-in concentrations of miR-122 in ME15
cell lysate was recorded and plotted against the corresponding concentration. A
logistic model was applied and a sigmoidal fit drawn. With the received curve
we can basically map the resulted response in an experiment to its concentration.
The lower limit of detection based on 3×SD above the background is just an
estimation. Enough values for correct statistics are missing.
Unfortunately all measured points are in the region below the EC50. Therefore
the accuracy for slope and end-point is not given.
For the dose response curve we took the deflection amplitude values at the exact
same time spot for all measurements after the wash step (minute 34.6). The chosen
spot in the end phase was set right after relaxation and before the cantilever
bending starts to drift. The time-stamp equals the local minimum which was
already used before as explained in Sect. 3.4.5. In earlier experiments we normally
took an average over all points in the end-phase. This would also lead to a feasible
result for the cell lysate experiments
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Usually, respectively in earlier experiments we took an average over all points
in the end-phase. This should also lead to a feasible result for the cell lysate
experiments but was not applied.
Even though we have proven the possibility of receiving a quantitative result,
the cantilever system is favored for qualitative statements. Mapping a signal
to a dose response curve is a common method to quantify results. In our case
the problem is that the cantilever deflection has several origins (as explained in
Sect. 1.3) and is not fully understood yet. This makes a quantitative statement
very difficult. For each system an own dose response reference curve has to be
recorded under similar conditions (pH, salt concentration, background matrix).
3.4.7 miR-122 detection in plasma
miRNAs have a high poteintial as biomarkers to determine the health status
of subjects or single organs (see Sect. 1.5). Therefore there direct detection is
of high interest. miR-122 is specifically expressed and highly abundant in the
human liver [44] and conserved between vertebrate species [43]. Acetaminophen in
high doses induces liver toxicity in rats. In an experiment control versus treated
we could show the fast and reliable detection of miR-122 in rat plasma which
is a biomarker for liver toxicity. The significant difference of miR-122 level in
the control and treated samples could be shown resulting in ∼200 nm absolute
differential deflection between treated and control injection.
100µL EDTA-Plasma probes were obtained from an untreated control rat and
from an Acetaminophen treated one after 24 h. Both samples were diluted with
600µL PBS buffer. Dilution was done to end up with enough sample for the injec-
tion according to previous protocols matching the cell lysate experiments. Prior to
injection both samples were denatured for 5 min at 80 ◦C followed by 5 min incuba-
tion on ice. The CLA chip was functionalized according to pattern Fig. 2.3 with
the same set of thiolated ssDNA (miR-122 sense: identical for rat and human [43]).
To get further experience the experiment will be repeated and other expertise
with plasma or serum will be gained. Furthermore an experiment with absolute
negative control should be performed. Here we recommend to spike the positive
sample after denaturation with complementary ssDNA to block all binding sites.
The resulting differential deflection should be zero. This would exclude that
other factors which might be changed in the treated sample are the origin of the
observed deflection. This is a common problem in all assays for microbiological
screens. In most of the cases not only the biomarker of interest is affected by a
treatment but also many other factors which might interfere with the assay result.
A good assay is specific enough to only respond to changes of the biomarker of
interest.
An experiment with a different dilution is the next step to confirm the dose-
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response dependency.
An unspecific signal from the protein composition which might also be different
for control and treated is not expected because the changes are in the minor
percentage in respect of the total protein concentration.
3.5 General Discussion
We experienced high chip to chip variabilities during most of the cell lysate exper-
iments. A major reason is expected to be the sample preparation. Samples were
denatured for improved subsequent hybridizations. The increased temperature
followed by quick cooling down (5 min at 80 ◦C followed by 5 min incubation on
ice) leads to a “melting” of DNA/RNA double strands and denatures proteins as
well. This leads to the additional benefit that DNase or RNase function will be
stopped. Main reason for the denaturing is the chance to increase the amount of
target in single strand form, which is necessary for the direct binding assay.
Spinning down proteins after denaturing might have a positive effect such as a
simple sample preparation. By spinning down the proteins and removing the
formed pellet we partially purify our sample and get rid of disturbing cellular
parts. Although the mini spin centrifuge is not able to spin down DNA/RNA,
denatured proteins might catch sterically or by charge the DNA/RNA and pull it
down during centrifugation.
Depending on the spin duration the effect will be more or less distinctive and
leads to the chip to chip variabilities.
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Conclusion
We successfully set up a direct binding assay for the label-free detection of non-
coding RNAs by a nanomechanical sensing system based on cantilever arrays.
Sensitivity in the lower pM regime and specificity towards single basepair mis-
match were shown. In several steps towards the detection of miRNA biomarkers in
biological relevant probes we finally achieved the detection of specific miRNA out
of cell lysate and plasma. The specific detection of a short oligonucleotide strand
at 100 pM concentration in physiological buffer conditions demonstrated proof of
concept of a newly built setup. By the detection of short single stranded oligos
in totRNA background and the detection of spike-in target in cell lysates the
fundamental potential of our system was shown. An ultimate goal was achieved
by the detection of F7 mRNA transcripts out of cell lysate positive for the target
and the detection of naturally occurring miR-122 miRNA in cell lysate as well as
plasma as described at the beginning. Qualitative results were supported by a
broad comparison with negative control for each sample. Furthermore we set up
a first attempt for quantitative analysis by referring to a dose response curve for
the specific application of miR-122 detection in HuH7 cell lysate.
Assay development was supported by SPR. In a series of experiments we could
show the feasibility of chip regeneration by urea as well as concentration and
specificity studies.
In a broad series of buffer validation tests in several hybridization applications,
such as SPR measurements and DNA microarray experiments (results not shown),
we came to the conclusion that the formerly used (e. g. by M. Hegner and
Ref. [13]) 0.1×SSC buffer is not the most favored hybridization buffer for our
application. With PBS (+) we achieved the highest hybridization signals similar to
commercially distributed and highly sophisticated buffers supplied by Affymetrix
(Affymetrix Inc.) or Illumina (Illumina Inc.) hybridization buffers.
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4.1 CLA Instrumentation5
Equilibration time and drift were significantly reduced by the fast temperature
control system and continuous flow measurement. After installing the cantilever
chip it takes about 1.5 h until the system is ready to measure. The major time
consuming step is the cantilever functionalization although the protocol was
simplified by using pre-gold coated arrays and UV/O3 activation. Sample changes
(opening the box for less than 5 min) can easily be done during experiments. The
time it needs to restabilize the temperature is less than 30 min and the chamber
temperature is not even affected. With CO2 sparging, pressure compensation
and Halar tubing the formation of gas bubbles and their time consuming removal
was avoided. Further investigations into the effect of the continuous flow on
the cantilevers were carried out and are negligible, respectively fully reversible
during a full injection cycle. The gain in drift reduction (approx. 10 nm/min)
compared to the flow induced bending ∼7 nm) leads to the assumption that a
measurement under continuous flow is an improvement. State of the art electronic
components and investigations into signal stability led to a stable and reliable
device (fluctuations <5 nm for functionalized cantilever in liquid with a typical
recording timescale of 0.25 Hz). Device control, measurement and data analysis
by LabVIEW led to a fast and straightforward workflow. The specific detection
of a short oligonucleotide strand at 100 pM concentration in physiological buffer
conditions demonstrated proof of concept of this setup.
Sample volume could be reduced to 600µL without losing sensitivity. An
automated injection cycle with the following parameter was established and led to
the possibility to overlay the injection of a negative control and sample of interest:
(i) injection of 600µL probe at 150µL/min; (ii) incubation of analyte on sensor
for 10 min; (iii) wash step with 1’000µL buffer at 150µL/min. Baseline and end
phase were recorded at 10µL/min constant flow to avoid diffusion effects.
4.2 Surface Plasmon Resonance Technology
Biacore SPR as a “gold standard” for label-free detection has many advantages
compared to the CLA technology. The linear response between adsorbed mass
and signal amplitude as well as the quantitative result are two main features.
Furthermore the Biacore system has a very elaborate liquid handling system
and microfluidic network keeping the sample volume very low. Signal handling
respectively drift handling is highly implemented leading to a very user friendly
device. The handy and simple chip format is an additional advantage of the SPR.
5Partially published in Peter Noy et al.,“Instrument for Label-Free Detection of Noncoding
RNAs”, Journal of Sensors, vol. 2012, 2012.[27]
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To differentiate between match and mismatch configurations, thus specificity,
we focus on the CLA platform on the signal strength, compared to the SPR
platform where the signal amplitude does not change in the same percentage. In
SPR, the kinetics, respectively dissociation leads to the necessary information
about specificity. Not perfectly matching strands dissociate much faster than
perfect match configurations. Dissociation time is dependent on the amount of
mismatch base-pairings. A mismatch strand with 3 mismatch sites dissociates
faster than a configuration with 2 mismatch sites. Slowest dissociation is observed
with a perfect match configuration as shown in Fig. 3.24. Dissociation is con-
figuration dependent and also dependent on the mismatch position (no further
investigations were made into that topic). Distinguishing for specificity by SPR is
feasible due to its capability to observe kinetics. Kinetic studies belong to the
SPR technology’s major benefits and are usually one of the Biacore’s main fields
of applications. Negative controls are required because interpretations are only
feasible in referenced measurements where an analyte is compared with a negative
control.
The reason for the discrepancy between CLA and SPR has its origin in the way
how the transducer generates a signal. Where on the SPR an additional mass
leads to the same change of index of refraction (as long as the distance to the
sensor surface is equal for specific and unspecific bound material), we expect that
the change of surface stress is higher for specifically bound material as compared
to unspecifically bound material (higher sterical forces, more changes in charge
density and better shielding of the sensor surface against the surrounding liquid).
The evanescent wave in SPR has an exponential decay and penetrates about
200 nm into the media. All molecules present in the evanescent field contribute
to the response of the SPR sensor. In contrast to SPR, the CLA is less sensitive
to changes in unspecific surface load as long as the additional load does not lead
to additional surface stress in the boundary layer between the surface of the
cantilever and the liquid environment.
As final conclusion, we concur that it is advantageous to use different kinds
of transducers observing different kinds of physical properties to gain a better
understanding for detection of biomolecules especially with label-free techniques.
On the SPR platform regeneration by HCl is not feasible. Regeneration of the
surface is not 100 %. The endpoint after regeneration does not equal the baseline.
Furthermore a degeneration of the assay (signal amplitude decreases for each
repeated cycle) is assumed.
Regeneration by 4 M urea works well and is consistent over 88 hybridization cycles.
A quantitative measurement is possible and is the SPR’s big advantage com-
pared to other techniques as mentioned before. The binding curve is concentration
dependent in a certain dynamic range.
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In our experiments the sensitivity of the SPR assay was by a factor 1’000
less than the analogue CLA assay. Although SPR is an elaborate technique for
biomolecular interaction analysis its sensitivity for the mentioned application
seems to be limited and not feasible for a biological study. Furthermore the
dynamic range is limited and insufficient (approx. one order of magnitude).
Labeled SPR assays increasing the mass can achieve higher sensitivities such as
shown in Ref. [49] but do have all the drawbacks of labeling as discussed before.
4.3 Biological Application
In a first attempt we have successfully proven the detection of 500 pM F7-1 single
strand RNA (ssRNA) in a background of 10 nM totRNA. In terms of specificity
the negative control did not induce any differential cantilever deflection at all,
which led to an optimal differentiation between probe and negative control.
For higher competition fragmented totRNA can be used. The “Bauer Core Stan-
dard Protocol” (Appendix A.1) with 35 min fragmentation time leads to a feasible
fragment length of approx. 90 nt.
Urea regeneration in between the two injection steps of negative control and sam-
ple is necessary for the successful detection of specific targets in background. This
leads to the conclusion that totRNA and cellular fragments bind unspecifically
to the CLA and impairs a specific binding of target ssRNA in the subsequent
probe injection. This is different compared experiments without background
where the injection of a mismatch and subsequent injection of a match strand
did not require regeneration in between for successful analysis. The unspecific
adsorption of totRNA on the sensor surface is equal for probe and reference can-
tilever. This is proven by the resulting zero differential deflection during negative
control injection. totRNA binds with higher affinity than a pure mismatch sample.
The detection of spiked-in short ssRNA in diluted and undiluted cell lysate
is possible proven by the detection of 500 pM spike-in F7 target in HepG2 cell
lysate and down to 10 pM detection of miR-122 target in ME15 cell lysate.
With undiluted cell lysates it is not possible to interpret the signal behavior during
injections due to strong fluctuations in the deflection signal and drop of sum
signal due to the viscosity, inhomogeneity and opacity of the sample. End point
measurements are feasible and the sum signal fully regenerates after flushing the
chamber with buffer.
Urea regeneration works fine for cell lysate measurements proven by the fact that
a direct injection of 500 pM target leads to the same differential deflection as the
injection of sample after negative control analysis with regeneration in between.
Compared to previous experiments the injections of negative sample cell lysates do
induce a differential deflection. One explanation is the fact that certain targets are
not absolutely zero for our negative control samples. This leads to the conclusion
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that our system is highly sensitive and good references plus the comparison of
sample to a negative control are necessary.
The detection of naturally occurring F7 mRNA transcripts in Hep3B cell
lysate(1:1 diluted and undiluted) is possible. Signal amplitudes from naturally
occurring concentrations are in the range or even above the results from previous
measurements with 500 pM spike-in target.
We can clearly distinguish between positive and negative probe supporting the
statistical correctness of our experiments. This was shown by the non-overlap of
±1 SD areas for the differential signal of analyte and negative control.
The detection of the miRNA miR-122 in HuH7 cell lysate was achieved. ME15
thereby is a feasible negative control. Therefore the CLA platform is a sensitive
and reliable tool for direct miRNA detection in cell lysates.
Due to the complex maturation process of miRNA the ratio between ssRNA
and dsRNA is unknown. Single stranded miRNAs are required for sufficient
hybridization to our direct binding assay. The detection is possible either due to
the competition of the high amount of capture ssDNA on the sensor surface or by
a sufficient amount of naturally occurring ssRNA. Denaturing the samples prior
to the hybridization supports the amount of free ssRNA target strands.
The effect of eventually bound Ago proteins respectively RISC on the target
strands is unknown. Bound proteins could either support the cantilever’s surface
stress development or lower the binding affinity; plus sample denaturation might
unfold bound proteins.
Further advantage of denaturing the samples (5 min up to 80 ◦C) is the inhibition
of RNase activity.
The denaturing process leads to the formation of visible particles due to dena-
tured proteins. During a short spin in a mini spin centrifuge those particles from
partially a pellet. A few particles stay in liquid. Cellular fragments of bigger size
can stick to the CLs and induce a false signal. Large deflections or drop of sum
signal due to scattering the laser light might occur. By flushing the chamber with
high flow speeds (150–250µL/min) and/or urea sticking particles can eventually
be washed away.
By working with diluted cell lysates (1:1 with PBS buffer) the obstruction of CLs
due to denatured protein particles can be minimized.
A partially purified sample by spinning down the denatured proteins is not favored.
The possibility to drag down oligonucleotides during the spinning process exists
and has to be avoided. Therefore we prefer to work with possibly higher protein
contaminated samples but in return for sure not losing any target and to work
with fine suspensions which tend to stick less to the CL than whole protein colloids
which form during centrifugation.
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Repeated Peltier tests to track the functionality of the CLA array are crucial.
Denatured protein in the high dense cell lysates tend to stick to the cantilevers.
By comparing the Peltier tests before and after each injection malfunctioning
cantilevers can be excluded and wrong signal interpretation avoided. Consistent
Peltier tests prove that the mechanical properties of a cantilever array do not
change during multiple injections.
NaOH regeneration is not feasible. Although high signal intensities during
the second injection step were recorded, NaOH regeneration induces drift and
long equilibration times are required. The effect of the strong pH change might
be the source for the observed effects and might have additional impacts such
as degradation on the chip and biolayer. Furthermore SPR experiments support
the vague effects during NaOH regeneration inducing strong drifts and unstable
baseline re-achievements. The regeneration with urea is more controllable.
Compared to the shown SPR experiments with more than 25 hybridiza-
tion/regeneration cycles, the regeneration procedure on the CLA is not fully
satisfying. Two hybridizations on the same chip work fine and data is shown to
prove the consistency of the assay for two full injection cycles with urea regenera-
tion in between.
4.4 Surface analysis and CLA rear-side passiva-
tion6
Some problems were encountered with sample handling due to the delicate nature
of the cantilevers. Those were partially solved by the manufacturing of a sample
holder where the cantilevers were fixed for batch processing and analysis.
In general we did not achieve a successful and complete trial with rear-side
passivated CLAs. There are still some steps in the process which would require
further optimization, and the inclusion of replicates would give a clearer picture of
the results obtained. In general when coating the CLA, the problematic step seems
to be the drying. Changing the functionalization protocol might solve the problem.
Alternative protocols are described in the literature [50, 51]. The functionalization
by a UV-linker might be extremely robust and a well-established technique for
SuSoS, but does not seem to be optimal for our microdevices. Furthermore we
do not require a very enduring coating. The passivation only has to retain for
6Results achieved in collaboration with SuSoS (SuSoS AG, Switzerland) as part of the
purchase order for surface analysis and modification. Text partially free translated from untitled,
unpublished protocol and results of SuSoS, unpublished 2011.
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one experiment, because we are still working with disposable chips. Plus, the
passivation “only” has to retain under physiological conditions.
During a wider coating development process several cantilevers should be
investigated to determine whether the coating process is successful. Results
should show the effect of the coating on the Au and Si sides of the cantilever after
treatment on passivated cantilever devices which are nevertheless promising.
The Si side of the cantilevers should be coated with PVP in order to render the
surface resistant against unspecific binding. The gold surface should be protected,
to provide a clean, reactive gold surface.
In a discussion with the surface specialists from SuSoS the following knowledge
was gained: An EtOH wash step after Plasma or OV/O3 cleaning would be
recommended to either get rid of oxide layers in case of Plasma cleaning or to
get rid of oxidized thiols which did not went in a volatile state during the UV/O3
treatment.
The similarity of pre Au coated arrays and fresh Au coated ones was confirmed
by SuSoS. Both methods are equivalent as long as there is an adhesion layer on
it and the Au is cleaned by UV/O3 or Plasma. To store the chips a pure Ar
atmosphere is not even necessary according to SuSoS.
4.5 Final Conclusion
CLA is a feasible technology for the label-free detection of noncoding RNAs.
Although the quantitative informative value is only possible by references, CLA is
fully capable of a qualitative analysis of biological probes. SPR has its limitations
in sensitivity and dynamic range, but is useful for quantitative comparisons and
establishing the CLA technology.
Assay development in terms of capture probe density for highest signals is different
for CLA and SPR as expected from previous studies from the literature. Besides
sensitivity the way specificity is expressed differs for CLA and SPR. SPR is a
feasible tool to observe kinetics whereas the CLA has its limitations in observing
effects during reaction.
Although the detection of microRNA in several kinds of biological probes is
feasible, experiments are still highly elaborate (especially compared to Biacore
experiments). Rendering the cantilever rear-side against unspecific bindings by a
non-fouling layer might simplify the complex interpretation of cantilever deflection
sources. An advanced CLA chip handling and improved microfluidics will help to
overcome the steps towards commercial application. Pre-gold coated arrays and
improved device control, measurement and data analysis were steps in the right
direction towards industrial application.
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In terms of biology, ncRNAs are highly interesting biomarkers and a promising
therapeutic approach. Although miRNAs are present as double strand in many of
the maturation steps, the detection of mature miRNA is possible by direct binding
assays of single strands. Thermal denaturing improves subsequent hybridization.
The author recommends the CLA technology as described for the detection of
ncRNAs.
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Outlook
5.1 Pharmaceutical Industry
Biomarker detection and system biology belong to the main pillars of innovative
pharma research. Biomarkers are the key tools to characterize mechanisms and
pathways processes. System biology is the understanding of the complexity of
biological processes. New tools for personalized healthcare will be essential and
early predictions are one of the most important factors to keep costs at a minimum.
Personalized healthcare is one of the most important strategies for today’s drug
development.
Where old paradigms in for example cancer therapy focused on toxicity, non-
selectivity and chemotherapy drugs, there have been fundamental changes in the
field of oncology during the past two decades. One important change has been the
increased focus on understanding tumors at the molecular level, which has major
implications for both diagnostics and therapeutics. It has been known for quite
some time that cancer is not a single disease; rather, it is a family of diseases,
many of which are mortal. As technology advances, so does our understanding of
the true diversity of cancer. Years ago, cancer was diagnosed and treated primarily
based on where the physician found it. This approach was not particularly suc-
cessful. Our appreciation of the true diversity of cancer has, over time, extended
to the microscopic level, to the molecular level, and, most recently, to the genetic
level. Collectively, appreciation for the true diversity of cancer is producing a shift
from the old paradigm of toxic, non-selective cytotoxic drugs selected primarily on
the anatomic site of the tumor, to a new paradigm of truly integrated diagnostics
and targeted therapeutics, where selection of particular therapies is based on the
molecular and genetic characteristics of the tumor [CRED, F. Hoffmann-La Roche
Ltd].
In pharmaceutical industry a whole new world opened with the discovery of
the RNA interference effect by siRNAs. siRNA has the therapeutic potential as a
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new potent and selective drug class. siRNAs directly act on the origin of many
biological mechanisms solving a miss functions on a molecular level leading to
what we recognize as diseases (as illustrated in Fig. 5.1).
 
Background image “cell”:  
Hanahan and Weinberg, The Hallmarks of Cancer, Cell (2000) 100, 57-70
Small 
Molecules  
Monoclonal  
Antibodies 
(a) Antibodies and small molecules limited to
“druggable” targets.
 
Background image “cell”:  
Hanahan and Weinberg, The Hallmarks of Cancer, Cell (2000) 100, 57-70
siRNA  
(b) Potential use of the RNAi platform.
Figure 5.1: (a) Current approaches for cancer treatment by monoclonal anti-
bodies and small molecules. “Druggable” targets are highly limited. (b) Possible
approaches for cancer treatment by RNAi. Almost any cellular process could be
regulated. The most suitable targets could be picked. [free translated from Dr.
Alfred Mertens, siRNA Therapeutics: reality or dream (oral presentation), 2009]
Other drug classes are Small Molecules such as chemical compounds for treat-
ment and therapeutic proteins including proteins such as antibodies and other
biological compounds for treatment.
5.1.1 The siRNA Problematic
2010, F. Hoffmann-La Roche Ltd. discontinued their whole siRNA research section.
The main hurdle to overcome is the delivery which could not be satisfyingly solved
until today (see Sect. 1.5).
Nevertheless we have to keep in mind that we are still in a very young and early
stage of research. If we compare where we stand with RNAi compared to today’s
high-end drugs such as Monoclonal Antibody (Mab) as shown in Fig. 5.2, there is
still time for further research and a final product is not be expected in the next
few years.
siRNA and miRNA do have for sure a huge potential for pharmaceutical
industry and both would perfectly fit in the tendency towards personalized health-
care and could solve many assignments. Either for the detection as biomarkers
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Figure 5.2: Discovery time-line of Mabs and RNAi: The figure shows the
time-line between production of first monoclonal antibodies and their successful
application in the drug market. In comparison an analogue time-line for RNAi is
shown. It is clearly visible that RNAi research is still in its early decade and time
is needed for further R&D before successful products will enter the market.
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in diagnostics or in clinical and non-clinical studies during RNAi based drug
development a high need exists for the detection of ncRNAs.
5.2 CLA Instrumentation
An advanced CLA chip handling and improved microfluidics will improve the
CLA instrument towards industrial application.
Although the required sample volume of 600µl for the actual protocol can be
drastically reduced and sample dilution is possible as shown in the experiment
detecting miRNA in rat plasma (Sect. 3.4.7) the volume is too high for a com-
mercial biological application. Figure 5.3 shows a possible microfluidic injection
method for small probe volumes.
        
 
 
 
 
Flow chamber
Septum
Probe injection
by syringe or pipette
Injection chamber
with applied 
overpressure
Inlet for buffer Outlet
Probe
CLA
Figure 5.3: Schematic drawing of possible miniaturized sample handling: A
direct injection of probe into the chamber would drastically reduce the amount of
sample needed. Furthermore adsorption onto the tubing walls would completely
be avoided.
A bandpass filter (635 nm) in front of the PSD suppresses ambient light and
might enable measurements with an open box.
Implementing a beam splitter in the optical path between chamber and PSD
would enable a constant observation with the camera. The actual mirror with tilt
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function could be kept fix leading to an additional improvement to the instrument.
The distance between CLA and PSD would be more defined and drift by slight
mirror movements avoided. Furthermore the camera position could be chosen
more flexible.
In case we have to measure much smaller signals (PSD voltages), respectively
voltages, we could implement a lock-in amplifier (e. g. HF2LI, Zurich Instruments,
Switzerland). With an implemented lock-in the laser-light would be modulated and
we would be able to measure a very precise readout even with the PSD exposed to
ambient light (e. g. with open box). This was never realized because measured volt-
ages were in an detectable range and readout with an open box was never required.
In the introduction we claimed the CLA static mode technique to be mass
independent. This relatively unique property of the nanomechanical sensor plays
a fundamental role for the specific detection of target strands as explained in this
thesis. The following experiment could be set up for further evidence: The pure
oligo with target sequence could be compared to longer oligos with the target
sequence at the 5’ end plus a scrambled tail. On Biacore this should lead to an
increased response for longer oligos because more mass binds to the surface. On
the CLA we would only expect a slight signal increase due to steric hindrance.
Furthermore, investigations into the effect of matching sequence location on longer
target strands could be carried out. The effect of binding a target sequence
somewhere in the middle of a long oligo compared to a matching sequence at the
5’ or 3’ end is an open question and not of importance for short ncRNA detection
but might be interesting for genomic applications.
5.3 Biological Application
The undiluted cell lysate probes do not contain any PBS buffer or only a few micro
liters. By adding Mg2+ to the cell lysate probes we might be able to improve the
hybridization efficiency.
In case a negative control sample is missing, the positive sample could be
taken and an excess of sense match added. This would block all target strands
and only a few ones could bind to the assay due to competition.
To avoid dragging down the DNA/RNA during centrifugation, we could in-
crease the salt concentration which favors the DNA/RNA to stay in solution.
Protease could help to homogenize the cell lysate samples, which might reduce
the viscosity and particles.
As ultimate assay the DNA/RNA detection could be combined with protein de-
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Name (Ref. [43]) rno-miR-16 MIMAT0000785
Sequence UAG CAG CAC GUA AAU AUU GGC G
Reverse complement 5’ → 3’ CGC CAA TAT TTA CGT GCT GCT A
Name (Ref. [43]) rno-miR-192 MIMAT0000867
Sequence CUG ACC UAU GAA UUG ACA GCC
Reverse complement 5’ → 3’ GGC TGT CAA TTC ATA GGT CAG
Table 5.1: Table of miRNA sequences for further experiments.
tection on CLA. Few of the cantilevers could be used for the detection on genomic
level and other for the e. g. corresponding proteins. Ideally such detection would
be performed in a combined mode CLA instrument. The dynamic mode provides
an interesting tool for protein research characterizing the intrinsic mechanics of
biological receptors like ligand binding and conformational changes.
5.3.1 microRNA detection in rat plasma
The detection of miRNA biomarkers in plasma is an actual hot topic in pharma-
ceutical industry. Due to the promising results from the miR-122 detection in rat
plasma for liver toxicity screening we will further investigate in that particular
direction. Planned is the detection of miR-192, another Acetaminophen inducible
microRNA and miR-16, a constitutive, not-regulated microRNA present at rela-
tively high levels (see Tab. 5.1). Furthermore the experiments will be repeated to
gain more information about reliability of the CLA assay.
5.4 SPR
In terms of signal response comparison of SPR versus CLA the following question
raised: How many bound molecules (stated as mass/weight) are required to induce
a cantilever deflection? Would this mass be theoretically visible on the Biacore?
The answer to this question would give further clarity to the assays’ efficacies. An
idea would be to determine the actual amount of bound oligos on the CL. This
would be possible by labeled probes or in dynamic mode (if sensitivity of dynamic
mode is high enough). Due to the fact that the readout of labeled probes bound
to a surface is much more difficult (higher error) than in solution, the bound
probes could be stripped (by melting) from the surface and analyzed in solution.
To understand the basics behind the differences between SPR and CLA re-
sults and gain more fundamental information about the CLA response, further
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investigations have to be carried out.
We expect the reason for the different assay properties in a non-linear behav-
ior of the CL response, which has to be proven for example by comparing the
slope of the early non-linear region of binding curves which do not go into satura-
tion. An example for such recorded curves is given in Qavi et al. Fig. 3 a) Ref. [52].
Follow up experiments with concentration series of simple oligo hybridization
on the SPR system led to further discussions and conclusions:
- The more repeated hybridization cycles were performed the more stable
(less drift) the signal gets.
- Saturation was reached at 100 nM injected concentration (150µl, 5µl/min).
Endpoint even though saturation was reached slightly less (∼30 %) than
after injecting a 1’000 nM sample.
- Below 50 nM concentration the significance gets vague (this does not refer
to the experiments with focus on low concentrations where significant values
down to 10 nM were achieved).
- Although the Biacore system is very robust and precise instrument errors
such as liquid handling malfunctions occurred.
- We still observe a refractive index change during the injection of probes
although the running and sample buffer were identical. A percentage of
H2O in the samples from the stock would lead to a negative signal. We
observe a positive signal increase not correlating to the amount (per mill)
of H2O in the samples. A stabilizing agent in the DNA samples could be
the reason and has to be discussed with the supplier (Microsynth).
- The influence of conformational changes of the biolayer during hybridization
is unknown but might be existing. Tendencies towards negative signals
during low concentration injection are an indication. This would lead to a
cancellation of signal due to conformational change and mass adsorption.
Contra this hypothesis is the size and distance of the biolayer. It is less
than 10 nm and very close to the sensor surface and therefore in the strong
regime of the evanescence field. Due to the fact that a surface propagating
wave only has a TM mode only an influence on the polarisability of the TM
mode would lead to a strong influence.
- The influence of bi-valent ions (magnesium and calcium) on the surface
bound molecules is not well understood. They could interfere with the assay
(changes of kinetics, respectively surface properties or act competitive). A
HEPES buffer with NaCl could be an alternative to test the influence of
bi-valent ions. For biological applications bi-valent ions cannot be excluded
because most natural probes (cell lysates, serum) contain calcium.
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Appendix: Material, Methods
and Instrumentation
A.1 Assay development
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neMESYS®  dosing unit 
 
 
High Precision Syringe Pump 
cetoni GmbH 
Am Wiesenring 6 
07554 Korbussen 
Germany 
Phone: +49 36602 338 0 
Fax: +49 36602 338 11 
Email: info@cetoni.de 
www.cetoni.de 
04.12.2009 
Features 
The dosing module is a pulsation-free dosing unit for high-
precision dosing of fluid streams in the range of microlitres and 
nanolitres. Connect up to 12 of these modules to a BASE-
module. 
 
 
 
 
 
 
 
 
 
 
Dosing Performance 
Gear 1,0 14,1* 23,7 29,2
Pusher Velocity min (nm/s) 383,333 27,259 16,190 13,146
Pusher Velocity max (mm/s) 89,000 6,329 3,759 3,052
Pusher Force max. (N) 40 390 660 815
Syringe 0,5 µl / 60 mm stroke  
Flow Rate min (pl/min) 191,667 13,630 8,095 6,573
Flow Rate max (µl/min) 44,500 3,164 1,879 1,526
Dosing Vol. min (pl) = 1 step 4,100 0,289 0,172 0,140
Syringe 100 µl / 60 mm stroke  
Flow Rate min (nl/min) 38,333 2,726 1,619 1,315
Flow Rate max (ml/min) 8,900 0,633 0,376 0,305
Dosing Vol. min (pl) = 1 step 8,138 0,579 0,344 0,279
Syringe 2,5 ml / 60 mm stroke  
Flow Rate min (µl/min) 0,958 0,068 0,040 0,033
Flow Rate max (ml/min) 222,500 15,822 9,397 7,630
Dosing Vol. min (pl) = 1 step 203,450 14,468 8,593 6,977
Syringe 25 ml / 60 mm stroke  
Flow Rate min (µl/min) 9,583 0,681 0,405 0,329
Flow Rate max (ml/min) 2225,000 158,222 93,973 76,303
Flow Rate min (µl/min) 9,583 0,681 0,405 0,329
*standard configuration 
 
 
 
 
Valve options 
Orifice Working Pressure (max) Materials 
DN 0.60 mm* 3 bar FFPM / EPDM / FPM 
DN 1.35 mm 1 bar FFPM / EPDM / FPM 
*standard configuration 
 
 
 
 
 
Mechanical Drawing 
Mechanical Data 
Weight .......................................................................... 1,3 kg
Dimensions (L x W x H) ..............................310 x 47 x 56 mm
 
 
Electrical Data 
Power Supply Voltage ............................................... 24 VDC
Dosing Unit Current typical at 24 VDC............................0,3 A
Dosing Unit Current peak at 24 VDC ..............................0,6 A
 
 
Environment 
Operating Temperature ....................................... 0°C to 45°C
Storage Temperature........................................ -40°C to 75°C
Operating Humidity ...................... 20% to 80%, non-condens.
Storage Humidity ......................... 20% to 80%, non-condens.
 
 
Interfaces 
CAN.................................................................max. 1 Mbit / s
RS-232 .......................................................max. 115200 bit/s
 
 
Configuration 
Gear ....................................14,1  (optional  1  /  23,7  /  29,2)
Syringes outer diameter........................................ 6 to 30 mm
Syringes stroke............................................................ 62 mm
 
 
Valve 
Body material................................................................ PEEK
Seal material.......................................... FFPM (EPDM, FPM)
Temperature media ............................................. 10 to +40°C
Viscosity ......................................................... max. 20 mm2/s
Internal Volume ...........................................................< 13 µl
Orifice ................................................ DN 0.6 mm or 1,35 mm
Port connection.......................................Flange, UNF 1/4”-28
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A.2.1 LabVIEW connections
Signal
Name
Signal
Type
NI-
Channel
NI-
Connector
Rack
Connector
Rack
Wire
PSD SUM+ AI 0 68 15ab W2 gn
PSD
DIFF+
AI 1 33 17ab W2 bn
Temp.
U-Ref.
AI 2 65 19ab W1 ws
Temp.
Room
AI 3 30 20ab W1 bn
Temp. Box AI 4 28 21ab W1 gn
Temp.
Chamber
AI 5 60 22ab W1 gb
BNC In AI 6 25 - W3 bn
PSD SUM- AI 8 34 16ab W2 gb
PSD DIFF- AI 9 66 18ab W2 ws
PSD GND AI GND - 67 - W2 shield
Temp.
GND
AI GND - 59 - W1 bu
BNC In
GND
AI GND - 27 - W3 ws
Laser Sel.
A0
DI P0.0 52 27/28ab W3 ws
Laser Sel.
A1
DI P0.1 17 29/30ab W3 bn
Laser Sel.
A2
DI P0.2 49 31/32ab W3 gn
Laser
Enable
DI P0.3 47 25/26ab W3 gb
Chamber
Peltier
Enable
DI P0.4 19 23/24ab W4 ws
Laser GND D GND - 15 - W3 ra
Chamber
Peltier
GND
D GND - 18 - W4 bn
Table A.1: CLA instrument’s electronic signal connections.
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Objective Compare the mixing efficiency of shaker MixMate from Eppendorf with the
BioShake iQ from Quantifoil Instruments in 96 and 384 well plates
material MixMate shaker form Eppendorf (mixing radius 1.5 mm)
BioShake iQ from Quantifoil Instruments (mixing radius 1 mm)
Eppendorf 96/500ul deepwell plate Prot LoBind PCR clean, #0030 504.119
Eppendorf 384/200 µl deepwell plate DNA LoBind, #0030 523.130
Costar 384 PS clear plate, flat bottom # 3702
Bromophenol blue solution in 10% glycerol / water.
1 X PBS solution
protocol The different volumes of PBS are first pipetted in the wells, for each volume 5 wells are
used. Then 10 µl of BPB soln are pipetted very carefully in the bottom of the well, so as
the colored layer is well separated from the PBS solution.
The plate is inserted and shacked.
The rating is done visually after the given time.
Experiment on January 05, 2010
B.1 Assay development Chapter B: Appendix: Results
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IQ Instruments BioShake iQ at 1000 rpm
Buffer Dye sol 0.5 1 2 3 4 5 1*
50 10 2 2 2 2 2 2 2
100 10 2 2 2 2 2 2 2
200 10 2 2 2 2 2 2 2
300 10 1 1 2 2 2 2 2
400 10 1 1 1 2 2 2 2
Eppendorf MixMate at 1000 rpm
Buffer Dye sol 0.5 1 2 3 4 5 1*
50 10 2 2 2 2 2 2 2
100 10 2 2 2 2 2 2 2
200 10 2 2 2 2 2 2 2
300 10 2 2 2 2 2 2 2
400 10 2 2 2 2 2 2 2
* at 1400 rpm with new sample
SCORING
0 1 2
not mixed not complete mixed
Dilution (ml) Time (min)
Plate 96 deepwell 500ul Eppendorf, #0030 504.119
Time (min)Dilution (ml)
Chapter B: Appendix: Results B.1 Assay development
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IQ Instruments BioShake iQ at 2000 rpm
Buffer Dye sol 1 2 3 4 5 10 15 16* 20* 21**
20 10 1 2 2 2 2 2 2 2 2 2
40 10 0 0 1 1 1 1 1 2 2 2
60 10 0 0 0 0 1 1 1 2 2 2
80 10 0 0 0 0 0 0 0 1 1 2
Eppendorf MixMate at 2000 rpm
Buffer Dye sol 1 2 3 4 5 10 15 16* 20* 21**
20 10 2 2 2 2 2 2 2 2 2 2
40 10 2 2 2 2 2 2 2 2 2 2
60 10 1 2 2 2 2 2 2 2 2 2
80 10 1 1 1 1 1 2 2 2 2 2
* at 2200 rpm (+ 1 min increments)
** at 2400 rpm (+ 1 min increments)
SCORING
0 1 2
not mixed not complete mixed
Dilution (ml) Time (min)
Plate 384 well flat bottom Costar # 3702
Dilution (ml) Time (min)
B.1 Assay development Chapter B: Appendix: Results
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IQ Instruments BioShake iQ at 2000 rpm
Buffer Dye sol 1 2 3 4 5 10 15 16* 20* 21**
25 10 2 2 2 2 2 2 2 2 2 2
50 10 1 1 1 1 1 1 2 2 2 2
100 10 0 0 0 0 1 1 1 1 1 2
150 10 0 0 0 0 0 1 1 1 1 1
Eppendorf MixMate at 2000 rpm
Buffer Dye sol 1 2 3 4 5 10 15 16* 20* 21**
25 10 2 2 2 2 2 2 2 2 2 2
50 10 2 2 2 2 2 2 2 2 2 2
100 10 1 1 1 1 1 1 2 2 2 2
150 10 0 0 0 0 1 1 1 1 1 2
* at 2200 rpm (+ 1 min increments)
** at 2400 rpm (+ 1 min increments)
SCORING
0 1 2
not mixed not complete mixed
Dilution (ml) Time (min)
Plate 384 deepwell 200ul Eppendorf, #0030 523.130
Dilution (ml) Time (min)
finally managed to complete mix 
at 2600 rpm for 1 min
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200ul
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300ul
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400ul
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100ul
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type and volume of well 
Mixing efficiency of Variomag, Variomag 1536 and MixMate 
BioShake iQ
MixMate
96 deepwell plate 384 deepwell plate 384 square well plate 
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B.2 CLA Instrumentation
B.2.1 Fluidics
Fluid H2O 20
◦C H2O 20 ◦C
Flow rate 0.001 l/min
≡ 1’000µL/min
0.001 l/min
≡ 1’000µL/min
Density 998.206 kg/m3 998.206 kg/m3
Dynamic viscosity 1001.61× 106 kg/ms 1’001.61× 106 kg/ms
Tubing shape circular tube circular tube
Tubing dimensions d: 0.03 in, l: 1 m d: 0.0015 in, l: 1 m
Flow speed 0.04 m/s 0.15 m/s
Reynolds number 28 56
Flow laminar laminar
Tubing roughness 0 mm 0 mm
Tubing friction coeffi-
cient
2.31 1.15
Zeta value 3026.21 3026.21
Pressure loss 20.17 mbar 322.78 mbar
Table B.1: Calculation of pressure loss over tube distance for tubing diameter
of 0.03 in which corresponds to the actual tubing dimension and 0.015 in. A flow
speed of ∼150µL/min has been approved by M. Hegner to be a feasible value for
proper liquid exchange in the chamber.
Halar PEEK Teflon
25 cc
100 in2
· 24h · atm
mil
@ 24 ◦C
14 cc
100 in2
· 24h · atm
mil
@ 24 ◦C
800 cc
100 in2
· 24h · atm
mil
@ 24 ◦C
Table B.2: Gas permeability values for Halar, PEEK and Teflon tubing from
Upchurch Scientific, respectively Ercatech.
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B.2.2 Optical Fibers
Figure B.1: A cross-section of a bad cleavage site with dirt on the core and
some cracks in the cladding. Such a fiber can not be used for proper light guiding.
Damages can be detected by observing the light projection and investigating the
fiber-ends with some optical magnification tools like a binocular.
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27.04.2010 Pigtail laser projection on wall 
Mounted lasers in optical setup to check the array linearity and laser spot quality. 
A  
Date Image Laser Lens I Lens I Orientation Lens II Lens II Orientation 
27.04.2010 IMG_0408.JPG 8x Planoconvex f50 Laser -> |)   
 
B  
Date Image Laser Lens I Lens I Orientation Lens II Lens II Orientation 
27.04.2010 IMG_0409.JPG 8x Bestform f25 MellesGriot Laser -> (|   
 
C  
Date Image Laser Lens I Lens I Orientation Lens II Lens II Orientation 
27.04.2010 IMG_0410.JPG 8x Bestform f25 MellesGriot Laser -> (| Plano-conv. f50 Laser -> |) 
 
D  
Date Image Laser Lens I Lens I Orientation Lens II Lens II Orientation 
27.04.2010 IMG_0411.JPG 8x Bestform f25 MellesGriot Laser -> |) Plano-conv. f50 Laser -> |) 
 
E  
Date Image Laser Lens I Lens I Orientation Lens II Lens II Orientation 
27.04.2010 IMG_0412.JPG FC  Planoconvex f50 Laser -> |)   
 
- No major differences between lenses and setups. (B) leads to best result and will therefore be used 
in the final setup. 
- Laser spot quality is not sufficient for application. Fibers have to be stripped and cleaved newly. 
Chapter B: Appendix: Results B.2 CLA Instrumentation
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B.2.3 Beam waist calculation
The spot size can be calculated theoretically from the beam waist and wavelength
of the laser light as explained in Fig. B.2 and equations B.1, B.2.
𝑧𝑅 
𝑤0 
𝑤𝑧 2𝑤0 
𝑧 
Figure B.2: Schematic drawing of laser light beam shape with w0: beam waist,
wz: spotsize at z.
Beam waist calculation:
w(z) = w0 ×
√
1 +
(
z
zR
)2
(B.1)
zR =
pi × w02
λ
(B.2)
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B.3 Surface Plasmon Resonance Technology
SPR is the gold standard for quantification of surface occupancy by biological
interactions. Goal was to gain an additional knowledge for the CLA technology
as well as referencing the CLA in terms of sensitivity and specificity.
To get an impression how the SPR signal is acquired, we recorded the reflection
versus incidence angle (Fig. B.3) on a very basic and fully accessible experi-
mental device (Francis Mueller, F. Hoffmann-La Roche, Ltd., Switzerland) with
Kretschmann configuration. As sample we had chosen a Au metallic layer (44 nm)
towards ambient air. Starting at a small angle, a slight increase in reflection can
be observed until the critical angle of the total reflection Θcrit is reached. In an
optimal case, where the Au layer has perfect dimensions, the resonance angle
ΘSP can be zero [16]. The reflection increases again after leaving the resonance
conditions at higher angles.
Figure B.3: Recorded signal of reflection versus incidence angle measured with
a basic SPR device on a 44 nm Au metallic layer towards air.
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B.4 Biological Application
B.4.1 NaOH chip regeneration
We observed a very unstable sum and averaged differential signal after inject-
ing NaOH. The strong pH from the NaOH (pH 14) might be too harsh for the
cantilever. Many unknown effects might occur on the chip and biolayer and it
might be possible that the chamber is not fully washed with the chosen settings
or equilibration times were not reached.
NaOH regeneration is not favored which was additionally proven in Biacore exper-
iments (results not shown). Very high fluctuations and suspicious effects (loss of
signal and long equilibration times) were induced. Urea for chip regeneration was
therefore favored although the signals intensities were promisingly high and above
all expectations with NaOH (see Fig. 3.34). A shorter incubation phase plus pro-
longed or repeated wash phase during NaOH regeneration might solve the problem.
B.4.2 Bioanalyzer Data
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Instrument Name: DE24802247 Firmware:
Serial#:
Assay Information:
C.01.069
DE24802247
Instrument Information:
Assay Origin Path: C:\Program Files\Agilent\2100 bioanalyzer\2100
expert\assays\RNA\Eukaryote Total RNA Nano Series II.xsy
Assay Class:
Version:
Assay Comments:
Eukaryote Total RNA Nano
2.6
Total RNA Analysis ng sensitivity (Eukaryote)
 
© Copyright 2003 - 2009 Agilent Technologies, Inc.
Chip Information:
Chip Comments:
Type: G2938B
Chip Lot #:
Reagent Kit Lot #:
1/10 unfragmented
RIN: 8.60
10' fragmented
RIN: 2.40
20' fragmented
RIN: 2.50
35' fragmented
RIN: 2.50
45' fragmented
RIN: 2.60
60' fragmented
RIN: 2.60
2100 Expert (B.02.07.SI532) © Copyright 2003 - 2009 Agilent Technologies, Inc. Printed: 01.09.2010 09:42:04
2100 expert_Eukaryote Total RNA Nano_DE24802247_2010-09-01_09-24-18.xad Page of1 11
Created:
Modified:
01.09.2010 09:24:18
01.09.2010 09:40:03Data Path:
Eukaryote Total RNA Nano
C:\...Eukaryote Total RNA Nano_DE24802247_2010-09-01_09-24-18.xad
Assay Class:
Electrophoresis File Run Summary
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Sample Name Sample
Comment
Statu
s
Result Label Result Color
1/10 unfragmented RIN: 8.60
10' fragmented RIN: 2.40
20' fragmented RIN: 2.50
35' fragmented RIN: 2.50
45' fragmented RIN: 2.60
60' fragmented RIN: 2.60
Sample 7
Sample 8
Sample 9
Sample 10
Sample 11
Sample 12
Chip Lot # Reagent Kit Lot #
Chip Comments :
2100 Expert (B.02.07.SI532) © Copyright 2003 - 2009 Agilent Technologies, Inc. Printed: 01.09.2010 09:42:04
2100 expert_Eukaryote Total RNA Nano_DE24802247_2010-09-01_09-24-18.xad Page of2 11
Created:
Modified:
01.09.2010 09:24:18
01.09.2010 09:40:03Data Path:
Eukaryote Total RNA Nano
C:\...Eukaryote Total RNA Nano_DE24802247_2010-09-01_09-24-18.xad
Assay Class:
Electrophoresis File Run Summary (Chip Summary) 
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General Analysis Settings
Number of Available Sample and Ladder Wells (Max.) : 13
Minimum Visible Range [s] : 17
Maximum Visible Range [s] : 70
Start Analysis Time Range [s] : 19
End Analysis Time Range [s] : 69
Ladder Concentration [ng/µl] : 150
Lower Marker Concentration [ng/µl] : 0
Upper Marker Concentration [ng/µl] : 0
Used Lower Marker for Quantitation
Standard Curve Fit is Logarithmic
Show Data Aligned to Lower Marker
Integrator Settings
Integration Start Time [s] : 19
Integration End Time [s] : 69
Slope Threshold : 0.6
Height Threshold [FU] : 0.5
Area Threshold : 0.2
Width Threshold [s] : 0.5
Baseline Plateau [s] : 6
Filter Settings
Filter Width [s] : 0.5
Polynomial Order : 4
Ladder 
Ladder Peak Size
1 25
2 200
3 500
4 1000
5 2000
6 4000
2100 Expert (B.02.07.SI532) © Copyright 2003 - 2009 Agilent Technologies, Inc. Printed: 01.09.2010 09:42:04
2100 expert_Eukaryote Total RNA Nano_DE24802247_2010-09-01_09-24-18.xad Page of3 11
Created:
Modified:
01.09.2010 09:24:18
01.09.2010 09:40:03Data Path:
Eukaryote Total RNA Nano
C:\...Eukaryote Total RNA Nano_DE24802247_2010-09-01_09-24-18.xad
Assay Class:
Electrophoresis Assay Details
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Fragment table for sample 1  :  1/10 unfragmented
Name Start Size [nt] End Size [nt] Area % of total Area
18S 1'583 2'018 37.0 18.5
28S 3'372 4'247 47.8 24.0
1/10 unfragmented
Overall Results for sample 1  :  1/10 unfragmented
RNA Area: 199.6 
RNA Concentration: 151 ng/µl
rRNA Ratio [28s / 18s]: 1.3 
RNA Integrity Number (RIN): 8.6   (B.02.07) 
Result Flagging Color:
Result Flagging Label: RIN: 8.60 
2100 Expert (B.02.07.SI532) © Copyright 2003 - 2009 Agilent Technologies, Inc. Printed: 01.09.2010 09:42:04
2100 expert_Eukaryote Total RNA Nano_DE24802247_2010-09-01_09-24-18.xad Page of4 11
Created:
Modified:
01.09.2010 09:24:18
01.09.2010 09:40:03Data Path:
Eukaryote Total RNA Nano
C:\...Eukaryote Total RNA Nano_DE24802247_2010-09-01_09-24-18.xad
Assay Class:
Electropherogram Summary
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10' fragmented
Overall Results for sample 2  :  10' fragmented
RNA Area: 360.8 
RNA Concentration: 272 ng/µl
rRNA Ratio [28s / 18s]: 0.0 
RNA Integrity Number (RIN): 2.4   (B.02.07) 
Result Flagging Color:
Result Flagging Label: RIN: 2.40 
2100 Expert (B.02.07.SI532) © Copyright 2003 - 2009 Agilent Technologies, Inc. Printed: 01.09.2010 09:42:04
2100 expert_Eukaryote Total RNA Nano_DE24802247_2010-09-01_09-24-18.xad Page of5 11
Created:
Modified:
01.09.2010 09:24:18
01.09.2010 09:40:03Data Path:
Eukaryote Total RNA Nano
C:\...Eukaryote Total RNA Nano_DE24802247_2010-09-01_09-24-18.xad
Assay Class:
Electropherogram Summary Continued ...
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20' fragmented
Overall Results for sample 3  :  20' fragmented
RNA Area: 344.9 
RNA Concentration: 260 ng/µl
rRNA Ratio [28s / 18s]: 0.0 
RNA Integrity Number (RIN): 2.5   (B.02.07) 
Result Flagging Color:
Result Flagging Label: RIN: 2.50 
2100 Expert (B.02.07.SI532) © Copyright 2003 - 2009 Agilent Technologies, Inc. Printed: 01.09.2010 09:42:04
2100 expert_Eukaryote Total RNA Nano_DE24802247_2010-09-01_09-24-18.xad Page of6 11
Created:
Modified:
01.09.2010 09:24:18
01.09.2010 09:40:03Data Path:
Eukaryote Total RNA Nano
C:\...Eukaryote Total RNA Nano_DE24802247_2010-09-01_09-24-18.xad
Assay Class:
Electropherogram Summary Continued ...
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35' fragmented
Overall Results for sample 4  :  35' fragmented
RNA Area: 229.1 
RNA Concentration: 173 ng/µl
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B.4.3 Peltier Test
Data from F7 detection in Hep3B cell lysate
Two Peltier peaks (Fig. B.4) were recorded under similar experimental conditions
(Detection of F7 in Hep3B cell lysate as shown in Fig. 3.34). Peltier test 1 ((a)
and (c), before injection 1) and Peltier test 2 ((b) and (d), before injection 2)
are almost identical proving the consistency of mechanical properties over two
injections with chip regeneration in between. Furthermore the functionality of
single cantilevers can be monitored (example Fig. B.4: malfunction of CL4 in (a)
and (b)).
Data from miR-122 detection in ME15 and HuH7 cell lysate
A series of Peltier peaks were recorded in the experiment of miR-122 detection in
ME15 and HuH7 cell lysate. Results are shown in Fig. B.5. Peltier peak 1, 2 and
3 were recorded before injection 1, before injection 2 and after injection 2. The
loss and regaining of cantilever signals is clearly visible. Therefore Peltier tests
are a necessary tool to keep track of the cantilever functionality.
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Figure B.4: Two sets of sequential Peltier peak tests: Graphs show the cantilever
deflection signal for all 8 CLs induced by a heat pulse. Upper graphs (a) and
(b) belong to the same experiment series and lower graphs (c) and (d) belong to
the same experiment, respectively CLA chip. For each set the Peltier test was
recorded before a first (negative control) and a second (analyte) injection with
regeneration in between. CL4 in (a), (b) is defect visible by the odd deflection
signal during the Peltier test. Otherwise the cantilever characteristics are almost
identical for the initial and follow up test. Furthermore the deflection amplitudes,
respectively the mechanical properties of each array is similar.
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Figure B.5: Series of three Peltier tests performed during one experiment on
the same CLA chip: Tests were recorded before a first (negative control) and
second (analyte) injection with regeneration in between and after the second
injection. Before the two injections ((a) and (b)) the cantilever characteristics
are almost identical. After the second injection (c) at least CL4 and CL6 are
different. Reason could be sticking protein particles on the CLs. In that specific
experiment the odd behaving CLs were excluded for final data processing and
result presentation as shown in Fig. 3.36.
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Glossary
AB Antibody.
AFM Atomic Force Microscope.
Ago Argonaute.
avg Average.
BF Brightfield Microscopy.
BW Bandwidth.
cDNA complementary DNA.
Chap. Chapter.
CL Cantilever.
CLA Cantilever Array.
DF Darkfield Microscopy.
diff Differential - Differential signal, respectively
probe CL minus reference CL.
DNA Deoxyribonucleic acid.
dsRNA double strand RNA.
DTT Dithiothreitol.
ELISA Enzyme-Linked Immunosorbent Assay.
ESD Electrostatic Sensitive Device.
Fig. Figure.
HCV Hepatitis C.
LabVIEW Laboratory Virtual Instrumentation Engineer-
ing Workbench; a platform and development
environment for visual programming language
from National Instruments.
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Glossary Glossary
Lit. Literature.
Mab Monoclonal Antibody.
MCU 11-Mercapto-1-undecanol.
miRNA micro RNA.
mRNA messenger RNA.
ncRNA noncoding RNA.
NI National Instruments.
nt Nucleotide.
NTC Negative Temperature Coefficient Thermistors.
PBS Phosphate Buffered Saline.
PBS (+) Phosphate Buffered Saline with Calcium and
Magnesium.
PCR Polymerase Chain Reaction.
PEG Polyethylene glycol.
PMT Photomultiplier.
PSD Position Sensitive Detector.
PVP Polyvinylpyrrolidone.
QCM Quartz Crystal Microbalance.
qPCR Real Time Quantitative Polymerase Chain Re-
action.
R&D Research & Development.
ref Reference - Reference Cantilever.
Ref. Reference.
RISC RNA-Induced Silencing Complex.
RNA Ribonucleic acid.
RNAi RNA interference.
rRNA ribosomal RNA.
RTq-PCR or qPCR Real Time Quantitative Polymerase Chain Re-
action.
RU “Response Units”.
SAM Self-Assembled Monolayer.
SD Standard Deviation.
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Glossary Glossary
Sect. Section.
SEM Scanning Electron Microscope.
siRNA small interfering RNA.
snoRNA small nucleolar RNA.
snRNA small nuclear RNA.
SPR Surface Plasmon Resonance.
SSC Saline-Sodium Citrate.
ssDNA single strand DNA.
ssRNA single strand RNA.
Tab. Table.
totRNA total RNA.
tRNA transfer RNA.
VCSEL Vertical Cavity Surface Emitting Laser.
VI Virtual Instrument - A LabVIEW program.
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